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ABSTRACT 
The ETS family of transcription factors bind to site-specific DNA via DNA-binding 
domains called the ETS domains. The ETS domains are structurally homologous but divergent in 
primary sequences. PU.1 is an essential transcription factor and its biological activity is primarily 
controlled by up- and down-regulation of its expression. Aside from down-regulated expression, 
only a few inhibitory mechanisms are known for PU.1. The most understood one involves PU.1 
forming a heterodimer with other protein partners, such as GATA-1. However, unlike auto-
inhibited ETS-family members whose activity is regulated by autoinhibitory elements that 
reduce the net affinity of binding to specific DNA, PU.1 has no such regulatory mechanism at 
the protein-DNA level. We report here that PU.1, unlike its auto-inhibited paralog Ets-1, forms a 
2:1 complex with site-specific DNA (>10 bp) in a negatively cooperative manner. We also 
detected potential interface (193DKDK196) of the PU.1 dimer by using heteronuclear single 
quantum correlation (HSQC) NMR. Self-titration of PU.1 is a negative feedback mechanism at 
the protein-DNA level. Following these findings, our group found the presence of the IDRs 
flanking the ETS domain does not change the DNA binding modes of the PU.1 ETS domain, yet 
the PEST domain modifies DNA recognition by the ETS domain through changing DNA 
binding affinities. We successfully assigned ~90% or more backbone amide resonances in the 
1H-15N HSQC spectra of hPU.1 constructs with and without IDRs, in the absence and presence 
(1:1 complex) of DNA. Using the fully assigned HSQC spectra, we studied fast (ps to ns) time 
scale internal dynamics of PU.1 protein. Spin relaxation rates and heteronuclear 1H{15N}-NOE 
were acquired for the hPU.1 proteins with and without DNA by NMR. We demonstrated that the 
PEST domain remains disordered but becomes more dynamic upon specific DNA binding. In 
terms of DNA recognition, the presence of the PEST domain increases the affinity of 1:1 
complex of the ETS domain with cognate DNA, without perturbing the structure or changing the 
fast time scale backbone motions of the ETS domain. 
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1 INTRODUCTION  
1.1 Eukaryotic gene transcription overview 
RNA polymerase needs to bind to a promoter sequence, and transcription factors need to 
bind to enhancer sequences for the initiation of transcription on an opened chromatin template 
(1). Transcription factors are the proteins necessary for the initiation of transcription but not a 
part of RNA polymerase. Many roles of transcription factors are known: recognition of (i) cis-
acting elements of DNA, (ii) other transcription factors, and (iii) RNA polymerase, by forming 
an initiation complex (1). The mechanism of transcription in eukaryotes is quite different from 
that in prokaryotes. Prokaryotic transcription occurs on a DNA template, while eukaryotic 
transcription occurs on a chromatin template (1). Prokaryotic RNA polymerase reads DNA 
sequences and binds to promoters, but eukaryotic RNA polymerase cannot do the same (1). This 
is the reason why many eukaryotic transcription factors need to bind to cis-acting sites before 
RNA polymerase binds to DNA. These transcription factors are called basal transcription factors 
and form a DNA complex, to which RNA polymerase binds to initiate transcription (1). 
Only a single RNA polymerase is known for prokaryotes, but three types of RNA 
polymerase occur in eukaryotes: (i) RNA polymerase I that transcribes 18S/28S rRNA, (ii) RNA 
polymerase II that transcribes mRNA and a few small RNAs, and (iii) RNA polymerase III that 
transcribes tRNA, 5S ribosomal RNA, and some small RNAs (1). Basal transcription factors 
form a complex with DNA at promoters for all three types of RNA polymerase. The structure of 
the transcription factor/DNA complexes for RNA polymerase I and III is simple, but the one for 
RNA polymerase II is huge (1). The structure formed by basal transcription factors and RNA 
polymerase are called basal transcription apparatus (1). The promoters typically lie upstream of 
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the start point for RNA polymerases I and II, while they are located downstream of the start point 
for most of RNA polymerase III (1). 
RNA polymerases and thousands of proteins, including basal and general transcription 
factors (TFs), are responsible for gene activation and repression (1). Transcription reactions 
proceed through three stages: initiation, elongation, and termination. Binding of TFIID to the 
TATA box or Inr is the first step in initiation (Fig. 1.1). Other TFs subsequently bind to the 
initiation complex in a defined order. When RNA polymerase II binds to the complex, it initiates 
transcription. Binding of TFIIE and TFIIH enables to melt DNA and allow polymerase 
movement. Initiation is followed by promoter clearance and elongation, which requires 
phosphorylation of the carboxy-terminal domain (CTD). During termination, synthesized mRNA 
is released, and RNA polymerase II dissociates from the template DNA. 
1.2 Interactions that contribute to DNA recognition by transcription factors 
Proteins use similar strategies to recognize nucleic acids (2). The general principles to 
recognize cognate sites by transcription factors are the same: it is based on the sequence and 
structure (2). One of the forces that are involved in noncovalent protein-nucleic acid complex 
formation and contribute most is electrostatic one (2). Nucleic acids are polyanions, and DNA 
binding domains of transcription factors are typically positively charged due to an abundance of 
lysine and arginine residues in them (2). Many other weak forces for interactions are also 
involved in the protein-nucleic acid complex formation, such as hydrophobic and polar ones 
(direct and water-mediated hydrogen bonds) (3). Therefore, the sum of weak interactions drives 
complex formation (3). 
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1.3 helix-turn-helix and winged helix-turn-helix transcription factors 
The helix-turn-helix (HTH) is a common motif for DNA recognition in prokaryotes and 
bacteriophage (2). DNA binding proteins such as bacteriophage λ-repressor and bacterial Trp 
repressor were the first HTH transcription factors (TFs) that were characterized biologically and 
structurally in prokaryotes and bacteriophage (2). Interestingly, HTH TFs in prokaryotes and 
bacteriophage are homodimers in general, while eukaryotic HTH TFs are monomeric (2). HTH 
motif is typically comprised of three core helices that form a right-handed bundle with a tight 
turn between helix #2 and #3 (so-called H2 and H3) (Fig. 1.2 A). A hydrophobic core at the 
interface of the three helices stabilizes the overall structure as well as serves to present the DNA 
recognition helix (helix #3; H3). Upon specific DNA binding, the DNA recognition helix is 
inserted into the DNA major groove, where the H3 sidechains specifically contact both 
nucleotide bases and sugar-phosphate backbone. Helix #1 (so-called H1) and the turn between 
H2 and H3 also contact DNA. A variety of orientations of H3 with the DNA major groove are 
known among HTH TFs, thereby different regions of the DNA recognition helix serve for 
specific DNA binding (2). 
Winged helix-turn-helix (wHTH) motif is a variant of the HTH motif and belongs to 
Winged helix DNA-binding domain superfamily (EBI entry: IPR036390) (2). The wHTH 
motif/domain contains one or two wings (W1-2), three α-helices (H1-3), and three β-sheets (S1-
3). A typical wHTH domain consists of the three helices bundled from the HTH motif and an 
additional antiparallel β-sheet located adjacent to the HTH motif and over the DNA minor 
groove (Fig. 1.2 B). This β-sheet makes an additional DNA backbone contact. Many proteins in 
this superfamily contain a second wing which is comprised of the turn between H2 and H3 or 
resides by N- or C-terminal extensions to the wHTH domain (2). 
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The prototypical wHTH motif is seen in HNF-3 protein (2). The structure of 1:1 bound 
HNF-3γ/DNA complex shows that α-helix #3 (H3) fits well into the major groove of B-form 
DNA, which mediates sequence-specific DNA contacts, and that two wings (the loop between 
S1 and S2; the loop after S3 to the C-terminus) mediates DNA backbone contacts to the flanking 
minor grooves (2). 
1.4 ETS Transcription factors 
1.4.1 ETS Transcription factors overview 
The ETS (E twenty-six) family of transcription factors were originally identified as Ets 
and Myb genes transduced by E26 virus (4). They are found from sponges to humans (i.e., 
throughout Metazoa), and 28 human genes are known (5). All family members bind to site-
specific DNA via structurally conserved DNA-binding domain called “ETS domain” that 
consists of ~85 amino acids and exhibits the winged helix-turn-helix (wHTH) motif. ETS TFs 
bind to specific purine-rich DNA sequences with a consensus sequence (core motif: 5’-
GGA(A/T)-3’) for ETS proteins (6). And further specificities for each family member are given 
by the flanking sequences of the 5’-GGA(A/T)-3’ core. The ETS domains are structurally similar 
to each other, but their primary sequences are highly different from one another. 
1.4.2 Combinational regulation of ETS Transcription factors 
ETS proteins form heterodimers with other transcriptional regulators either through the 
ETS domain or through regions outside the ETS domain. The dimer formation reinforces site-
specific binding to DNA due to so-called combinational regulation (cf. Chapter 1.8.1 for details).  
The ETS family members SAP-1 and Elk-1 cooperatively bind to the c-fos promoter with 
the MADS-box serum response factor (SRF) (7). Both SAP-1 and Elk-1 have a sequence of 20 
amino acids called B-box, which is required for interaction with SRF (7). The cooperativity of 
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SAP and Elk-1 requires an interaction between the B-box and the DNA binding domain of SRF 
(7). Direct interactions of the SAP/Elk-1 DNA binding domain with the SRF are also required 
for DNA recognition by the complex (7). SAP-1 binds to c-fos sites efficiently in the absence of 
SRF, whereas Elk-1 does not. Then, SRF is thought to modify the DNA binding properties of 
Elf-1. The structure of the ternary SAP-1/SRF/DNA complex was solved (PDB 1HBX; Fig. 1.3 
A) (8). A direct interaction between the DNA recognition helices of SRF and SAP-1 is visible in 
this structure. Tyr65 that is conserved in almost all the ETS family plays a key role in mediating 
the extensive interaction (8). SRF reorients the Tyr65 residue of SAP-1 for optimal DNA contacts 
to the GGAA core sequence. Structural comparison of the SAP-1/SRF/DNA complex with site-
specific 1:1 Elk-1/DNA complex revealed that the conserved Tyr residue is oriented to prevent 
interactions with the GGAA consensus sequence. This explains why nascent Elk-1 cannot bind 
to c-fos promoter sites in the absence of SRF (9). Modeling studies of Elk-1/SRF complex with a 
c-fos promoter site further suggested that the conserved Tyr residue in Elk-1 is reoriented to 
make similar interactions with SAP-1: namely, interactions between Elk-1 and SRF, unless 
otherwise it is a low-affinity DNA site for Elk-1 (10). 
Another example of combinational regulation in the ETS family is the ternary Ets-
1/Pax5/DNA complex (PDB 1K78; Fig. 1.3 B) (11). The affinity of Ets-1 for the mb-1 promoter 
is low in the absence of Pax5, and Pax5 selectively recruits Ets-1 to the promoter. The structure 
of the Ets-1/Pax5/DNA complex has been compared with that of site-specific 1:1 Ets-1/DNA 
complex. Then, the side-chain interactions at the Ets-1/Pax5 interface have been found to 
reorient a conserved Tyr residue (Tyr395) in the DNA recognition helix for optimal DNA 
contacts. Taken together, a conserved feature of such ternary complexes in the ETS family is the 
reorientation of residue(s) in the DNA binding domain for optimal DNA contacts. 
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1.5 Biological roles of ETS Transcription factors 
1.5.1 Overview of biological roles of ETS proteins 
ETS proteins transcriptionally regulate many viral and cellular genes (12). ETS TFs 
control gene expression which is important for biological processes such as cellular proliferation 
and differentiation, cell cycle regulation, cell signaling, hematopoiesis, apoptosis, and metastasis 
(12). ETS proteins are an important family of transcription factors, thereby aberrant activity of 
ETS TFs has been found to be associated with a lot of diseases. One of those diseases is cancer 
that results from the loss of cellular homeostasis, i.e., the balance between cellular proliferation 
and cell death. And many oncogenes are regulated by ETS target genes (13). Human cancer 
associated with the activity of ETS TFs includes breast cancer, prostate cancer, 
leukemia/lymphoma, and Ewing’s sarcoma, etc. (13). 
1.5.2 Biological roles of PU.1 
The transcription factor PU.1 was discovered by Moreau-Gachelin et al. in 1988 (14). 
They reported it is the product of an upregulated gene in murine erythroleukemia, due to proviral 
integration of the spleen focus forming virus (SFFV) (14). This gene was named SFFV proviral 
integration site 1 (Sfpi1) in mice and SPI1 in humans. Klemsz et al. isolated the cDNA of the 
gene coding for an ETS transcription factor and named it PU box binding-1 (PU.1) (9). 
PU.1 is an essential transcription factor, and its main biological role is the development 
of hematopoietic stem cells (HSCs) in the immune system (15). PU.1 is a central transcriptional 
regulator of HSCs differentiation into lymphocytes and myelocytes, B and T cell development, 
and HSCs maintenance (16). This function spans from early to late stages of progression in a 
lineage- and cell type-specific manner; thus, it controls proliferation, terminal differentiation, and 
maintenance of HSCs (17). Therefore, PU.1 is a key transcriptional regulator within the 
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hematopoietic system and plays critical roles in both the innate and adaptive immune systems by 
controlling cell differentiation. 
Many target genes of PU.1 have been described since its discovery. Turkistany et al. 
studied the identity of target genes from the published literature (18). Because PU.1’s primary 
role is transcriptional activation, they sorted PU.1 target genes into four criteria. (i) The genes are 
activated by PU.1 as seen by the changes in mRNA levels in response to PU.1 expression. (ii) 
The genes have at least one PU.1 binding site that contains the consensus sequence 5’-GGAA-3’ 
(with the exception of 5’-AGAA-3’). (iii) Transient transfection experiments in vitro and/or 
mutational studies of the predicted binding site(s) can demonstrate that the genes are 
transcriptionally activated by PU.1. (iv) Site-specific PU.1 binding demonstrated by EMSA 
and/or ChIP. Thus, they identified 110 PU.1-activated genes based on these criteria. They also 
found the subcellular location of the 110 target gene products by subsequent bioinformatics 
analysis (18): 22 in the nucleus; 21 in the cytoplasm; 44 in the plasma membrane; and 23 in 
extracellular space. Thus, 61% (67 of 110) of the gene products regulated by PU.1 reside in the 
plasma membrane or are secreted. Therefore, PU.1 plays an important role in regulating cellular 
communication. Several cytoplasmic proteins regulated by PU.1 also mediate intracellular 
signaling downstream of plasma membrane proteins such as BTK. Most PU.1-activated nuclear 
proteins such as GATA-1 and IRF4 are important transcription factors. Thus, PU.1 possibly 
controls downstream gene networks. 
Furthermore, PU.1 activates transcription of genes coding for antibodies, antibody 
receptors, cytokines such as interleukin 3 (IL-3), cytokine receptors, chemokines, chemokine 
receptors, and integrins (18). 
8 
1.5.3 PU.1 protein and diseases 
Deregulation of PU.1 activity has been linked to at least three human diseases: 
rheumatism, Alzheimer’s disease, and hematologic cancers. Thus, PU.1 not only works as an 
indispensable regulator of normal HSCs but also has pathogenic functions in the hematopoietic 
immune system. Genome-wide analysis of epigenomic elements by Dozmorov et al. provided 
statistical evidence for PU.1 as a transcriptional regulator of genes associated with rheumatism 
(19). Gjoneska et al. recently reported the upregulation of PU.1 expression in Alzheimer’s 
disease (20). 
PU.1 is known as a tumor suppressor in myeloid cells. Inactivating mutations of the SPI1 
gene, which codes for PU.1, have been identified in patients of acute myeloid leukemia (AML) 
(21). Also, the expression of PU.1 is often suppressed in AML (22). Recent studies have shown 
that minimal PU.1 expression reduction (35%) is sufficient to induce preleukemic stem cells, 
which leads to transformation to AML (23). The downregulation of PU.1 expression is also 
associated with myeloma and classical Hodgkin disease (24,25). 
1.6 Structures of PU.1 ETS domain 
ETS subfamily belongs to the winged helix-turn-helix (wHTH) superfamily as mentioned 
above. The ETS domain (DNA binding domain) is the only ordered region for PU.1 protein (Fig. 
1.4). Therefore, PU.1 is a Type I transcription factor. Two structures have been determined for 
the PU.1 ETS domain. One is a co-crystal structure of PU.1 ETS domain and 16-bp high-affinity 
DNA (PDB: 1PUE) (26). The other is a solution NMR structure of PU.1 ETS domain and all the 
C-terminal residues, in the absence of DNA (PDB: 5W3G). Interestingly, these structures are 
almost identical to one another (Fig. 1.5, A-C). ETS domains in their family are structurally 
similar to each other, although their primary sequences are mutually far different. For example, 
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the tertiary structure of the ETS domain of Ets-1 (PDB: 1K79) is superimposable with that of 
PU.1 (Fig. 1.5 D). However, Ets-1 and PU.1 belong to individual family members which are 
physiologically quite far from each other (27). 
As mentioned above, Kodandapani et al. solved a co-crystal structure of murine PU.1 
ETS domain (171-258 a.a.) and 16-bp DNA (5’-AAAAAGGGGAAGTGGG-3’) at 2.3 Å 
resolution (PDB: 1PUE) (26). The PU.1 ETS domain has a globular structure (33 × 34 × 38 Å3) 
that consists of three α-helices (H1, H2, and H3) and four antiparallel β-sheets (S1, S2, S3, and 
S4). The structure is typical of a winged helix-turn-helix (HTH) family, consisting of H2-loop-
H3 as HTH and another loop between S3 and S4 as a wing. Thus, the ETS domain of PU.1 and 
other family members have a loop-helix-loop motif. 
The DNA-binding site of the ETS domains has four strictly conserved residues: K219, 
R232, R235, and K245 in murine PU.1. R232 and R235 in H3 directly contact the bases of 
GGAA (the consensus sequence of the ETS family) in the major groove. These arginine residues 
also make water-mediated contacts with the bases of the GGAA core. K245 contacts phosphate 
backbone of the GGAA strand in the minor groove, and K219 contacts phosphate backbone of 
the other strand. It is notable that R81 and R84 of Fli-1, which correspond to R232 and R235 of 
PU.1, respectively, do not contact DNA directly. However, intermolecular NOE has been 
observed between the arginine residues and DNA by NMR (28). 
1.7 Regulation/control of PU. 1 activity in the cell 
1.7.1 Regulatory mechanisms of PU.1 activity 
The biological activity of PU.1, as an essential transcription factor, is primarily controlled 
by up- and down-regulation of its expression. In addition to downregulation in expression, a few 
other inhibitory mechanisms for PU.1 are known: formation of a heterodimer with other protein 
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partners such as GATA-1 (29). Auto-inhibited ETS-family members are regulated by inhibitory 
helices packing against their DNA-binding domain in the unbound state. However, PU.1 has no 
such regulatory mechanism. 
1.7.2 Roles and functions of autoinhibition for ETS transcription factors 
Autoinhibition is a control mechanism of protein activity, whereby inhibitory module or 
domain of a protein interacts with another part of the protein so that it works for negative 
regulation (30). Many protein regulation mechanisms are known to proceed through 
autoinhibition (30). For example, alternative splicing or proteolysis would remove the 
autoinhibitory module (30). Post-translational modifications (PTM) or protein-protein 
interactions (PPI) in response to cellular signaling would relieve or reinforce autoinhibition and 
enable the protein to control downstream events (31). 
Autoinhibition has been described as a key regulatory mechanism for ETS transcription 
factors at the protein/DNA level (30).  Most of the 28 paralogs of ETS family in humans, except 
a few members including PU.1, have been described to possess autoinhibition (31). They 
typically have a common mechanism in which autoinhibitory elements, typically helices (α- or 
310-helix), adjacent to the ETS domain, make DNA binding unfavorable. Thus, one can 
determine if an ETS protein is autoinhibited or not by detecting reduced affinity for site-specific 
DNA of a full-length protein (or a construct harboring both ETS domain and adjacent 
autoinhibitory elements) by comparison with an isolated ETS domain. 
One way to classify the ETS family members is based on the number of autoinhibitory 
helices on both sides of the ETS domain (31). Ets-1 and Ets-2 have two helices on both sides of 
the ETS domain (N-terminal HI-1 and HI-2; C-terminal H4 and H5). GABPA and ETV6 have 
only C-terminal helices (H4 and H5). ELK4 has only one inhibitory helix (H4) at the C-terminal 
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side of the ETS domain. And several members, including PU.1, FLI1, SPDEF, ELF3, ELF5, 
ELK1, ELK3, and ELK4, have no autoinhibitory helices adjacent to the ETS domain (31). 
Among the ETS family members, Ets-1 has been most characterized about autoinhibition.  
The autoinhibitory module of Ets-1 consists of the four helices (HI-1, HI-2, H4, and H5) and the 
interfaces with H1 of the ETS domain (Fig. 1.6, A and B). Early work on Ets-1 demonstrated that 
HI-1 unfolds upon binding to a specific DNA. Thus, the autoinhibition is thought to give an 
energetic penalty to the protein on DNA binding and to reduce net affinity (32). Recent dynamics 
studies by NMR revealed that both HI-1 and HI-2 unfolds upon binding to both specific and 
nonspecific DNA (33). Structural data of Ets-1 gives an insight that the inhibitory helices of Ets-
1 lie on the distal surface from the DNA binding site. This leads to the understanding that 
binding to DNA and unfolding of autoinhibitory elements are allosterically coupled (34,35). 
In the presence of all the four inhibitory helices, the net affinity of Ets-1 is reduced to a 
half (36). And the presence of an intrinsically disordered serine-rich region (SRR), which is 
located at the N-terminus of HI-1 and transiently interacts with both the ETS domain and the 
inhibitory module, diminishes binding affinity of Ets-1 up to 20-fold (36). Transient interactions 
with the SRR are enhanced by promoting multisite phosphorylation levels in response to Ca2+ 
signaling. Thus, the autoinhibition of Ets-1 is linked with cellular signaling events mediated by 
Ca2+-dependent kinases such as CaM kinase II (36). Taken together, Ets-1 autoinhibition is 
associated with a conformational equilibrium between transcriptionally inactive and active states. 
Upon specific DNA binding, helices HI-1 and HI-2 unfold, and Ets-1 becomes flexible and in an 
active state. The inactive state of Ets-1 is favored and therefore stabilized by transient 
interactions of the SRR with the ETS domain and the autoinhibitory module (the four inhibitory 
helices). These interactions are dependent on multisite phosphorylation of the SRR. 
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Various other examples of autoinhibition for ETS proteins have been reported. ETV6 has 
two C-terminal helices H4 and H5. H5 sterically blocks the DNA-binding interface of its ETS 
domain, which leads to attenuate DNA binding greatly (37). ETV4 and ETV5 in the PEA3 
subfamily have non-helical autoinhibitory elements (sequences) on both sides of their ETS 
domains (38,39). The cooperative binding of USF-1, a binding partner of ETV4, has been 
reported to enhance the DNA-binding affinity of ETV4 by interacting with the inhibitory 
elements (38). The autoinhibitory element of ELF3 is an ordered coil sequence, immediately C 
terminal to S4 of its ETS domain (31). 
The autoinhibited ETS proteins mentioned above have autoinhibitory element(s) 
appended to both sides of or only C-terminal to the ETS domain, whereas distant sequences from 
the ETS domain autoinhibit two subfamilies (ESE and TCF) of ETS proteins. In the case of ESE 
subfamily, ELF3 (ESE-1) is autoinhibited by the transactivation domain at the center of the 
protein, thereby disruption of the transactivation domain enhances specific DNA binding (40). 
On the other hand, ELF5 (ESE-2) is autoinhibited by the N-terminal sequences of the protein 
(41). In the case of TCF subfamily, the autoinhibition of ELK1, ELK3, and ELK4 involves 
interactions between the B-box, the transactivation domain, and the NET inhibitory domain 
(31,42-44). Intramolecular and intermolecular interactions with the helix-loop-helix Id proteins 
are also part of the autoinhibition of TCF subfamily (45). Moreover, phosphorylation of the 
transactivation domain of the TCF subfamily by MAP kinases enhances specific DNA binding 
(46). 
Various autoinhibitory mechanisms have been presented for the ETS TFs. Thus, an 
interesting question worth discussing is whether common features in the autoinhibition occur in 
the ETS family. DNA-binding domains for TFs are in general conformationally dynamic, which 
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is necessary for TFs to search for specific binding sites in a majority of nonspecific DNA, with 
DNA-scanning quenched upon specific DNA binding (47,48). DNA-binding interfaces in the 
ETS domains of Ets-1 and ETV6 are also conformationally dynamic as probed by NMR and 
HDX experiments (33,37), and this feature is likely to be common for ETS domains. 
Furthermore, such flexibility of the DNA-binding site presumably explains why Ets-1 protein 
shares the same binding interface for specific and nonspecific DNA binding (33). Collectively, 
diverse autoinhibitory elements adjacent to the ETS domain presumably reduce these dynamic 
properties of the ETS family, like the autoinhibitory helices of Ets-1 regulate its DNA-scanning 
motions. 
1.8 Protein-protein interactions (PPIs) of ETS domains 
1.8.1 Classification of protein-protein complexes 
Classification of protein association into functionally and structurally related classes is 
important. Both the function and performance of the protein complex need to be considered for 
classification. Nooren and Thornton defined protein complexes as (i) either obligate or non-
obligate and as (ii) either permanent or transient (49). An obligate protein complex is defined as 
one in which each subunit is too unstable to be found in vivo. A non-obligate protein complex is 
defined as one in which each subunit is stable and can be found in vivo. The terms permanent 
and transient classify protein complexes based on their lifetime. A permanent protein complex is 
defined as very stable associations. A transient protein complex is defined as one in which each 
subunit associates and dissociates in vivo. Notably, an obligate protein complex is the only 
permanent one in this definition, while a non-obligate protein complex can be either permanent 
or transient. In the literature, each of the two terms in each group (group (i) and (ii) above) is not 
14 
used to discriminate one from the other (50). They are considered to be interchangeable in 
protein-protein complexes (51). 
While there have been many reports about protein oligomerization, our understanding of 
its supramolecular assembly and function is still limited compared to our knowledge of tertiary 
protein structures (52). One way to characterize the relationship between protein quaternary 
structure and function is to engineer or mutate a protein into a different oligomeric state, as we 
have studied here. Self-association of proteins is a common feature in the cells, and it has been 
estimated that 70-80% of cellular proteins are tetramers composed of four monomers associated 
noncovalently to function as oligomeric proteins (53,54). Various other oligomeric forms of 
proteins occur from a simple dimer to a complex form composed of many subunits, but the 
majority of them are either homo-dimers or homo-tetramers (55). 
Oligomeric proteins consist of either homo- (identical) or hetero- (non-identical) 
subunits. Homo-oligomers associate either in an isologous or heterologous manner (52). An 
isologous association is symmetric and uses the same contact surfaces (residues), while a 
heterologous association is asymmetric and uses non-identical contact surfaces (52). Hetero-
oligomers form only a heterologous assembly by their nature. This classification applies to 
protein oligomers except for some oligomeric interactions such as domain swapping, which is 
discussed below. Oligomeric protein structures are also classified into two groups: an obligate or 
non-obligate interaction (49). Obligate oligomers are usually very stable and exist as oligomers, 
thus their monomeric components are unstable and not found in vivo. On the other hand, non-
obligate oligomers associate and dissociate in vivo. These protein oligomers can be further 
classified. Dynamic oligomeric orders (equilibrium) and transient interactions are produced by 
weak interactions and altered by molecular or physiological triggers. Such an equilibrium in the 
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oligomeric state can be important in protein function. The interfaces of non-obligate oligomers 
are typically smaller and less hydrophobic than those of obligate oligomers, probably to meet 
folding and solubility requirements for monomers in non-obligate oligomers (49). 
1.8.2 Heterodimers of ETS domains and binding partners 
PPIs regulate many eukaryotic transcription factors through their DNA-binding domains 
or additional subunits to function, typically as non-covalent dimers (56). For ETS transcription 
factors, dimers can be formed through ETS domains or other domains such as the PNT domain 
that approximately one-third of ETS family have, for both homodimerization and 
heterodimerization (31). Heterodimerization enables precise control of tissue-specific 
transcriptional regulation for the ETS family (57). Thus far, several structures of heterodimers of 
the ETS domain in (ternary) complex with DNA have been determined: GABPα/β (58), Ets-
1/Pax-5 (11), ELK4 (SAP-1)/SRF (59), and PU.1/IRF4 (60). 
The heterodimeric structure of the ETS domain of the GABPα subunit in a complex with 
GABPβ subunit at 2.15 Å resolution (PDB: 1AWC) was reported in 1998 (58). The total buried 
surface area of the dimerization interface is 1600 Å2, where hydrophobic contacts in the main 
part and some water-mediated hydrogen bonds are observed (58). The ankyrin repeats of GABPβ 
insert into a depression of GABPα formed by H1, H4, H5, and the loop between H3 and S3. 
Even though GABPβ subunit does not have direct DNA contacts, the formation of GABPα/β 
heterodimer increases DNA-binding affinity compared to monomeric GABPα, presumably due 
to indirect GABPβ-DNA interaction mediated by hydrogen bonding from Lys69 of GABPβ to 
Gln321 of GABPα (58). 
Heterodimeric Ets-1/PAX5 complex with the mb-1 promoter DNA (PDB: 1K78) has only 
180 Å2 dimerization interface area because PAX5 binds to its cognate DNA site located on the 
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opposite side from Ets-1 (11). The DNA has variant 5’-GGAG-3’ core. mb-1 promoter has a 
low-affinity sequence for Ets-1. Thus, this interaction is critical for binding. It is because the 
heterodimeric complex forms optimal DNA contacts of the Tyr395 side chain in H3 (DNA-
recognition helix) of Ets-1 as well as the further formation of van der Waals and salt bridge 
contacts (11). This is a good example to illustrate that the DNA-recognition helix H3 plays a key 
role in both protein–DNA and protein-protein interactions. 
The interface of the Ets-1/PAX5 complex is similar to that of ELK4 (SAP1)/SRF 
complex with DNA (PDB: 1K6O (59)). Note that optimal DNA contacts like Ets-1/PAX5 are 
formed once SRF binds to its cognate DNA and ELK4 protein. In the heterodimeric complex of 
ELK4/SRF with DNA, further contacts between ELV4 and DNA are formed by reorientation of 
conserved Tyr and Arg residues of ELK4, after a small hydrophobic pocket in ELK4 H3 
accommodates Leu155 of SRF (59). 
PU.1 forms a heterodimer with the interferon regulatory family transcription factor IRF4 
in the presence of immunoglobulin light-chain gene (λB) enhancer DNA (60). Low-affinity 
DNA binding of IRF4 increases co-operativity 20- to 40-fold, presumably because PU.1 forms a 
salt bridge with IRF4 and gains binding energy (60). Thus, in the cases of Ets-1, ELK4, and 
PU.1, dynamic co-operativity upon binding to their heterodimeric binding partners in the 
presence of DNA are observed either by optimizing binding to low-affinity DNA sequences or 
by gaining binding energy. 
A number of other binding partners of PU.1 have been identified for each domain of 
PU.1 (61). Proteins such as TFIID, TBP, GATA-1, and GATA-2 interacts with the 
transactivation domain (N-terminus). PU.1 interacting partner (PIP) and ICSBP are known to 
interact with the central PEST domain, and phosphorylation of Ser148 residue in murine PU.1 
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plays an essential role in this protein-protein interaction (62). Proteins including c-Jun, c-Myb, 
GATA-1, GATA-2, and NF-IL6 interact with the C-terminal ETS domain. 
In the case of binding through the ETS domain of PU.1, a critical PU.1 coactivator c-Jun 
interacts with the ‘wing’ of the winged HTH motif (the S3/S4 region), which is also the binding 
site for GATA TFs (GATA-1 and GATA-2), and therefore they compete to bind. Through these 
events, transactivation of both PU.1 and GATA TFs is repressed (63). Interestingly, a 
structurally homologous ETS family member ERG also binds to the Jun basic domain via its 
ETS domain, but the ‘wing’ is not the dimerization interface, which reflects functional diversity 
of the ETS domain (64). Instead, Arg367 and Tyr371 in H3 of ERG are critical for the interaction 
(64). PU.1 also interacts with NF-IL6 via two regions: the ‘wing’ (the same interface as binding 
to c-Jun and GATA) and the S2-H2-H3 region (65). 
1.8.3 Homodimers of ETS domains in the presence of DNA 
In addition to transcriptionally active 1:1 protein/DNA complex, homodimerization of 
many ETS family members has been reported including Ets-1, Elk-1, ETV1, ETV6, FEV, ERG, 
and PU.1 (66-70). Here, it is noteworthy that all of these ETS domain homodimers are 2:2 
protein/DNA complex except for an example of 2:1 protein/DNA complex of Ets-1 in a non-
reducing environment, where two Cys residues from each subunit are likely to form a disulfide 
bond (71). Among the ETS proteins capable of homo-dimerizing, Ets-1 has been studied most 
extensively. For example, positively co-operative binding of Ets-1 at 2:2 protein/DNA 
stoichiometry is observed at repeated (palindromic) specific DNA sites such as stromelysin-1 
promoter (72). Such a positively cooperative DNA binding of Ets-1 is known to counteract its 
autoinhibition (73). Three homodimeric structures of Ets-1 have been determined by 
crystallization (PDB: 2NNY, 3MFK, and 3RI4) (Fig. 1.7) (72,74,75). 
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Ets-1 has two dimerization interfaces for its homodimerization. For the structures 2NNY 
and 3MFK, the binding mode is head-to-head on palindromic specific sites, with HI-2 and the 
loop between HI-2 and H1 contacting the loop between H2 and H3 reciprocally. For the 
structures 3MFK and 3RI4, the binding mode is also head-to-head on palindromic specific sites, 
with HI-1 reciprocally contacting H4, HI-2, and the loop between HI-1 and HI-2. It is notable 
that 3MFK has two dimerization interfaces. 
In the case of Elk-1 (PDB: 1DUX), the homodimer (2:2 protein/DNA complex) has a 
reciprocal interface involving H1 and the H1/S1 loop of each subunit. The dimerization interface 
of Elk-1 is similar to that of Ets-1, except that Elk-1 does not have autoinhibitory helices 
appended to the ETS domain. In the 2:2 complex structure of Elk-1, the DNA-binding site 
locates on the almost opposite side of the dimerization interface, which is different from Ets-1 
that forms head-to-head 2:2 complex. Furthermore, both ETV1 (PDB: 4AVP) and FEV (PDB: 
2YPR) structures have a dimerization interface at H1, H4, and the S1/S2 loop, involving an 
intermolecular disulfide bond, although their orientations and surface positions are different from 
each other. 
1.8.4 Homodimerization of ETS proteins in the absence of DNA 
The ETS domain of Elk-1 is known to mediate homodimerization of Elk-1, and the 
resulting homodimer is given cytoplasmic stability to resist proteasomal degradation as well as 
localization to the nucleus (68). In the same report, PU.1 in the nucleus forms homodimer(s) in 
the absence of DNA but is monomeric upon binding to high-affinity DNA (68). This report 
suggests the biological relevance of PU.1 homodimerization mediated by the ETS domain and 
also arises a new question of whether PU.1 can dimerize in the presence of DNA. 
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1.8.5 Potential for dimerization of PU.1 at a single cognate site of DNA 
In our previous work, we observed the potential for the ETS domain of PU.1 to dimerize 
at a single specific site by ITC titration experiments in 2012 (76). When a forward titration was 
performed by adding PU.1 protein to site-specific DNA, initially stable titration heats (ΔH°) 
started increasing beyond the 1:1 protein:DNA ratio and returned to baseline after a second 
equivalence point. Thus, two distinct phases (Fα and Fβ) were observed. Next, when a reverse 
titration was performed by adding DNA to PU.1 protein, two distinct transitions of ΔH° were 
observed. Negative ΔΔH° transition (Rα) from the beginning of titration to the first equivalence 
point (1:1 protein:DNA ratio) and positive ΔΔH° transition (Rβ) from the first to the second 
equivalence point were observed. It is noteworthy that the magnitudes and signs of the ΔH° are 
different between the forward and reverse titrations. Collectively, we observed the potential of 
two distinct DNA binding modes (1:1 and 2:1 protein:DNA ratio) for PU.1. Also, the negative to 
positive transition in the reverse titration (Rα and Rβ) implies that a 2:1 (PU.1:DNA) complex is 
formed in a negatively cooperative manner. 
1.8.6 Free energy landscape of PU.1 ETS domain in solution 
The free energy of the four states of PU.1 (i.e., monomeric and dimeric PU.1 in the 
absence or presence of site-specific DNA) were further analyzed under standard state conditions, 
in the same study (76). Among the four states of PU.1, the unbound PU.1 monomer is most 
unstable, and the 1:1 DNA-bound complex is most stable. Furthermore, taking the free energy 
between these two monomeric states into account, the DNA-free dimer is less stable than the 
DNA-bound dimer (i.e., 2:1 PU.1/DNA complex) although the magnitudes of ΔG° between 
DNA-free and -bound dimer significantly depends on the flanking sequences of the core DNA-
binding motif of PU.1 (76). Taken together, the free energy (G°) gradient of the PU.1 ETS 
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domain is as follows: unbound monomer > PU.1 dimer in the absence of DNA > 2:1 DNA-
bound complex > 1:1 DNA-bound complex. 
1.9 Intrinsically disordered regions (IDRs) of ETS domains 
1.9.1 Intrinsically disordered proteins (IDPs) and regions (IDRs) 
A large fraction of any eukaryotic proteomes consists of polypeptides that are unlikely to 
form well-defined, three-dimensional structures (77). Recent studies support that such protein 
segments can be functional even in the absence of stable and globular tertiary structures (78-80); 
these protein segments are referred to as intrinsically disordered regions (IDRs) now. Biased 
amino acid composition and low sequence complexity are characteristic of IDRs. IDRs cannot 
form the hydrophobic core necessary for making up fixed tertiary structures due to low 
proportions of bulky hydrophobic amino acids (81). Proteins that are composed of only 
disordered sequences and thus have no tertiary structures are called intrinsically disordered 
proteins (IDPs) (77). However, the majority of eukaryotic proteins consist of both IDRs and 
structured regions (77). 
1.9.2 Emerging roles of IDRs for transcription factors 
IDRs are known to be functional since the mid-1990s (82), and the reports on IDRs have 
changed the classic paradigm of protein structure-function relationship. IDRs are unable to make 
stable and well-defined tertiary structures. Instead, their disorder is dynamic, and therefore, they 
can rapidly form a range of conformations (81). Thus, IDRs can display various binding affinity 
and kinetics due to their dynamic properties (81). 
TFs have many advantages with the disorder, which facilitate their function and 
regulation, such as conformational plasticity and binding promiscuity (81). TFs with disorder can 
adopt different conformations and interact with multiple binding/interaction partners, which in 
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turn promotes the assembly of macromolecule complexes (81). This explains why eukaryotic 
TFs exhibit a significantly higher degree of disorder than prokaryotic ones (83). 
1.9.3 IDRs of transcription factors and diseases 
IDRs can cause diseases either through dysregulation or aggregation of proteins (84). 
Diseases associated with TFs that contain IDRs include multiple types of cancer (85-87), 
neurodegenerative diseases (88-90), cardiovascular diseases (91), and type 2 diabetes (92). One 
of the ETS family members FLI1 can be a cause of Ewing’s sarcoma by generating an oncogenic 
fusion protein EWS-FLI1 (86). This is an example of cancer that IDRs drive through 
dysregulation (chromosomal translocation in this case). Aberrant oligomers of IDRs can 
assemble into pathological aggregates (amyloids). TFs with IDRs can be dysfunctional as such 
and cause neurodegenerative diseases such as Alzheimer’s disease (93). 
1.9.4 PEST sequences 
A protein region that destabilizes a protein and its half-life by >100-folds was identified 
using computational methods in the 1980s (94). This small region is enriched in Pro (P), Glu (E), 
Ser (S), and Thr (T) and forms a degradation signal, thus it was named the PEST region after the 
four representative amino acids (95,96). PEST region is hydrophilic and consists of at least 12 
amino acids, flanked by positively charged amino acids – Lys, Arg, and His (94). About 10% of 
proteins have such a sequence, and interestingly, proteins with a shorter life span have higher 
populations of PEST sequences. Various regulatory proteins such as p53, Jun, Fos, Myc, and 
protein kinases and phosphatases have PEST sequences (94). Proteins with the PEST sequence 
get degraded by the proteasome, but the mechanism is still not clear yet (94). 
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1.9.5 Difficulties in NMR spectral assignment of IDRs 
While IDPs are hard to study by crystallography because of their inherent structural 
flexibility, NMR is a powerful tool to study protein structure, dynamic properties, interactions, 
and so on. A 2D 1H-15N HSQC spectra can be considered as a protein “fingerprint” since it 
contains well-dispersed peaks of all backbone amide resonances except Pro residues that do not 
appear in 1H-15N HSQC spectra. However, residues in IDRs display severe spectral overlap (97). 
Unfortunately, Pro residues are highly abundant in IDRs, which makes sequential backbone 
assignment of IDPs even more difficult than we analyze ordered proteins (97). 
To overcome such difficulties, measurements at low temperatures and pH are often used 
for the backbone assignment of IDPs (97). Improved instrumental sensitivities have been 
achieved for the following reasons (97). (i) Non-uniform sampling technologies allow for high-
dimensionality experiments. (ii) Faster acquisition of NMR experiments using cryoprobe allows 
longitudinal relaxation experiments and direct detection of heteronuclei (13C). The latter has also 
helped overcome line broadening problems. Signal overlap problems require the future 
development of NMR techniques (97). 
1.9.6 Gaining structures in IDPs 
IDPs are sensitive to chemical environments such as pH, temperature, and ligand binding. 
In a recent study, some IDPs gained more compact structures with higher α-helical content under 
acidic conditions because electrostatic repulsion of negatively charged residues reduced (98). 
Thus, IDPs are suggested to be stabilized by favorable electrostatic interactions. 
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Figure 1.1 Assembly of the preinitiation complex (PIC) in the initiation step of eukaryotic 
transcription. 
 
In eukaryotes, each gene has its own promoter near and upstream of the gene. RNA polymerase 
II binds to a promoter sequence of DNA. For promoters that contain TATA box, TBP (TATA 
box binding protein) binds to the TATA box and initiates transcription complex assembly. 
Activation signals from mediators and coactivators are sent to transcription activators. The 
chromatin remodeling complex and coactivators activate chromatin. Subsequently, PIC is 
assembled by RNA polymerase II, using five general transcription factors (TFIIA, IIB, IIE, IIF, 
and IIH).  
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Figure 1.2 Helix-turn-helix and Winged helix-turn-helix transcription factors. 
 
A, a solution NMR structure of the Trp repressor and DNA complex (PDB: 1RCS). The protein 
subunits are shown in green, with the helix-turn-helix (HTH) domain highlighted in red. B, a 1:1 
complex of HNF-3 (shown in green) and DNA (PDB: 2HDC). The winged-helix-turn-helix 
(wHTH) domain and the second wing are highlighted in red.  
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Figure 1.3 Combinational transcriptional regulatory complexes in the ETS family. 
 
A, a crystal structure of ternary SAP-1/SRF/specific DNA complex (PDB: 1HBX). The ETS 
domain of Sap-1 is shown in green. The MADS-box DNA binding domains of SRF (SRF-d and 
SRF-p) are in blue and magenta. B, a crystal structure of ternary Ets-1/Pax5/specific DNA 
complex (PDB: 1K78). The ETS domain of Ets-1 is shown in green and Pax-5 is in blue. 
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Figure 1.4 Nomenclature and domain organization of hPU.1 protein. 
 
In PU.1 protein, the ETS domain is the only ordered region. hPU.1 protein mainly consists of 
four parts. N-terminal transactivation domain (1-116), PEST domain (117-164), ETS domain 
(165-258), and C-terminal disordered residues (259-270). Therefore, the ETS domain is flanked 
by IDRs. 
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 C                                             D 
      
 
Figure 1.5 PU.1 structures in the presence and absence of DNA, an overlay of PU.1 in 
the presence and absence of DNA, and an overlay of PU.1 and Ets-1. 
 
A, a crystal structure of PU.1/specific DNA complex (PDB: 1PUE). The ETS domain of PU.1 is 
shown in green. B, a solution NMR structure of unbound PU.1 ETS domain (PDB: 5W3G). The 
ETS domain of PU.1 including C-terminal IDR is shown in magenta. C, an overlay of PU.1 in 
the presence (green) and absence (magenta) of cognate DNA. D, an overlay of PU.1 (green) and 
Ets-1 (yellow; PDB: 1K79) in the presence of cognate DNA. 
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Figure 1.6 Autoinhibitory module of Ets-1. 
 
A, The autoinhibitory elements of Ets-1 flank both termini of the ETS domain. B, the auto-
inhibitory module of Ets-1 consists of the four helices (HI-1, HI-2, H4, and H5) and the 
interfaces with H1 of the ETS domain (PDB: 1R36). 
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Figure 1.7 2:2 Ets-1/DNA complex. 
 
A crystal structure of (Ets-1)2/2DNA quaternary complex (PDB: 3RI4), where head-to-head 
binding between ETS domains on palindromic cognate DNA sites are observed. Two ETS 
domains of Ets-1 are shown in cyan and magenta. The helices HI-2, H4, and H5 are involved in 
docking of HI-1 from the other Ets-1 subunit.  
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2 MULTIPLE DNA-BINDING MODES FOR THE ETS FAMILY TRANSCRIPTION 
FACTOR PU.1 
2.1 Preface 
The content in this chapter is based on a peer-reviewed paper: Multiple DNA-binding 
modes for the ETS family transcription factor PU.1. Esaki S, Evich MG, Erlitzki N, Germann 
MW, Poon GMK. Journal of Biological Chemistry. 2017 Sep 29;292(39):16044-16054 (99). I 
prepared the protein and DNA samples in this work. I conducted the SNS-dye binding assays and 
NMR experiments. NMR experiments and analysis were in collaboration with Drs. Markus 
Germann and Marina Evich. This work was supported by National Science Foundation Grant 
MCB 15451600 and National Institutes of Health Grant R21 HL129063. 
2.2 Abstract 
The eponymous DNA-binding domain of ETS (E26 transformation-specific) transcription 
factors binds a single sequence-specific site as a monomer over a single helical turn. Following 
our previous observation by titration calorimetry that the ETS member PU.1 dimerizes 
sequentially at a single sequence-specific DNA-binding site to form a 2:1 complex, we have 
carried out an extensive spectroscopic and biochemical characterization of site-specific PU.1 
ETS complexes. Whereas 10 bp of DNA was sufficient to support PU.1 binding as a monomer, 
additional flanking bases were required to invoke sequential dimerization of the bound protein. 
NMR spectroscopy revealed a marked loss of signal intensity in the 2:1 complex, and mutational 
analysis implicated the distal surface away from the bound DNA as the dimerization interface. 
Hydroxyl radical DNA footprinting indicated that the site-specifically bound PU.1 dimers 
occupied an extended DNA interface downstream from the 5’-GGAA-3’ core consensus relative 
to its 1:1 counterpart, thus explaining the apparent site size requirement for sequential 
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dimerization. The site-specifically bound PU.1 dimer resisted competition from nonspecific 
DNA and showed affinities similar to other functionally significant PU.1 interactions. As 
sequential dimerization did not occur with the ETS domain of Ets-1, a close structural homolog 
of PU.1, 2:1 complex formation may represent an alternative autoinhibitory mechanism in the 
ETS family at the protein-DNA level 
2.3 Introduction 
The differentiation of distinct lineages of blood cells from a single progenitor species 
occurs in a multistep process, termed hematopoiesis, that is intricately controlled at the 
transcriptional level. The ETS family transcription factor PU.1 ranks among the most essential 
hematopoietic regulators in ensuring the continued self-renewal of this progenitor, the 
hematopoietic stem cell (17). PU.1 is also essential for directing correct differentiation of the 
hematopoietic stem cell to various cell lineages. Crucially, PU.1 governs cell fate specification 
and functions in a transient, dosage- and cell stage-dependent manner (100). In mature cells, 
graded PU.1 activity is also required for key cellular processes and the specialization of mature 
cells into function-specific subtypes. Aberrant PU.1 activity is linked to a spectrum of diseases, 
including rheumatism (19), hematologic cancers (24,25,101), and Alzheimer’s disease (102). 
Clearly, knowledge of the regulatory mechanisms of PU.1 is essential to an understanding of its 
role in normal biology and in disease. 
Biological modulation of PU.1 activity is generally attributed to up- or down-regulation 
at the level of expression. With a metabolic half-life of ~50 h, a period that spans the entire cell 
cycle (103), the cellular persistence of PU.1 means that downregulation of its own expression 
cannot alone provide a complete description of PU.1 regulation, as additional dampening 
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mechanisms are required to prevent open-ended escalation of PU.1 activity during its lifetime in 
the cell. 
Outside of down-regulated expression, few inhibitory mechanisms have been described 
for PU.1. The best understood is the mutual antagonism between PU.1 and the zinc finger 
transcription factor GATA-1, wherein each protein inhibits DNA binding by the other during 
myelopoiesis (29). In addition, PU.1 is one of only a few ETS family members that lack so-
called autoinhibition, a regulatory mechanism in which helices adjacent to the ETS DNA-
binding domain allosterically reduce DNA-binding affinity (Fig. 2.1 A) (104). In the case of Ets-
1, the archetypal autoinhibited ETS paralog, interactions with partner proteins, such as Pax5 
(105) and AML1/RUNX1/CBFα2 (73), relieve autoinhibition and restore high-affinity binding. 
Thus, in the absence of lineage-specific inhibitory partners such as GATA-1 or some intrinsic 
regulatory alternative to autoinhibition, PU.1 would be continuously poised in a functionally 
uncontrolled, transcriptionally permissive state. 
In previous work, we have observed in calorimetric titrations the potential for the 
eponymous DNA-binding domain of PU.1 to dimerize at a single cognate DNA-binding site 
(76). Whereas dimerization of ETS domains of other ETS family homologs bound to two sites 
(i.e. 2:2 complexes) has been reported (74,106-109), self-association at a single site is poorly 
understood. We have carried out an extensive series of spectroscopic and biochemical 
experiments to directly characterize the variable binding modes of PU.1 as a function of DNA 
sequence and site size. The results show a site-specific 2:1 complex in exchange between free 
PU.1 on the one hand and the 1:1 site-specifically bound state on the other, while contacting the 
DNA over an extended interface beyond the single helical turn observed in the 1:1 co-crystal 
structure. Sequential dimerization imposes the dual requirements of specific DNA as well as a 
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site size longer than 10 bp. Nonspecific DNA forms oligomeric but not 1:1 complexes at 
equilibrium. Sequential dimerization of site-specifically bound PU.1, which sequesters excess 
circulating PU.1 from accessible DNA target sites, suggests itself as a potential mechanism of 
negative feedback in the absence of inhibitory binding partners.  
2.4 Materials and methods 
2.4.1 Proteins 
Recombinant constructs representing the ETS domain of murine PU.1 (residues 167–272, 
designated PU.1∆N167) and Ets-1 (residues 331–440, designated Ets-1∆N331) were cloned with 
a thrombin-cleavable C-terminal His6 tag as described (110). A similarly tagged construct for 
autoinhibited Ets-1 (residues 280–440, Ets-1∆N280) was a gift from Dr. Lawrence P. McIntosh 
(University of British Columbia). Unlabeled constructs were overexpressed in Escherichia coli 
in LB medium. Uniformly 15N-labeled PU.1∆N167 was expressed from 5-ml starter cultures in 
LB broth grown at 37 °C for ~8 h. All of the culture was inoculated into 250 ml of LB broth, 
grown at 37 °C for ~16 h, and harvested. The cell pellet was resuspended in standard M9 
medium containing 15NH4Cl, MgSO4, CaCl2, trace metals, minimal essential medium vitamins, 
and glucose. Protein expression was induced with 0.5 mM isopropyl 1-thio-β-D-
galactopyranoside overnight at 25 °C. Both unlabeled and isotopically labeled constructs were 
purified as described (111). In brief, cleared lysate was first purified by immobilized metal 
affinity chromatography, cleaved with thrombin, dialyzed against 10 mM NaH2PO4/Na2HPO4 
(pH 7.4) containing 0.5 M NaCl, and polished on Sepharose SP (GE Healthcare). Buffers used 
with Ets-1 constructs, which harbored reduced cysteines, additionally contained 0.5 mM tris(2-
carboxyethyl)phosphine-HCl. Protein concentrations were determined by UV absorption at 280 
nm using the following extinction coefficients (in M-1 cm-1): 22,460 (PU.1∆N167), 32,430 (Ets-
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1∆N331), and 39,880 (Ets-1∆N280). The labeling efficiency of 15N-labeledconstructs was >98%, 
as judged by mass spectrometry (Fig. S1).  
2.4.2 Nucleic acids 
Synthetic DNA oligonucleotides were purchased from Integrated DNA Technologies 
(Coralville, IA) and annealed to form duplex binding sites harboring the high-affinity 5’-
AGCGGAAGTG- 3’, low-affinity 5’-AAAGGAATGG-3’, or nonspecific 5’-AGCGAGAGTG-
3’ DNA sequence (ETS-specific core consensus in boldface type). Fluorescent DNA probes were 
constructed by annealing a Cy3-labeled oligonucleotide with excess unlabeled complementary 
strand as described (112). 
2.4.3 Fluorescence polarization titrations  
ETS protein binding to fluorescently labeled DNA sites was measured using a Molecular 
Devices Paradigm plate reader as described (113). In brief, DNA probe (0.5 nM) was incubated 
to equilibrium with graded concentrations of purified PU.1∆N167 in a total volume of 30 μl of 
10 mM Tris-HCl (pH 7.4) containing 150 mM total Na and 0.1 mg/ml bovine serum albumin. 
Steady-state fluorescence parallel and perpendicular to the incident polarized light was acquired 
at 595/35 nm upon excitation at 535/25 nm. Each data point represents the mean ± S.E. of five 
consecutive measurements as an indication of instrumental noise. Anisotropy data were fitted 
with a 1:1 or sequential binding model (112) to directly estimate the dissociation constants of the 
PU.1/DNA 1:1 and 2:1 complexes. 
2.4.4 Pulsed field gradient diffusion-ordered NMR (DOSY) 
NMR experiments were performed on Bruker Avance 500 and 600 MHz spectrometers, 
equipped with a 5 mm TBI and QXI probe, respectively (Bruker). Purified PU.1ΔN167 (~250 µM) 
and DNA (~600 µM high-affinity, low-affinity and non-specific duplexes) were extensively co-
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dialyzed against 10 mM NaH2PO4/Na2HPO4 (pH 7.4) containing 150 mM NaCl, lyophilized, and 
re-dissolved to their previous volumes with 99.996% D2O. The pH* (meter reading) of the 
reconstituted samples was 7.6. Protein was titrated with DNA to the indicated ratios in the text. In 
the case of low-affinity and nonspecific DNA, turbidity was observed at ratios below DNA:protein 
= 1:3 immediately after titration that resolved overnight at room temperature. A 1D pre-saturation 
(zgpr) spectrum was measured for each titration prior to diffusion measurements. Diffusion 
experiment parameters (Δ, δ and gradient strength) were first optimized by running 1D diffusion 
experiments (stebpgp1sd) at 2 and 95% gradient strengths with 100 ms and 5 ms, Δ and δ diffusion 
times, respectively for ~10% signal retention. Using these parameters, a pseudo-2D DOSY 
experiment using stimulated echo with bipolar gradient pulses (stebpgp1s) was acquired with 16k 
× 20 data points with a spoil gradient of 1.1 ms and 4.0 s relaxation delay from 2 to 95% gradient 
strength with a linear ramp. Data was processed with Bruker Topspin T1/T2 software using manual 
peak picking. Care was taken to avoid NMR peaks that potentially overlap with free DNA at 1:1 
(protein:DNA) and excess DNA titrations. The intensity I of each picked peak was fitted to the 
following equation as a function of field gradient strength g: 
 
2
0( )
DQgI g I e−=                                                           (E1) 
 
where I0 is the reference (unattenuated) intensity, D the diffusion coefficient, and Q is a 
constant consisting of fixed parameters specific to the experimental configuration. 
2.4.5 2D 1H-15N HSQC NMR 
Purified [15N] PU.1∆N167 (~0.5 mM) was extensively dialyzed together with various 
duplex DNA constructs (~2 mM) in separate dialysis tubings against 11 mM 
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NaH2PO4/Na2HPO4, pH 7.6, 167 mM NaCl, and 0.1% NaN3 and adjusted to 10% D2O. DNA 
was titrated into protein to achieve the desired DNA/protein ratios. 1H-15N correlated 
measurements were made using a phase-sensitive, double inept transfer with a GARP decoupling 
sequence, and solvent suppression (hsqcf3gpph19). Spectra were acquired with 1024 × 144 data 
points and zero-filled to 4096 × 4096. 
2.4.6 ANS fluorescence  
ANS (ammonium salt, Alfa Aesar) was prepared at 2 mM in 10 mM NaH2PO4/Na2HPO4 
(pH 7.4) buffer containing 150 mM NaCl and stored in the dark at 4 °C. Triplicate samples of 
PU.1 with or without 16-bp high-affinity DNA plus various controls were prepared in the same 
buffer before the addition of ANS to 200 μM. Final concentrations of PU.1 and DNA were as 
indicated under “Results.” After incubation for 30 min, the fluorescence intensity of each sample 
was read at 370/530 nm or scanned from 400 to 750 nm with a Paradigm plate reader. 
2.4.7 Hydroxyl radical DNA footprinting  
A 130-bp DNA fragment harboring a copy of the high-affinity PU.1-binding site 5’-
AGCGGAAGTG-3’ was generated by PCR using two primers, of which the one encoding the 
5’-CACTTCCGCT-3’ strand had been 5’-end–labeled with [32P]ATP. After purification by 
agarose gel electrophoresis, the radiolabeled fragment (<1 nM) was incubated to equilibrium 
with graded concentrations of PU.1∆N167. Each sample was digested with hydroxyl radical, 
purified, resolved by denaturing polyacrylamide gel electrophoresis, and digitized by 
phosphorimagery as described (114). Lane traces were constructed, and bands were indexed 
using a C ± T chemical sequencing reaction. Peaks were fitted as a superposition of Gaussian 
distributions, numerically integrated, and normalized to a band outside of the binding site to 
quantify fractional protection relative to the unbound sample. 
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2.4.8 Structure-based calculations 
Self-diffusion constants for unbound and 1:1 DNA-bound PU.1∆N167 were computed 
using the software HydroPRO (115). DNA-bound and unbound PU.1 structures were templated 
from the co-crystal structure with DNA (PDB code 1PUE) (26), appended with additional 
residues present in PU.1∆N167, and relaxed by all-atom molecular dynamics simulation for 200 
ns following our established protocol (113). Computations were carried out using volumetric 
values for D2O at 25 °C, namely a density of 1.107 g/ml, viscosity of 1.25 centipoises, and 
partial specific volume of 0.70 ml/g. 
Continuum electrostatics of PU.1 in the co-crystal structure were computed using APBS 
(116). Calculations were performed for an aqueous solution containing 0.15 M NaCl at 25 °C 
and rendered on the solvent-accessible surface from -1 to +1 kT/e. 
2.4.9 ITC 
Purified PU.1 or Ets-1 was dialyzed extensively together with 23-bp DNA harboring the 
protein’s respective optimal target (5’-AGCGGAAGTG-3’ for PU.1; 5’-GCCGGAAGTG-3’ for 
Ets-1) in separate compartments, against 50 mM NaH2PO4/Na2HPO4, pH 7.4, 150 mM total Na+, 
0.1 mM EDTA, and 1 mM dithiothreitol. Titrations were performed by injecting DNA (initial 
concentration ~500 μM) into protein (~50 μM) in a Nano ITC instrument (TA Instruments). Data 
fitting to empirical 1:1 and cooperative models was performed as described (117) only to 
demonstrate the models qualitatively, not for quantitative estimation of the binding affinities, due 
to the very strong dissociation constant of the 1:1 complex (10-9 M). To compare the calorimetric 
enthalpies for DNA binding by PU.1 with those for Ets-1, which exhibited strictly 1:1 behavior, 
the calorimetric enthalpies for PU.1/DNA binding were decomposed as follows to extract the 
enthalpy changes for the 1:1 complex. Whereas PU.1∆N167 dimerizes in both unligated and 
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DNA-bound states, the former occurs at considerably higher concentrations (near 10-3 M) 
(76,118) than those used in the “reverse” DNA-into-protein titrations shown in Fig. 2.1 (A and 
B). Under these conditions, the biphasic profile arises from the 1:1 complex being strongly 
favored and yielding a 2:1 complex only in excess protein at the initial phase (Rα) of the titration 
as shown in Scheme 1, where P and D represent PU.1∆N167 and site-specific DNA in their 
various free and bound states. The two phases Rα and Rβ are marked in the reverse titration 
shown in Fig. 2.1B. Because the transition from the 1:1 to 2:1 PU.1/DNA complex occurs 
sequentially, both phases are well-defined and extracted according to the technique of “total 
association at partial saturation” (119). 
 
To compare the enthalpy changes meaningfully with the manifestly 1:1 binding for Ets-1 
in Fig. 2.1 (C–F), the complex heats in the reverse titrations are dissected to account for the 
thermodynamics of coupled dimerization and dissociation of PU.1 as shown in Scheme 2. The 
calorimetric enthalpy marked Fβ has been measured previously for PU.1∆N167 under the same 
solutions (76). Based on ∆HRβ = -44.2 ± 1.4 kJ/mol (cf. Fig. 2.1B) and ∆HFβ = 17.1 ± 0.7 kJ/mol 
(76) at 25 °C, the enthalpy change for the formation of the canonical 1:1 complex was -27.1 ± 
1.6 kJ/mol. Thus, the enthalpy change for formation of the 1:1 complex from unbound 
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constituents was larger in magnitude than that for minimal (∆H1:1 = -12.0 ± 0.4 kJ/mol) and 
autoinhibited Ets-1 (∆H1:1 = -8.1 ± 0.4 kJ/mol) at 25 °C. 
2.5 Results 
A1:1 protein/DNA site stoichiometry is universally observed in co-crystal structures of 
ETS family transcription factors, including PU.1 (27,30) (Fig. 2.1 A). Nevertheless, calorimetric 
measurements of DNA binding by the PU.1 ETS domain (encoded by the C-terminal fragment, 
PU.1∆N167) showed that PU.1 bound site-specific targets with non-1:1 stoichiometry (76). 
When site-specific DNA was titrated into PU.1∆N167, the protein bound the DNA in a 
negatively cooperative manner (Fig. 2.1, B and C). Dimerization was strictly noncovalent, as 
PU.1∆N167 harbored no cysteine residue. To broaden our observations and determine whether 
2:1 binding was a class property of ETS domains, we measured high-affinity site-specific 
binding by the ETS domain of Ets-1 (encoded by the C-terminal fragment Ets-1∆N331), which 
contained two free cysteines. Although PU.1∆N167 and Ets-1∆N331 represent sequence-
divergent ETS members, their backbones are superimposable in their DNA-bound states (120). 
At comparable concentrations as PU.1∆N167 (~40 μM) and under reducing but otherwise 
identical conditions, Ets-1∆N331 bound site-specific DNA at strictly 1:1 stoichiometry (Fig. 2.1, 
D and E). Moreover, the inclusion of flanking elements known to autoinhibit Ets-1 (Ets-1∆N280) 
did not affect the binding stoichiometry (Fig. 2.1, F and G). Thus, dimerization at a single site 
was not shared by Ets-1 but was particular to PU.1 and possibly other sequence-similar ETS 
homologs. 
Although the ITC titrations could be fitted empirically with model-dependent profiles, the 
high concentrations (>10-5 M) required for the experiments precluded an accurate quantitative 
determination of binding affinities due to the strong dissociation constant of the 1:1 complex (10-
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9 M). We therefore titrated a 20-bp Cy3-labeled duplex oligonucleotide harboring the same high-
affinity site as used in the ITC experiments and measured binding from changes in fluorescence 
polarization of the DNA probe (Fig. 2.2 A). The binding data yielded a biphasic profile to which 
a sequential binding model (111) was fitted with dissociation constants of 7.0 ± 1.3 nM and (1.2 
± 0.8) × 103 nM, or a (negative) cooperativity parameter of ~170. Constraining the model to 1:1 
binding significantly compromised the fit to the data (green curve in Fig. 2.2 A). To determine 
whether a single helical turn of contact interface, as observed in the co-crystal PU.1/DNA 
structure (26), was sufficient to support sequential binding of PU.1, we repeated the titration with 
a DNA construct in which only the core 10 bp of the cognate site (5’-AGCGGAAGTG-3’) was 
duplex. Binding to the 10-bp duplex exhibited monophasic binding that was well-described by a 
1:1 model with a ~2-fold reduction in dissociation constant (12 ± 2 nM). To further determine 
whether the excess binding to the 23-bp construct represented nonspecific interactions, we 
measured PU.1∆N167 binding to an isomer of the 20-bp DNA in which the core 5’-GGAA-3’ 
consensus was mutated to 5’- GAGA-3’. In contrast with the specific site, binding to the 
nonspecific site was >100-fold weaker (2.1 ± 0.2 μM) than either site-specific DNA and yielded 
a Hill coefficient of well above unity, indicative of concerted binding of two or more equivalents 
of PU.1∆N167 (Fig. 2.2 B). The titrations therefore showed that sequential dimerization of the 
PU.1 ETS domain, wherein excess protein self-titrated the canonical 1:1 PU.1/DNA complex to 
form a 2:1 complex, was exclusive to site-specific DNA longer than 10 bp. Although nonspecific 
DNA bound PU.1 in multiple equivalents, it did not form a 1:1 complex at equilibrium (Fig. 2.2 
B). 
To evaluate site-specific PU.1 dimerization in the presence of excess nonspecific DNA, 
as would be encountered under genomic conditions, we titrated a 209-bp fragment harboring a 
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single high-affinity PU.1-binding site with PU.1∆N167. Resolution of the DNA by native gel 
electrophoresis (Fig. 2.2 C) showed a PU.1-bound band that transitioned to a less mobile band at 
~100-fold excess protein with respect to the specific site (1 nM), in agreement with the 
sequential site-specific dimer observed in the fluorescence polarization titrations. The low 
mobility and broadness of the dimer peak suggested that this complex was interconverting 
between free and bound states at rates comparable with electrophoretic separation of the two 
complexes (121). The dimeric peak occurred in advance of a final nonspecific complex that was 
not detected in the gel. The latter state was verified with an isomeric nonspecific DNA fragment 
that failed to yield PU.1∆N167 at any defined stoichiometry (Fig. 2.2 D). Thus, the 
electrophoretic data showed that the sequential dimerization of PU.1 at a single embedded 
cognate site effectively resisted competition from excess nonspecific DNA. 
2.5.1 Hydrodynamic characterization of PU.1/DNA complexes by NMR spectroscopy  
To characterize the solution behavior of the PU.1/DNA complex directly, we interrogated 
PU.1∆N167 with site-specific and nonspecific DNA oligonucleotides hydrodynamically by 
diffusion-ordered NMR spectroscopy (see “Materials and methods”). At 250 μM protein, we 
measured a self-diffusion coefficient of (9.1 ± 0.1) × 10-11 m2/s for unbound PU.1∆N167 (13.0 
kDa) in D2O at 25 °C. Comparison with a computed value (115) under equivalent conditions for 
a PU.1∆N167 monomer derived from the co-crystal structure of the 1:1 PU.1 ETS/DNA 
complex (see “Materials and methods”) found good agreement (8.8 × 10-11 m2/s). An unbound 
PU.1 dimer modeled as a pair of rigid spheres would exhibit a diffusion coefficient at 75% of the 
monomer (122), or ~7 × 10-11 m2/s. Thus, although unbound PU.1 was known to dimerize at very 
high concentrations (76,118) in vitro, PU.1∆N167 was monomeric under the conditions of the 
DOSY experiments. 
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We tracked the self-diffusion coefficients of PU.1∆N167 at graded stoichiometric ratios 
of DNA (Figs. S2.2 and S2.3; parametric values in Table 1). Titration with 16-bp high- or low-
affinity site-specific DNA lowered the apparent diffusion coefficient to a minimum of (5.9 ± 0.1) 
× 10-11 m2/s at, within experimental uncertainty, a DNA/PU.1 ratio of 0.5 (i.e. PU.1/DNA 2:1). 
The subsequent addition of site-specific DNA past this point increased the diffusion coefficient 
to a stable value of (7.5 ± 0.2) × 10-11 m2/s at 1:1 equivalence and beyond (Fig. S2.3 A). This 
biphasic behavior was consistent with the other titration data by ITC, fluorescence polarization, 
and gel mobility shift. This change in DOSY intensity was not due to simple contributions from 
added DNA because we had carefully avoided peaks that overlapped with DNA (Fig. S2.2). The 
measured diffusion coefficient upon reaching molar equivalence also agreed with a computed 
value (115) of 7.3 × 10-11 m2/s based on the 1:1 PU.1/DNA co-crystal structure. Finally, the 
sequential transitions in diffusion coefficients at half and unit molar equivalence were 
incompatible with a 2:2 complex. Thus, the DOSY titrations indicated that PU.1 formed 
exclusively a 2:1 complex with site-specific DNA at PU.1/DNA up to 2:1, followed by a 1:1 
complex at molar equivalence and above. 
In contrast with site-specific DNA, nonspecific binding by PU.1∆N167 showed 
qualitatively different behavior (Fig. S2.3 C). Specifically, titration of PU.1∆N167 with 16-bp 
nonspecific DNA yielded only a single inflection point at a DNA/PU.1 ratio of 0.5 and a stable 
diffusion coefficient of (6.6 ± 0.2) × 10-11 m2/s, between the site-specific 1:1 and 2:1 complexes. 
Thus, the DOSY titration data pointed to the exclusive formation of a defined dimeric 
nonspecific 16-bp complex. An alternative scenario in which PU.1∆N167 formed a mixture of 
2:1 and 1:1 complexes was not likely, as the apparent diffusion coefficient would be 
composition-dependent and change upon continued titration of DNA. 
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As the fluorescence polarization titration showed that the 10 bp of site-specific DNA 
bound PU.1∆N167 in a 1:1 complex but was insufficient to invoke sequential dimerization, we 
repeated the DOSY titrations with a 10-bp duplexes. In stark contrast with their 16-bp parents, 
all of the 10-bp complexes regardless of sequence gave indistinguishable hydrodynamic profiles 
showing single inflections (Fig. S2.3, D–F). If the site-specific 10-bp 1:1 complexes maintained 
the structure observed in the co-crystal structure, their computed (115) diffusion coefficient 
would be 7.9 × 10-11 m2/s under the present experimental conditions. Thus, the measured 
diffusion coefficients of the 10-bp complexes (~6.5 × 10-11 m2/s), which were significantly lower 
even than their 16-bp 1:1 counterpart, were unexpected for a 10-bp 1:1 complex. We confirmed 
the 1:1 stoichiometry of the 10-bp PU.1/DNA complexes by examining the 1H spectra of the 10-
bp high-affinity DNA in the imino region at graded PU.1∆N167 concentration. Resonances 
corresponding to free DNA were exhausted by unit molar protein/ DNA ratio (Fig. S2.4). Thus, 
PU.1 bound 10-bp DNA exclusively as monomers even at excess concentrations, and sequential 
dimerization of PU.1 was limited to site-specific DNA longer than 10 bp. Moreover, the data 
implied that the protein underwent significant conformational changes to hydrodynamically 
larger structures than the same protein bound to 16-bp site-specific DNA.  
2.5.2 Structural properties of the site-specific PU.1 ETS dimer  
We recorded 1H-15N HSQC spectra of uniformly 15N-labeled PU.1∆N167, which showed 
a structured protein with well-dispersed cross-peaks in the absence of DNA (Fig. 2.3A). Upon 
the addition of 16-bp high-affinity DNA (Fig. 2.3, B–D) to a DNA/PU.1 ratio of 1:2, we 
observed the immediate disappearance of ~80% of the NH resonances and a marked loss of 
chemical shift dispersion, but no sign of precipitation even after prolonged incubation (~24 h). 
The addition of a second half-equivalent of DNA to DNA/PU.1 1:1 promptly restored the NH 
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resonances, with significant chemical shift perturbations compared with the free protein. The 
further addition of excess DNA produced no further changes to the HSQC spectrum. 
When we repeated the HSQC titration using the same high-affinity 10-bp construct as in 
the DOSY experiments, we observed a progressive disappearance of resonances past the half-
equivalence point and no further change past the 1:1 equivalence point (Fig. 2.3, E–H). The 
monotonic transition for the 10-bp DNA tracked the changes in diffusion coefficient (Fig. 2.3, 
E–H), in contrast with the sharply biphasic behavior of the 16-bp site. 
To better understand the effect of binding site size on the bound protein’s conformation, 
we probed DNA-bound PU.1∆N167 with 8-anilino-1-naphthalenesulfonate (ANS), an indicator 
dye of solvent-exposed hydrophobic moieties. Unbound PU.1 at 50 μM induced strong blue-
shifted ANS fluorescence associated with a significant number of untitrated basic residues, 
which paired with the anionic dye (123), in the absence of DNA (Fig. 2.4 A). DNA alone 
induced a negligible effect on ANS fluorescence. After subtraction of a dye-only control, ANS 
fluorescence of PU.1 was reduced about 3-fold upon binding a half-equivalent of the 16-bp site-
specific DNA (2:1 complex), and another 8-fold at unit equivalence (1:1 complex) (Fig. 2.4 B). 
The higher sensitivity to ANS, together with the NMR DOSY data, suggest that the DNA-bound 
PU.1 dimer may be less structured than in the 1:1 complex.  
2.5.3 Topology of the site-specifically bound PU.1 dimer  
The attenuation in NMR signal from the 2:1 complex suggests intermediate exchange 
between these two states. As a result, although the disappearance of 80% of cross-peaks in the 
DNA-bound PU.1 dimer (cf. Fig. 2.3 B) precluded a direct identification of the residues involved 
in 2:1 complex formation, the remaining resonances still provided valuable clues to the location 
of the dimerization interface. We overlaid the HSQC spectra for free and bound PU.1 to 16-bp 
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DNA and identified resonances that showed strong overlap throughout the titration (Fig. 2.5, A–
E). Using a reported 1H-15NHSQCassignment of the PU.1 residues 167–260 (118), which applied 
well to PU.1∆N167 (Fig. S2.5), we identified well-resolved, well-overlapped resonances for 
Arg173, Ala210, Lys224, Gly238, Gly241, Lys247, and Ser255. Resolvable resonances that overlapped 
only in the free and 1:1-bound states (i.e. no detectable signal in the 2:1 state), including Ser184, 
Trp192, Trp193, Asp197, and Thr200, mapped to solvent-exposed surfaces away from the DNA (Fig. 
2.5 F). Thus, the HSQC data implicated the distal surface of PU.1∆N167 opposite the DNA-
binding site as a major part of the dimerization interface of the site-specific 2:1 complex. 
To further understand how the distal surface of the PU.1 ETS domain was involved in 
dimerization, we examined the amino acids that mapped to that surface and noticed a sequence 
of four alternately charged residues, 195DKDK198, that comprise part of a β-pleated sheet. These 
residues include (Asp197) or are proximal to residues (Trp192, Trp193, and Thr200) whose 
resonances became reversibly undetectable in the 2:1 complex (Fig. 2.5, A and D). The 
195DKDK198 sequence gave rise to a charge distribution that suggested an electrostatically 
complementary interface for dimerization (Fig. 2.5 G). This hypothesis was further motivated by 
the low level of sequence conservation in Ets-1 (357TGDG360) and within the ETS family in 
general (113). We therefore cloned a PU.1∆N167 mutant harboring 195NINI198, which abrogated 
the charges but maintained similar side-chain structures and secondary structure propensities 
(124). In fluorescence polarization and gel mobility shift experiments, the mutant gave titration 
profiles that showed a single binding mode at up to 10 μM, a concentration at which DNA-bound 
wild-type PU.1 had undergone two binding transitions (Fig. 2.5 H; cf. Fig. 2.2). The anisotropy 
and electrophoretic mobility of the bound mutant corresponded to the 1:1 complex formed by 
wild-type protein. Thus, the 195NINI198 mutant confirmed that the distal surface was involved in 
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PU.1 dimerization. In addition, the mutant bound DNA ~10-fold more weakly (88 ± 11 nM) than 
wild-type PU.1∆N167, suggesting coupling between DNA binding and dimerization of the 
bound state. 
2.5.4 The 2:1 site-specific PU.1/DNA complex occupies an expanded DNA-binding 
site 
To define the contact interface of the 2:1 PU.1/DNA complex, we carried out hydroxyl 
radical (•OH) footprinting titration of a 130-bp radiolabeled DNA fragment harboring the same 
high-affinity binding site used in the other experiments. Previous footprinting studies of the 1:1 
site-specific PU.1/DNA complex by our group (76,114) and others (125,126) have established 
that two spaced clusters of minor-groove contacts flanking the 5’-GGAA-3’ core consensus 
generate a highly characteristic •OH footprint on the 5’-TTCC-3’ strand. We therefore used this 
biochemical signature to track changes in the DNA-binding site at graded concentration of wild-
type PU.1∆N167 (Fig. 2.6 A). Upon reaching PU.1∆N167 concentrations of ~10-7 M that 
saturated 1:1 complex (marked P1 and P2 in Fig. 2.6 B), additional PU.1∆N167 gave rise to 
protected positions near P2 (marked P*). In total, the footprint of the 2:1 complex spanned ~20 
bp of DNA. Quantitation of the protection from •OH at the protected bases as a function of PU.1 
concentration clearly recapitulated the sequential formation of the 1:1 followed by the 2:1 
complex observed in the other experiments (Fig. 2.6 C). In addition, the hypersensitive positions 
between P1 and P2, which is also diagnostic of site-specific 1:1 binding, was preserved in the 2:1 
complex and tracked the titration profiles produced by fluorescence anisotropy (cf. Fig. 2.2 A). 
Thus, the •OH footprints showed, at single-nucleotide resolution, that the site-specific 
PU.1∆N167 dimer made extended contacts with the DNA minor groove although the 
dimerization interface was distal from the DNA. The extended footprint exerted by the 2:1 
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complex also explained the 10-bp specific site’s apparent incompatibility with PU.1 
dimerization, which required several more flanking bases downstream of the 5’-GGAA-3’ core 
consensus, although its affinity for the 1:1 complex was only modestly compromised relative to 
longer DNA (cf. Fig. 2.2 A). 
2.6 Discussion 
When bound to sufficiently long site-specific DNA, the ETS domain of PU.1 self-
associates sequentially to a defined dimer, a behavior that is heretofore unknown for ETS 
transcription factors (19). The reversibility of dimerization is demonstrated by its independence 
on directionality. In gel mobility shift, fluorescence anisotropy, or DNA footprinting titrations in 
which excess protein was titrated into site-specific DNA, the 2:1 complex was produced 
subsequently to the canonical 1:1 complex. When the titration was reversed (DNA into protein), 
as was the case in the NMR and ITC studies, limiting concentrations of DNA directly yielded the 
2:1 complex. Impressively, the NMR titrations showed that even after prolonged co-incubation, 
the further addition of site-specific DNA converted the 2:1 complex rapidly and quantitatively 
into its 1:1 counterpart. Structurally, the identification of the solvent-exposed surface distal from 
the DNA as the dimerization interface on the one hand, and the expansion of the DNA footprint 
of the 2:1 complex on the other, suggested an allosteric coupling between the PU.1 dimers and 
their bound DNA. 
Although many DNA-binding domains are known to self-associate when they bind to 
site-specific DNA (127), this behavior is associated with systems in which the protein protomers 
bind multiple DNA subsites independently, such as the Trp repressor (128), or with positive 
cooperativity, such as the p53 core domain (129). Ets-1 and several other non-PU.1 ETS 
members can also bind as homodimers, but only to two tandem DNA sites (74,106-109). To our 
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knowledge, negatively cooperative binding to a single DNA site, as the PU.1 ETS domain is able 
to execute, has not been reported previously. 
2.6.1 Flanking sequence length as a specificity determinant of PU.1/DNA binding 
We tested a range of DNA lengths to define the site size requirements for PU.1 
dimerization in the bound state and to probe the relevance of dimerization in the presence of 
excess nonspecific DNA. We observed that the binding modes accessible to the ETS domain of 
PU.1 depended on a threshold length of bases flanking the core 10-bp binding site. Within the 
range of DNA lengths tested in the various experiments, 16-bp and longer DNA invoked 
sequential dimerization of bound PU.1. In stark contrast, in the absence of flanking bases, the 10-
bp DNA bound PU.1∆N167 exclusively with 1:1 stoichiometry (Figs. 2.2 B and 2.3). Thus, 10 
bp of site-specific DNA was insufficient to elicit the full site-specific behavior of the PU.1 ETS 
domain. Available evidence indicates that flanking sequence identity is not a determinant 
because we had observed two other site-specific DNA sequences yielding the same ITC profiles 
for PU.1∆N167 (76). 
The 10-bp complex represented a distinct binding mode as the bound PU.1 monomer was 
structurally different from its 16-bp counterpart as judged by their HSQC spectra (Fig. 2.3). This 
observation was unexpected, given the single turn of contacted double helical DNA in the co-
crystal structure of the high-affinity PU.1/DNA complex (26) and ETS/DNA structures more 
generally. Of relevance is the report that DNA with staggered ends was absolutely required for 
diffraction-quality crystals of the PU.1/DNA complex (130). The overhangs, which paired end-
to-end between asymmetric units, would result in essentially continuous DNA in the crystal. 
Additional interactions with flanking bases that are not part of the core sequence therefore 
stabilize the bound protein, and without this stabilization, dimerization becomes prohibitive. In 
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summary, flanking sequence length represents an essential additional determinant to fully specify 
cognate binding by PU.1 in solution.  
2.6.2 Functional relevance of self-titration as a potential negative feedback 
mechanism for PU.1 transactivation 
PU.1 is a highly inducible protein, ranging from <10 to >200 copies of mRNA per cell in 
murine bone marrow progenitors, depending on the stage of hematopoietic development (131). 
Under physiologic induction, PU.1 mRNA levels matching and even exceeding that of 
glyceraldehyde 3-phosphate dehydrogenase, an abundant glycolytic housekeeping enzyme, have 
been measured in cultured (132) and primary (133) human cells. This inducible expression 
profile suggests that interactions spanning a large range in affinity are likely to be biologically 
relevant. For instance, NMR characterization of the functionally essential PU.1/GATA-1 
interaction estimated its dissociation constant to be no stronger than 10-4 M in vitro (134) and did 
not appear to involve (as judged by chemical shift changes) the dimerization interface of PU.1. 
Many ETS family transcription factors, such as Ets-1, ERG, and members of the ETV 
subfamily, are regulated at the protein/ DNA level by inhibitory helices that pack against their 
DNA-binding domain in the unbound state (Fig. 2.1 A). Perturbing these helices imposes an 
energetic penalty on DNA-binding that maintains, by default, an autoinhibited state. Binding 
partners that disrupt the autoinhibitory interactions thus induce a transcriptionally permissive 
state (30). ETS paralogs, such as PU.1, that lack this mechanism would therefore be locked in a 
permissive state in the absence of some mechanism for negative regulation. Whereas 
functionally antagonistic binding partners, such as GATA-1, would serve such an inhibitory role, 
their expression profiles only partially overlap with that of PU.1 (the common myeloid 
progenitor in the case of GATA-1, 135). An intrinsic negative feedback mechanism is hitherto 
50 
unknown in PU.1. Our observation that PU.1 forms a reversible, negatively cooperative 2:1 
complex with site-specific DNA suggests “self-titration” as a potential mechanism of negative 
feedback: even if the 2:1 complex retains the functional activity of the 1:1 complex, removal of 
circulating PU.1 alone would attenuate transactivation of target genes. Consistent with this 
notion, we observed self-titration only with site-specific DNA and not nonspecific DNA. 
Moreover, we did not observe dimer formation with the structural homolog Ets-1, with or 
without its autoinhibition helices, when its cysteines were maintained in a reduced state (Fig. 2.1, 
D–G). Interestingly, a 2:1 Ets-1/DNA complex was reported under non-reducing conditions (71), 
reflecting the strong propensity for its two cysteine residues (which are not present in the PU.1 
ETS domain) to form nonnative disulfide linkages. 
The dissociation constant for binding to oligomeric nonspecific sites (~10-6 M) (114), 
such as that used in our NMR experiments, is only ~10-fold higher than the sequential affinity of 
the second equivalent of PU.1∆N167. It might therefore appear that the abundance of 
nonspecific DNA relative to specific sites would overwhelm self-titration of specific complexes. 
Our gel mobility data on binding to polymeric DNA (cf. Fig. 2.2 C) provide a useful insight into 
this question. Compared with titration of oligomeric site-specific DNA, formation of the 2:1 
complex at an embedded binding site flanked by substantial nonspecific DNA (~100 bp on each 
side) occurred at ~10-fold lower concentration (~10-7 M) and clearly preceded any nonspecific 
binding. The footprinting data showed the same behavior at a shorter (~130-bp) DNA fragment. 
This difference reflected the favorable contribution to reaching an embedded site from linear 
diffusion that was absent for an isolated counterpart. Thus, a complete description of the effect of 
excess nonspecific flanking DNA (as would be expected under genomic conditions) includes a 
competitive effect that is more than offset by favorable contributions from linear diffusion. 
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2.6.3 Nonspecifically bound PU.1 is oligomeric 
The 16-bp nonspecific site, involving only the isomeric reversal of two adjacent positions 
in the core consensus (5’- GGAA-3’ to 5’-GAGA-3’), forced the exclusive formation of a 
dimeric complex. No 1:1 complex was detectable at equilibrium. In the context of self-titration 
as a potential negative regulatory mechanism, this behavior suggests that the role of site-specific 
DNA (i.e. sequences harboring the core consensus) is not only to provide a much higher-affinity 
binding site for PU.1 but, perhaps more importantly, to “unlock” the transcriptionally active 1:1 
conformation. It may therefore be more appropriate to consider dimeric PU.1, as the default 
autoinhibited state, which becomes activated, by a coupled dissociation/order transition, upon 
encountering a specific DNA site at permissively low protein concentrations. 
2.7 Conclusion 
We report, for the first time, a 2:1 complex formed by PU.1 with a single cognate binding 
site. This complex forms negatively cooperatively with respect to the canonical, transcriptionally 
active 1:1 complex and resists competition from nonspecific DNA. It is kinetically stable (on the 
order of many hours) and interconverts efficiently with the 1:1 complex (within minutes) upon 
the addition of DNA. These biophysical properties of self-titration of PU.1 at site-specific DNA 
are biologically compatible and, indeed, physiologically appropriate given the significant 
accumulation of PU.1 under induction (>10-6 M), when negative feedback would be most 
required to dampen its transcriptional response. Self-titration therefore represents a potential 
buffering mechanism for self-regulation in ETS paralogs, such as PU.1, that lack autoinhibitory 
elements in their structures. 
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Table 2.1 Apparent translational self-diffusion coefficients of PU.1/DNA complexes. 
 
Diffusion coefficients (×10-11 m2 s-1), as plotted in Figure 2.3 in the main text, of PU.1ΔN167 alone 
and in complex with 16-bp and 10-bp high-affinity (5’-GCAAGCGGAAGTGAGC-3’), low-
affinity (5’-GCAAAAGGAATGGAGC-3’), and nonspecific DNA (5’-
GCAAGCGAGAGTGAGC-3’). The 10-bp DNA sites consist only of the underlined core 
sequences. 
 
 
DNA to 
PU.1 
molar 
ratio 
16-bp 
high-
affinity 
16-bp 
low-
affinity 
16-bp  
nonspecific 
10-bp 
high-
affinity 
10-bp 
low-
affinity 
10-bp  
nonspecific 
0  9.11±0.17 9.00±0.15 9.40±0.13 9.08±0.17 8.90±0.59 9.29±0.24 
1
6
 8.15±0.25 7.80±0.25 7.73±0.15   8.26±0.33 
1
4
       8.30±0.24 8.03±0.45   
1
3
 7.27±0.15 6.68±0.11 6.50±0.21   7.68±0.08 
1
2
 6.21±0.18 5.84±0.16 6.60±0.22 7.11±0.13 7.54±0.32 7.08±0.23 
2
3
  5.90±0.11 5.92±0.11 6.70±0.22   6.80±0.14 
3
4
        6.72±0.06 6.69±0.19   
5
6
  6.53±0.14 6.56±0.13 6.59±0.14   6.49±0.25 
1   7.00±0.14 7.38±0.12 6.70±0.10 6.27±0.10 6.68±0.18 6.88±0.18 
11
6
  7.72±0.27  6.46±0.27    
 11
4
   
 
 
 
 
 
6.64±0.14
 
6.43±0.19
 
7.02±0.10
 
11
3
 7.75±0.06  6.51±0.17    
11
2
 7.53±0.23 7.79±0.08  6.30±0.14 6.62±0.16 7.00±0.18 
31
4
     6.81±0.10   
2 7.56±0.10 7.84±0.15    6.59±0.28  
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Figure 2.1 Dimerization at a single cognate binding site is intrinsic to the ETS domain of 
PU.1, but not its structural homolog Ets-1. 
 
A, the co-crystal structures of PU.1 (gold; PDB code 1PUE) and Ets-1 (green), the latter with 
(1MDM) or without (1K79) part of its autoinhibitory domain (blue). All three structures show 
the canonical 1:1 binding stoichiometry with oligomeric DNA harboring a core 5’-GGAX-3’ 
consensus (red), as labeled. Note that the cognate DNA sequences in the co-crystal structures are 
not sequence-identical to the experimental sequences in this study. B, D, and F, representative 
ITC thermograms at 25 °C of DNA-into-protein titrations for the ETS domains of PU.1 (B) and 
Ets-1 (minimal ∆N331 (D); autoinhibited ∆N280 (F)). The ordinate is baseline-subtracted and 
normalized to the amount of DNA delivered per injection to aid comparison; exothermic 
response is upward. C, E, and G, the titration data for PU.1∆N167 was empirically fitted as a 
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negatively cooperative interaction. The two phases in the PU.1 titration (marked Rα and Rβ in C) 
represent the successive formation of a protein/DNA 2:1 complex (protein in excess) followed 
by the 1:1 complex. For Ets-1∆N331 (E) and Ets- 1∆N280 (G), a 1:1 model was empirically 
fitted to the data. The stronger and more complex apparent heats associated with the PU.1∆N167 
titrations included the dimerization and binding of PU.1∆N167 as a 2:1 complex, which 
dissociates to two 1:1 complexes as DNA reached molar equivalence, in addition to more 
enthalpically driven 1:1 binding than Ets-1. The details of the thermodynamic deconvolution are 
provided under “Materials and methods.” 
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Figure 2.2 Sequence and site size requirements for sequential dimerization of the specific 
DNA-bound ETS domain of PU.1. 
 
 
Fluorescence polarization titration of Cy3-labeled 20-bp (open symbols) and 10-bp (gray) DNA 
probes (0.5 nM) harboring the high-affinity site 5’-AGCGGAAGTG-3’ (A) and its isomeric 
nonspecific variant 5’-AGCGAGAGTG-3’ (B) with PU.1ΔN167. Curves represent a least-square 
fit of the data from triplicate experiments to a sequential 2:1 binding model (red) or a constrained 
to a 1:1 model (green). The latter afforded a poor fit of the data (p < 1 × 10-4, Fisher’s F-test on 
sums of squares). The nonspecific data was fitted with the Hill equation (black). C, Native 
electrophoretic mobility shift titration of a 209-bp DNA fragment (1 nM, marked “0”) harboring 
the same high-affinity site with PU.1ΔN167. Following formation of the 1:1 complex (marked 
“1”), a discrete, low-mobility species was present at 0.1 µM protein (marked “2”). At 1 µM protein 
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(103-fold excess), a nonspecific complex finally forms, which did not enter the gel, as confirmed 
with a fragment harboring the nonspecific sequence (D). The shadows lining the wells in Panel C 
represent an irregular imaging artefact of the stained gel, not protein-DNA complex, as it was 
observed even in the negative-control lane containing no PU.1 (marked “N”). 
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Figure 2.3 1H-15N HSQC NMR spectroscopy of PU.1/DNA complexes. 
 
Uniformly 15N-labeled PU.1ΔN167 was titrated with a 16- (A to D) or 10-bp (E to H) unlabeled 
high-affinity DNA at the indicated molar ratios. Each series of spectra was acquired with the same 
sample and intensity adjusted to the same noise level. 
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Figure 2.4 Biochemical characterization of PU.1/DNA complex conformation. 
 
A, fluorescence spectra of 50 µM PU.1ΔN167 alone or with 0.5, 1.0, or 2.0 molar eq of 16-bp site-
specific DNA after mixing with 200 µM ANS. Samples were excited at 375 nm. B, fluorescence 
intensity at 530 nm of PU.1ΔN167 with or without 16-bp DNA after subtraction of an ANS-only 
control, shown as average ± S.D. (error bars) of triplicate experiments. 
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Figure 2.5 Mapping the dimerization interface of the site-specific 2:1 complex. 
 
A, Overlay of 1H-15N HSQC spectra in the absence (green) or presence of 16-bp site-specific DNA 
at 0.5 (red) and 1.0 (blue) molar ratios. Peaks labeled in orange that showed strong overlap among 
all three states (blue/red/green) were taken to represent residues not involved in site-specific 
dimerization. Peaks labeled in purple that overlapped only in the unbound and 1:1-bound states 
(blue/green) were taken to represent residues involved in dimerization. Assigned resonances were 
as reported for residues 167 to 260 by Jia et al. (118). Boxes indicate regions that are magnified in 
Panels B to E. F, Mapping of the (purple) residues implicated in PU.1 dimerization to the 1:1 co-
crystal structure (PDB: 1PUE). G, continuum electrostatic surface potential of PU.1 in the co-
crystal structure. The residues 195DKDK198 are shown as spheres. H, DNA-binding profiles of a 
195NINI198 mutant of PU.1∆N167 by fluorescence polarization (20 bp) and gel mobility shift (209 
bp) under the same experimental conditions as in Fig. 2.2. Symbols represent replicate 
experiments; the curve represents a 1:1 fit to the data. Error bars, S.E. 
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Figure 2.6 Dynamics Expansion of the DNA contact interface in the 2:1 PU.1/DNA 
complex. 
 
A singly end-radiolabeled DNA fragment was titrated at equilibrium with PU.1ΔN167 and 
digested with •OH under single-hit conditions. A C+T reaction was included to index the 
digested DNA following denaturing electrophoresis. A, Image of the sequencing gel. N and U 
denote DNA digested without protein and undigested DNA, respectively. A second footprint was 
observed at a cryptic binding site (5’-ATGGGAATTC-3’) encoded by pUC19 vector further 
downstream from the cloned high-affinity site. The lower affinity of this site (136) meant that it 
did not generate the sequential 2:1 complex beyond the 1:1 footprint at the maximum PU.1 
concentration used. B, Traces of the indicated lanes. Brackets and red dots denote protected and 
hyper-sensitive positions at the indicated and higher protein concentrations, respectively, relative 
to a distal control peak marked with a hollow dot (○). C, Titration of the summed integrated 
intensities of the protected bases marked P1 and P2 (□) associated with the 1:1 complex, and P* 
(■) produced by the 2:1 complex in Panel B, normalized to the control peak intensity and scaled 
to [0,1]. Curves represent empirical fits to the Hill equation. D, Titration of the summed 
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integrated intensities of the hyper-sensitive peaks (●), scaled to [0,1] but normalized to the 
intensity at the highest PU.1ΔN167 concentration tested. The curve represents a fit by a 
sequential 2:1 binding model.  
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Figure S 2.1 MALDI-ToF spectra of unlabeled and 15N-labeled PU.1ΔN167. 
 
The expected MW for the unlabeled (A) and 15N-labeled (B) constructs were 12,847 and 13,018 
(assuming 99% enrichment), respectively. Both the +1 and +2 ions were detected.  
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Figure S 2.2 Diffusion ordered NMR (DOSY) spectra of PU.1 ETS domain, target DNA, 
and their complexes. 
 
Self-diffusion of unlabeled PU.1ΔN167, 16-bp high-affinity DNA, and mixtures of the two at 1:1 
and 2:1 molar ratios was determined in solution using pulsed field gradients. Protein 
concentrations were 250 µM (C), 204 µM (E), and 173 µM (G), and the DNA concentrations were 
562 µM (A), 102 µM (E), and 173 µM (G). At each gradient strength, the labeled peaks were 
individually fitted to Eq. (E1) to estimate the diffusion coefficient and then averaged. Fitted curves 
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of intensity decay for representative peaks at the indicated chemical shifts are shown in Panels B, 
D, F, and H. 
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Figure S 2.3 DOSY titrations reveal site requirements for dimerization of DNA-bound 
PU.1 in solution. 
 
Translational self-diffusion coefficients of PU.1ΔN167 alone and bound to a 16-bp high-affinity 
(A, 5’-GCAAGCGGAAGTGAGC-3’), low-affinity (B, 5’-GCAAAAGGAATGGAGC-3’), or 
nonspecific DNA sequence (C, 5’-GCAAGCGAGAGTGAGC-3’). Measurements were repeated 
using 10-bp duplex sites harboring only the underlined sequences under the same solution 
conditions (D to F). Lines represent linear fits of the data in the indicated ranges. The diffusion 
coefficients of the 16- and 10-bp DNA alone were (10 ± 1) and (14 ± 1) × 10-11 m2 s-1, respectively. 
Error bars, S.D. 
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Figure S 2.4  NMR spectroscopic changes to 10-bp site-specific DNA upon titration by 
the ETS domain of PU.1. 
 
Chemical shift perturbations of imino 1H resonances were monitored upon titration with 250 µM 
PU.1ΔN167 at the indicated molar ratios at 20°C using 1-1 Jump and Return pulse sequence (600 
MHz) (137). Each spectrum was referenced and normalized in intensity to DSS. Since the DOSY 
titration showed a single transition, resonances from unbound DNA would be expected to be 
persist up to the stoichiometric ratio of the complex. For the 10-bp high-affinity DNA, the 
observable imino 1H peaks in the unbound 10-bp high-affinity DNA were fully exhausted by unit 
molar equivalence. 
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Figure S 2.5 1H-15N HSQC spectra of unbound murine PU.1(167-260) and PU.1ΔN167. 
 
A truncated PU.1 ETS construct without the final 12 residues in the PU.1ΔN167 used in the 
experiments described in the main text was cloned and over-expressed as a uniformly 15N-labeled 
protein in E. coli similarly as PU.1ΔN167, and purified on Sepharose SP.  The 1H-15N HSQC of 
PU.1(167-260) (A) closely matched a previously reported spectrum of Jia et al. (118) which in turn 
allowed assignment of many resonances in PU.1ΔN167 (B). 
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3 CHARACTERIZATION OF INTRINSICALLY DISORDERED REGIONS ON 
INTERNAL DYNAMICS OF THE ETS DOMAIN OF PU.1 
3.1 Preface 
The objective of the study in this chapter is to characterize the effects of intrinsically 
disordered regions (IDRs; N-terminal PEST domain and C-terminal 12 residues) flanking the 
ETS domain on backbone dynamics of PU.1 using NMR. I prepared the protein and DNA 
samples in this study. I conducted all the NMR experiments with Dr. Markus Germann, except 
for the hydrogen-deuterium exchange (HDX) experiment. The HDX experiment was in 
collaboration with Dr. Marina Evich. Our collaborator, Dr. James Aramini at the City University 
of New York Advanced Science Research Center (CUNY ASRC), assigned the residues of 
hPU.1 ETS domain (residues 165-258) in the 1:1 complex with 16-bp site-specific DNA. This 
work was supported by NSF grant MCB 15451600 and NIH grant R21 HL129063. 
3.2 Abstract 
The presence of the IDRs flanking the ETS domain does not change the DNA binding 
modes of the PU.1 ETS domain (cf. Chapter 2), yet the N-terminal IDR (PEST domain) modifies 
DNA recognition by the ETS domain through changing DNA binding affinities. We used 3D 
NMR (HNCO, HN(CA)CO, HNCA, HNCACB, and HN(CO)CACB) to analyze the 1H-15N 
HSQC spectra of hPU.1 constructs with and without IDRs, and also in the absence and presence 
(1:1 complex) of DNA. Thus, we successfully assigned ~90% or more backbone amide 
resonances of hPU.1. Using the fully assigned HSQC spectra, we studied fast (ps to ns) time 
scale internal dynamics of PU.1 protein. Whole sets of 15N R1 and R2 relaxation rates and 
heteronuclear 1H{15N}-NOE were acquired for all the hPU.1 constructs with and without DNA. 
We found the PEST domain upon specific DNA binding becomes more dynamic in a disordered 
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structure. In terms of DNA recognition, the presence of the PEST domain increases the affinity 
of 1:1 complex of the ETS domain with cognate DNA, without perturbing the structure or 
changing the fast time scale backbone motions of the ETS domain. 
3.3 Introduction 
In Chapter 2, we found the ETS domain of PU.1 dimerizes at a single cognate site of 
DNA in a negatively cooperative manner via the ETS domain, while some ETS family members, 
including Ets-1, are unable to form a 2:1 complex in physiological conditions (99). This is the 
first direct demonstration of a 2:1 complex formation with site-specific DNA by an ETS family 
member to sequester excess protein of its own. Since PU.1 is one of a few members that lack 
autoinhibition, we proposed that this is a self-regulating and negative feedback mechanism of 
PU.1 protein instead of autoinhibition. We also detected the dimerization interface of PU.1 in the 
2:1 PU.1/DNA complex: the site distal to the DNA-binding interface, including the loop between 
S1 and S2 where four consecutive charged residues 193DKDK196 reside (99). 
Following what we discovered in Chapter 2, we planned to investigate the conformations 
and interactions that the PU.1 dimer displays upon binding with site-specific DNA. However, as 
we observed in Chapter 2, ~80% of the 1H-15N HSQC resonances disappear in 2:1 PU.1/DNA 
complex (Fig. 2.3, B), which unfortunately prevented us from direct observation of the DNA-
bound PU.1 dimer. On the other hand, both unbound PU.1 and 1:1 PU.1/DNA complex (Fig. 2.3, 
A and C) show well-dispersed HSQC peaks. Thus, we have decided to study internal dynamics 
of unbound and 1:1 DNA-bound PU.1 at atomic resolution by NMR, instead of directly 
examining the 2:1 PU.1/DNA complex. 
Moreover, the study in this chapter follows our recent studies of the roles of IDRs on 
DNA-free PU.1 homodimerization, which was previously observed in vivo by Evans et al. (68) 
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(138). The PU.1 dimers in the absence and presence of DNA antagonize to each other, and IDRs 
flanking the ETS domain play key roles for this phenomenon (138). We also found that DNA 
recognition by the ETS domain of PU.1 is modified by the presence of IDR. The N-terminal 
PEST domain is intrinsically disordered, and this nature is important because it facilitates the 1:1 
DNA complex formation. However, the affinity of the 2:1 PU.1/DNA complex is reduced by the 
disordered PEST (138). The DNA recognition of the ETS domain is not affected by the absence 
of C-terminal IDR. By contrast, PU.1 is unable to form a DNA-free dimer without C-terminal 
IDR (138). 
Thus, to study how the PEST domain modifies DNA recognition of PU.1, we tested 
whether or not the PEST domain changes the internal dynamics of the ETS domain using NMR, 
in this chapter. We, therefore, prepared three constructs of hPU.1 protein that consist of only the 
ETS domain (sΔN165), ETS domain and C-terminal IDR (ΔN165), and ETS domain and both 
N- and C-terminal IDRs (ΔN117), respectively (Fig. 3.2 A). As a first step, we worked on 
backbone assignment of PU.1 proteins consisting of the ETS domain and/or flanking IDRs (N-
terminal PEST domain and C-terminal 12 residues) in the absence and presence of cognate DNA 
because these backbone assignments give us opportunities to further investigate the 
hydrodynamic properties of hPU.1 protein at the residue-by-residue level. 
3.4 Materials and methods 
3.4.1 Protein and DNA sample preparation 
Molecular cloning. DNA fragments of hPU.1ΔN165 (human residues 165–270) and 
ΔN117 (human residues 117–270) were purchased from Integrated DNA Technologies 
(Midland, IA), and subcloned directly into the NcoI/HindIII sites of pET28b vector. The 
hPU.1sΔN165 (human residues 165–258) construct that lacks both N- and C-terminal IDRs 
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flanking the ETS domain was subcloned directly into the NcoI/NdeI sites of pET15b. All 
constructs were verified by Macrogen (Rockville, MD) using Sanger sequencing. 
Protein expression and purification. Three human PU.1 constructs were used in this 
study: sΔN165 (ETS domain only), ΔN165 (ETS domain and C-terminal 12 residues), and 
ΔN117 (N-terminal PEST domain, ETS domain, and C-terminal 12 residues). Uniformly 15N-
labeled or 15N/13C-labeled hPU.1 proteins were overexpressed in BL21(DE3) (for sΔN165 and 
ΔN165) or BL21(DE3) pLysS (for ΔN117) E. coli as previously described (99). In brief, the cell 
pellet of starter culture in 50 mL LB was harvested, washed, and resuspended in 1 L M9 minimal 
medium containing 15NH4Cl, MgSO4, CaCl2, trace metals, MEM vitamins, and unlabeled or 13C-
labeled glucose as required for 15N (or 15N/13C) labeling. Protein expression was induced with 
0.5 mM IPTG for 4 h at 30 °C (for sΔN165 and ΔN165) or 25 °C (for ΔN117). Bacterial pellets 
were resuspended in 10 mM sodium phosphate (pH 7.4), 500 mM NaCl and 0.1 mM 
phenylmethanesulfonyl fluoride, and shear-homogenized (Sonic Dismembrator FB-505, Fisher 
Scientific). The lysate was cleared by centrifugation and directly loaded onto a cation exchange 
column (HiTrapTM SP HP, GE Healthcare) under the control of a Bio-Rad NGS Quest 10 
instrument. After washing out residual impurities, the protein was eluted by a NaCl gradient 0.5-
2 M. Purified proteins were extensively dialyzed against 10 mM sodium phosphate buffer (pH 
7.0) containing 50 mM (for sΔN165) or 150 mM (for ΔN165 and ΔN117) total [Na+], 0.5 mM 
EDTA, and 0.01% NaN3. Each hPU.1 protein concentration was determined by UV absorption at 
280 nm using the extinction coefficients ϵ280 = 22,460 M−1 cm−1 (for sΔN165 and ΔN165) and 
23,593 M-1 cm-1 (for ΔN117). 
Nucleic acids. Synthetic DNA oligos were purchased from Integrated DNA Technologies 
and annealed as described (99). For NMR experiments using PU.1/DNA complex, 16-bp high 
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affinity DNA (5’-GCAAGCGGAAGTGAGC- 3’) was co-dialyzed with hPU.1sΔN165 or 
ΔN165 against 10 mM sodium phosphate buffer (pH 7.0) containing 50 mM (for sΔN165) or 
150 mM (for ΔN165 and ΔN117) total [Na+], 0.5 mM EDTA, and 0.01% NaN3. The 23-bp high 
affinity DNA (5’-GCGAATAAGCGGAAGTGAAACCG- 3’) was co-dialyzed with 
hPU.1ΔN117 against 10 mM sodium phosphate buffer (pH 7.0) containing 150 mM total [Na+], 
0.5 mM EDTA, and 0.01% NaN3. 
3.4.2 NMR Spectroscopy 
Sequential backbone assignment of hPU.1sΔN165, ΔN165, and ΔN117 constructs in the 
absence of DNA. 1H-15N correlated 2D HSQC measurements were made as previously described 
(99). NMR experiments for PU.1 backbone NH groups assignment were done using 976 μM 
(hPU.1 sΔN165), 682 μM (ΔN165), and 563 μM (ΔN117) protein samples in the absence of 
DNA, and 600 μM (ΔN165 and ΔN117) in 1:1 complex with cognate DNA. All NMR 
experiments were performed with a Bruker Avance 600 MHz spectrometer, equipped with a 5 
mm QXI probe, at 25 °C (298 K). Signals from backbone 1H, 13C, and 15N nuclei were assigned 
from five 3D heteronuclear experiments HNCO, HN(CA)CO, HNCA, HNCACB, and 
HN(CO)CACB (139). Obtained NMR spectra were processed using a Bruker TopSpin 3.2 or 3.5 
pl7, and the data analysis was achieved with NMRFAM-Sparky software (140). 
Nuclear spin relaxation measurements. Whole sets of 15N T1, T2, and heteronuclear 
1H{15N}-NOE data were acquired using Bruker Avance 600 MHz spectrometer, equipped with a 
5 mm HCN triple resonance probe, at 25 °C (298 K) (139). The hPU.1 protein concentrations 
were 870 μM (unbound sΔN165), 690 μM (sΔN165 in 1:1 complex with DNA), 600 μM (both 
unbound and 1:1 DNA-bound ΔN165, and 1:1 DNA-bound ΔN117), and 563 μM (unbound 
ΔN117). A total of 8 data sets were collected to measure T1 with delay values of: 0.005, 0.05, 
73 
0.125, 0.225, 0.350 0.500, 0.750, and 1.000 seconds for all constructs with and without DNA. A 
total of 7 data sets were collected to measure T2 with delay values of: 0.01, 0.02, 0.04, 0.07, 0.09, 
0.13, and 0.18 seconds (for sΔN165 with and without DNA), 0.01, 0.025, 0.05, 0.08, 0.1, 0.15, 
and 0.2 seconds (for unbound ΔN165 and ΔN117), 0.005, 0.01, 0.0175, 0.025, 0.03, 0.04, 0.05, 
0.06, 0.08, 0.1, 0.15, and 0.2 seconds (for 1:1 DNA-bound ΔN165), or 0.005, 0.01, 0.015, 0.02, 
0.025, 0.03, 0.04, 0.06, 0.08, 0.14, and 0.2 seconds (for 1:1 DNA-bound ΔN117). Data were 
processed with TopSpin 3.2, 3.5 pl7, or 3.6.1 (Bruker) to extract peak intensities and then fit as 
single exponential decay with Origin 9.1 (OriginLab). Steady-state heteronuclear 1H{15N}-NOE 
was acquired from the difference between spectra acquired with and without 1H saturation and a 
total recycle delay of 3s. Heteronuclear 1H{15N}-NOE error was derived by 
|𝑁𝑂𝐸|√{(
𝑛𝑜𝑖𝑠𝑒 𝑆𝑎𝑡
𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑆𝑎𝑡
)2 + (
𝑛𝑜𝑖𝑠𝑒 𝑈𝑛𝑠𝑎𝑡
𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑈𝑛𝑠𝑎𝑡
)2} using backgoround noise level of the spectra. 
3.5 Results 
3.5.1 The presence of the PEST domain does not change DNA binding modes of 
PU.1 
Our group recently found that the presence of the disordered PEST domain increases the 
affinity of 1:1 complex of the structured ETS domain with cognate DNA, while it reduces that of  
2:1 complex in physiological conditions (138). Based on this finding, we further studied the roles 
of the N-terminal PEST domain on DNA recognition of the ETS domain using NMR. 
Translational diffusion constants obtained by DOSY NMR revealed that PU.1 retains its ability 
to have multiple DNA binding modes with 23-bp site-specific DNA in the presence of the N-
terminal intrinsically disordered PEST domain flanking the ETS domain (hPU.1ΔN117 protein) 
(Fig. 3.1 A(a)). The finding is similar to the PU.1 behavior in the absence of the PEST domain 
with 16-bp specific DNA (i.e., forming both 2:1 and 1:1 PU.1/DNA complex in direct response 
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to the PU.1/DNA molar ratios) (cf. Fig. S 2.3). In contrast, hPU.1ΔN117 titration with 23-bp 
specific DNA showed a clear difference from that with 16-bp DNA in binding manners (Fig. 3.1 
A(b)). ΔN117 forms a 2:1 PU.1/DNA complex with 16-bp specific DNA in response to the 
PU.1/DNA ratio, but 1:1 PU.1/DNA complex formation does not reflect the molar ratio. 
Interestingly, the binding behavior of hPU.1ΔN117 to 16-bp DNA is also different from what we 
observed for PU.1 ETS domain (mPU.1ΔN167) to 10-bp specific DNA, as described in Chapter 
2 (cf. Fig. S 2.3). ΔN117 forms a 2:1 PU.1/DNA complex with 16-bp DNA, but ΔN167 does not 
with 10-bp DNA. In Chapter 2, we demonstrated that the DNA contact interface in the 2:1 
PU.1/DNA complex is longer than that in the 1:1 complex (cf. Fig. 2.6). The 16-bp DNA is 
probably long enough for the PU.1 ETS domain to function fully.  Based on the DNA binding 
manners of ΔN117 to 23- and 16-bp specific DNA, we can suggest that short (namely, 16 bp or 
less) DNA has a negative impact on DNA binding of PU.1 ETS domain in the presence of the 
flanking PEST domain. 
To monitor the protein “fingerprint” of both the PEST and ETS regions, we tested HSQC 
titrations in the same manner as described in Chapter 2. We acquired HSQC spectra of 
hPU.1ΔN117 in a titration with 23-bp specific DNA, at PU.1/DNA molar ratios of 0, 0.5, 1, and 
2 (Fig. 3.1 B). The ETS crosspeaks that are well-overlapped with our previous HSQC spectrum 
of mPU.1ΔN167 (cf. Fig. 2.3) exhibited almost the same trend at each molar ratio. The HSQC 
crosspeaks that are not overlapped with the crosspeaks of the ETS residues are most probably the 
PEST peaks. Such crosspeaks were clustered at ~8.2 ppm on the proton dimension, and these 
HSQC resonances showed little shifts upon specific DNA binding. 
Based on the results of the DOSY NMR described above, we further studied the impact 
of the DNA length on specific DNA binding of PU.1 ETS domain in the presence of flanking 
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PEST domain. We overlaid the HSQC spectrum of hPU.1ΔN117 in 1:1 complex with 16-bp 
specific DNA onto that with 23-bp specific DNA. Most of the crosspeaks overlapped well, but 
several peaks were found to be shifted. Notably, the peaks of K245-247 showed no overlap 
between these spectra (Fig. 3.1 C (a)). These three consecutive Lys residues are located at the 
center of the “wing” of PU.1 (Fig. 3.1 C (b)). The “wing” binds upstream of the core GGAA 
sequence of DNA. Thus, if the DNA is so short that the terminal base pairs fray in 1:1 
PU.1/DNA complex, these positively charged residues would structurally be perturbed due to 
charge-charge repulsion with phosphate groups of DNA. 
3.5.2 Sequential backbone assignment of three hPU.1 constructs sΔN165, ΔN165, 
and ΔN117 in the absence and presence of DNA 
To assign 1H-15N HSQC resonances of PU.1 backbone amides, we first focused on five 
specific amino acids Gly, Ala, Ser, Thr, and Pro in PU.1 as these amino acids have characteristic 
chemical shifts in clear backbone assignment (Fig. 3.2 A). Gly residues do not have beta carbons, 
and Ala residues have exceptionally small beta carbon chemical shifts. Ser/Thr residues have 
exceptionally large chemical shifts for beta carbons, and Pro residues do not have HSQC peaks 
of their own backbone amides. We used these residues for the starting points of the assignment. 
For example, the chemical shift of Ser253 beta carbon is much larger than most other beta 
carbons, and Gly254 has no beta carbon. Thus, we were able to find these consecutive residues at 
the initial stages of the DNA-free hPU.1ΔN165 assignment (Fig. 3.2 B). The N-terminal first 
residue is generally not observed in 1H-15N HSQC spectra. This was the case in our studies. 
Then we worked on the backbone assignment of the PU.1 protein containing only the 
ETS domain (hPU.1sΔN165; residues 165-258) in the absence of DNA. The first three residues 
at the N-terminus and residues L172, L180, S203, K204, K221, and K222 were unable to be 
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assigned because the corresponding resonances in the 1H-15N correlation spectra were not 
observed. The next assignment was done for DNA-free PU.1 protein containing the ETS domain 
and C-terminal IDR (hPU.1ΔN165; residues 165-270). L172, L180, S203, K204, and K222 were 
unable to be assigned, in the same manner as the hPU.1sΔN165, as described above. Besides, the 
assignment of R220 was not achieved. The C-terminal IDR contains two consecutive Pro 
residues (P268 and P269) that never appear on 1H-15N HSQC spectra due to the absence of 1H 
attached to its 15N in Pro. Moreover, we were unable to unambiguously assign R265. 
Likewise, the assignment was done with unbound hPU.1ΔN117 (residues 117-270) 
containing N-terminal IDR (PEST domain), the ETS domain, and C-terminal IDR. The same 
residues as ΔN165 were assigned in the ETS domain and C-terminal IDR. The PEST domain 
(residues 117-164) is disordered and therefore the 1H-15N HSQC resonances are clustered in the 
typical amide chemical shift region (~8.2 ppm of 1H). Moreover, this domain contains a lot of 
Pro residues (P122, 126, 129, 141, 142, 155, 157, and 161) that cannot be assigned. Thus, the 
sequential assignment of the PEST domain was much more difficult than the other part of the 
protein. Because N-terminal residues typically exhibit most negative {1H}-15N NOE (described 
in detail in 3.5.3 of this chapter), we used the heteronuclear NOE data to distinguish the N-
terminal Gly and Ser/Thr residues from the same amino acid residues at other sites. We were 
eventually able to assign the PEST residues except for L119, Q120, Y121, L124, Q139, D147, 
E149, in addition to all the ETS residues assigned for ΔN165. 
Thus, we successfully assigned 88 of 94 backbone amides of hPU.1sΔN165, 94 of 104 
resonances of ΔN165, and 126 of 144 residues of ΔN117 (Fig. 3.2 A). Likewise, at least ~90% of 
HSQC resonances of the same PU.1 proteins were assigned in 1:1 complex with cognate DNA 
(Fig. 3.2 B). 
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3.5.3 The PEST domain stays disordered but becomes more dynamic upon specific 
DNA binding 
Using the 1H-15N HSQC spectra of PU.1 proteins whose resonances were fully resolved, 
the well-dispersed crosspeaks of ΔN165 residues were found to be mostly overlapped with 
ΔN117 residues. Furthermore, all the residues in the PEST region were clustered at ~8.2 ppm on 
the 1H dimension for both unbound and 1:1-DNA bound ΔN117 (Fig. 3.4 A and B). This is 
characteristic of structural disorder of proteins in 1H-15N HSQC spectra. The chemical shifts of 
these PEST resonances were also similar for both unbound protein and 1:1 complex with specific 
DNA binding. Thus, 1H-15N HSQC chemical shifts strongly suggest that the PEST domain stays 
similarly disordered upon specific DNA binding in terms of structural perturbation. 
We further performed measurements of 15N relaxation parameters (namely, spin-lattice 
(R1) and spin-spin (R2) relaxation rate and the steady-state heteronuclear 1H{15N}-NOE) for 
hPU.1ΔN165 and ΔN117 residues both in the absence and presence (at 1:1 molar ratio) of 23-bp 
specific DNA (Fig. 3.5 A-L and Supplemental Table 3.1-3.4). We excluded those which were 
either overlapping or hardly visible. The NOE values were calculated from the intensity ratios of 
individual crosspeaks with and without 1H saturation (Fig. 3.5 F and L). The R1 and R2 values of 
hPU.1 proteins for both unbound and 1:1 DNA-bound forms were obtained by fitting the 
intensity of each crosspeak with a set of relaxation times (Fig. 3.5 A,B,D,E,G,H,J,K). 
To evaluate the quality of the spin relaxation data, we obtained the ranges of relative 
errors. The relative error ranges of R1, R2 and NOE are as follows. DNA-free ΔN165: 0.5-25.5%, 
1.2-7.9%, and 1.6-49.9%, respectively. DNA-free ΔN117: 1.6-62.2%, 1.0-22.6%, and 2.7-
343.0%, respectively. 1:1 DNA-bound ΔN165: 4.3-84.6%, 3.5-24.9%, and 1.3-25.9%, 
respectively. 1:1 DNA-bound ΔN117: 2.6-101.1%, 2.0-31.2%, and 0.8-597.3%, respectively. 
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Typical erros in replicated NMR relaxation experiments are 5-10% in the case of Ets-1 from 
literature (33), where their group conducted multiple NMR relaxation experiments and obtained 
standard errors. In contrast, our errors (standard deviation) were derived from experiments 
without replication. Namely, our R1 and R2 errors were derived from fitting and our NOE error 
was from signal intensities relative to background noise level. Thus, the high R1 or R2 errors of 
some PU.1 residues are attributed to both data fitting and significantly weak HSQC signals, and 
the high NOE errors of some PU.1 residues are due to significantly weak signals in the HSQC 
specta. We have high errors for some PU.1 residues. Notably, M185 and K245 have high errors 
because their HSQC signals are weak (Fig. 3.5 M), which resulted in high errors in the spin 
relaxation measurements. 
Large NOE values of the ETS residues and much smaller values of the PEST residues 
indicate that the ETS domain stays well-ordered, in contrast to the PEST domain which stays 
disordered upon specific DNA binding (Fig. 3.5 F and L). Much larger R1 (Fig. 3.5 D and J) and 
much smaller R2 (Fig. 3.5 E and K) values of the PEST domain than the corresponding values of 
the ETS domain also support this observation. Interestingly, 1H{15N}-NOE of unbound PU.1 
PEST domain contains both negative and positive values, and transition from highly negative to 
slightly positive is observed as the residues are closer to the well-ordered ETS domain. On the 
other hand, 1H{15N}-NOE of the PEST domain of PU.1 in the 1:1 complex is mostly negative, 
and no such transition of the degree of disorder is observable. Average NOE values of the PEST 
domain in unbound and 1:1 DNA-bound ΔN117 are -0.09 ± 0.04 and -0.30 ± 0.03, respectively. 
This suggests that the PEST domain becomes more dynamic upon specific DNA binding. 
Collectively, the N-terminal disordered region (PEST domain) flanking the DNA-binding 
domain stays disordered upon 1:1 specific DNA binding but becomes more dynamic. 
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3.5.4 Effects of the PEST domain on backbone motions of the ETS domain of PU.1 
in the absence of DNA and the 1:1 complex with cognate DNA 
To examine the effects of the PEST domain on backbone motions of the ETS domain of 
DNA-free PU.1, we compared heteronuclear 1H{15N}-NOE of ΔN165 and ΔN117. As our group 
reported recently, ΔN165 is monomeric, and ΔN117 is dimeric at the protein concentrations 
(~600 μM) used, in the absence of DNA, in physiological conditions (138). We compared the 
average NOE values of the ETS domain of DNA-free ΔN165 and ΔN117: 0.80 ± 0.02 and 0.74 ± 
0.01, respectively. Smaller average NOE of ΔN117 (than that of ΔN165) suggests that the ETS 
domain of PU.1 is overall more dynamic in the presence of the PEST domain, than in the 
absence. Furthermore, smaller average R1 (ΔN117: 1.79 ± 0.07 as compared to ΔN165: 2.10 ± 
0.05) and larger average R2 (ΔN117: 14.59 ± 0.29 as compared to ΔN165: 10.25 ± 0.15) 
relaxation rates of the ETS domain reflect the molecular mass difference (i.e., between ΔN165 
and ΔN117) in addition to the difference in dynamics. We subsequently subtracted heteronuclear 
NOE values of ΔN117 from ΔN165 in the absence of DNA (Fig. 3.5 N). The ETS domain of 
DNA-free PU.1 dimer (ΔN117) is more dynamic than the monomer (ΔN165) because most 
residues showed positive ΔNOE values, consistent with average NOE comparison above. We 
detected the residues with relatively large |ΔNOE| values (> 0.175). The results clearly show that 
three consecutive residues Asp184, Met185, and Lys186, located on the loop between H1 and S1, 
show large ΔNOE values, along with some other residues such as Ser202 (highlighted in the 
graph). This is consistent with the exchange broadening observed for the amide of Met185 (very 
weak correlation peak of Met185) in all the 1H-15N HSQC spectra of DNA-free PU.1. These 
characteristics of Met185 residue are consistent with the trends seen in the spin relaxation rates 
(anomalously large R2 rate constant) on the picosecond to nanosecond time scale and 
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conformational exchange dynamics on the millisecond to microsecond time scale (exceptionally 
large Rex value) for the PU.1 ETS domain from literature (118). Thus, Met185 alone or the region 
around the residue (the loop between H1 and S1) is in conformational equilibria and presumably 
responsible for PU.1 homodimer formation in the absence of DNA, by contributing to 
conformational exchange processes between monomer and dimer. On the other hand, the highly 
negative ΔNOE value of the Lys245 residue suggests that the residue is less dynamic in the DNA-
free dimer than in the DNA-free monomer. Therefore, the residue is probably important for 
maintaining the monomeric form of PU.1, which is consistent with our observation that the three 
consecutive Lys residues (i.e., Lys245-247) in the “wing” play an important role in DNA 
recognition of PU.1, as discussed above (cf. in Chapter 3.5.1). 
In order to test whether the PEST domain alters internal dynamics of the ETS domain of 
PU.1 upon specific DNA binding, we compared the average NOE values of the ETS domain of 
1:1 DNA-bound ΔN165 and ΔN117: 0.79 ± 0.02 and 0.81 ± 0.03, respectively. Thus, no 
difference was observed in the average NOE values for ΔN165 and ΔN117, suggesting that the 
presence of the PEST domain does not change the net dynamics of the ETS domain. 
Subsequently, we subtracted the heteronuclear NOE values of 1:1 DNA-bound ΔN117 from 
those of ΔN165 (Fig. 3.5 O), in the same manner as the unbound protein, as described above. 
The ΔNOE values were randomly dispersed in both positive and negative directions. This further 
suggests that the presence of the PEST domain causes no net change in the internal dynamics of 
the ETS domain in the 1:1 complex with cognate DNA. Namely, the ETS domain maintains 
similar levels of fast-time scale internal dynamics in total. This result presents a great contrast to 
our observation in dimeric (ΔN117) and monomeric (ΔN165) DNA-free PU.1 proteins, as 
described above. In the case of DNA-free PU.1, the ETS domain of PU.1, as a whole, is more 
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dynamic in ΔN117 than in ΔN165, primarily because the PEST domain facilitates dynamic 
homodimer formation of the ETS domain in the absence of DNA. 
In summary, the presence of the PEST domain alters the backbone dynamics of the PU.1 
ETS domain by facilitating the homodimerization of the ETS domain in the absence of DNA. On 
the other hand, in the event of site-specific 1:1 DNA-binding, the PEST domain becomes more 
dynamic but does not change backbone motions of the ETS domain. The well-overlapped ETS 
domain residues in the 15N-HSQC spectra of ΔN117 and ΔN165 indicate almost no structural 
perturbations resulting from the presence of the PEST domain. Thus, the presence of the PEST 
domain increases the affinity of 1:1 complex of the ETS domain with cognate DNA, without 
perturbing the structure or changing the fast time scale motions of the ETS domain. 
3.6 Discussion 
3.6.1 Optimal ionic strength and pH for PU.1 backbone assignment 
For the backbone assignment of unbound PU.1 ETS domain (hPU.1sΔN165; residues 
165-258), we conducted the NMR experiments using a ~0.8 mM protein sample, at 50 mM salt, 
at pH 7.0, at 25 °C, using a 600 MHz NMR spectrometer. The PU.1 construct was assigned with  
50 mM salt because low salt is known to avoid effectively broadening of signals and to make 
shimming of NMR magnet better. The other assignments (ΔN165 and ΔN117) were done in 
physiological conditions since no mal-effect by 150 mM salt was found. On the other hand, Jia et 
al. previously assigned backbone amides of PU.1 containing almost the same residues (residues 
166-258) as our sΔN165, at 2.5 mM protein sample at 400 mM salt, pH 5.5 and 30 °C, using a 
500-MHz NMR spectrometer (139). Except for the N-terminal residue that never appears in 1H-
15N HSQC spectra and L174, they successfully assigned 91 of 93 residues. L174 was not 
detectable in our experiments as well. Furthermore, McIntosh et al. reported an NMR structure 
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of unbound murine PU.1 ETS domain (PDB: 5W3G), at 150 mM salt, pH 5.5, and 25 °C, using 
an 850-MHz NMR spectrometer. They successfully assigned all the backbone amides with a 0.3 
mM protein sample to solve the structure. Their experimental conditions (salt concentration and 
temperature) except for pH (5.5) were the same as ours. 
We fully assigned the backbone structure of the PU.1 ETS domain with and without 
flanking IDRs using protein samples at relatively low concentrations (~0.8 mM or lower) in 
physiological conditions (pH 7.0) and with a 600-MHz NMR spectrometer. However, the 
experimental conditions of other groups which achieved almost 100% backbone assignments for 
PU.1 suggest that lowered pH (5.5) effectively reduces exchange-broadening. The charge of the 
hPU.1 ETS domain (residues 165-270) at pH 7.0 and 5.5 are estimated to be 18.9 and 22.3, 
respectively (http://protcalc.sourceforge.net/cgi-bin/protcalc). Thus, such a slight increase in the 
cationic charge density of the protein probably contributes to the local stability of PU.1, and the 
chemical exchange of PU.1 residues is minimized as a result. High salt generally causes line 
broadening in NMR, while low salt drives DNA-free homodimerization of the PU.1 ETS 
domain. Therefore, 150 mM salt probably provides optimal ionic strength for PU.1. Thus, the 
optimal conditions for NMR experiments of PU.1 backbone assignment we selected are 150 mM 
salt and pH 5.5. 
3.6.2 The presence of the IDR flanking the N-terminus of the ETS domain does not 
change the DNA-binding interface or dynamics of the ETS domain upon binding 
specific DNA, for both PU.1 and Ets-1 
The 1H-15N HSQC spectra of 1:1 specific DNA-bound hPU.1ΔN117 and ΔN165 
superimposed very closely (Fig. 3.4 B). This suggests that the PEST domain does not change the 
structural interactions of PU.1 with site-specific DNA. Our NMR relaxation experiments also 
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revealed that the presence of the PEST domain does not alter the backbone dynamics of the PU.1 
ETS domain on the sub-nanosecond time scale upon 1:1 specific DNA binding. The same trend 
was reported for the 1:1 complex of Ets-1 and specific DNA by Desjardins et al. (33). The Ets-
1ΔN279 protein contains the N-terminal intrinsically disordered region (partially truncated 
“serine-rich region (SRR)”) as well as the ETS domain with the inhibitory module (IM). The 
ΔN301 protein contains only the ETS domain with the IM. Desjardins et al. demonstrated that 
the presence of the N-terminal IDR neither perturbs the structure of the ETS domain nor changes 
dynamics of the Ets-1 upon binding to specific DNA, using 1H-15N HSQC spectra and 
heteronuclear NOE measurements. 
The SRR (residues 244 to 300) of Ets-1 inhibits DNA binding in a phosphorylation-
dependent manner, by stabilizing the IM and transiently associating with DNA recognition 
interface of the ETS domain (74,141-143). The SRR of Ets-1 contains five specific Ser residues 
(251, 270, 273, 282, and 285) that are the targets of phosphorylation (36). Likewise, the PEST 
domain of PU.1 contains Ser residues (130, 131, 140, and 146) as phosphorylation targets, whose 
phosphorylation increases the anionic charge density of the protein and enhances PU.1 binding 
activity (62,138,144-149). Transition in the degree of disorder, which is the same trend seen in 
the unbound PU.1 PEST domain as shown above, was reported previously for DNA-free Ets-1 
SRR using 1H{15N}-NOE measurements (34,35). Thus, neither of these IDRs (the PEST domain 
of PU.1 and the SRR of Ets-1) change the structure and dynamics of the ETS domain. Instead, 
the PEST domain and the SRR build up anionic charges. Consequently, the PEST domain 
increases transcriptionally active PU.1, and the SRR stabilizes autoinhibition. 
The SRR of Ets-1 interacts with the ETS domain via the DNA recognition interface in the 
absence of DNA, but DNA binding by the ETS domain is favored so that the association of DNA 
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and SRR is mutually exclusive (150). The chemical shift perturbations observed in the same 
study revealed that the SRR of Ets-1 also interacts with PU.1 via the same sites (H1 and the 
wing) that are perturbed by DNA-free dimer formation of PU.1 containing the PEST domain 
(138,150). Our heteronuclear NOE measurements revealed that the PEST domain is more 
dynamic in the 1:1 complex with site-specific DNA than in the unbound dimer (cf. Fig. 3.5 F and 
L). It is presumably because specific DNA binding is favored by the PU.1 ETS domain, and 
therefore the association of DNA and the PEST domain by the PU.1 ETS domain is mutually 
exclusive, in the same manner as Ets-1 (the ETS domain and the SRR). Consequently, the “free” 
PEST domain, which is acidic (pI: 3.5) in contrast to basic ETS domain (pI: 10.5), has charge-
charge repulsion with DNA in the 1:1 complex. As a result, the PEST domain becomes more 
dynamic than that in the DNA-free dimeric form. By contrast, the PEST domain in the DNA-free 
PU.1 dimer interacts with the ETS domain electrostatically from a distance and therefore 
stabilizes the homo-dimerization of the ETS domain. Furthermore, such an increase in the 
affinity of the 1:1 PU.1/DNA complex probably makes the complex more compact, and therefore 
the rotational correlation time of the complex becomes faster. Thus, faster average R1 (ΔN117: 
1.97 ± 0.10 as compared to ΔN165: 1.53 ± 0.07) and very similar average R2 (ΔN117: 30.57 ± 
1.06 as compared to ΔN165: 29.24 ± 0.65) relaxation rates of the ETS domain of ΔN117 in the 
1:1 complex do not directly reflect the molecular weight difference (i.e., between ΔN165 and 
ΔN117). 
3.6.3 PEST domain facilitates 1:1 binding of the ETS domain with specific DNA 
Our recent study revealed that the PEST domain drives DNA-free PU.1 dimer formation 
via the ETS domain (138). Considering the PEST domain is acidic (pI: 3.5) and the ETS domain 
is highly basic (pI: 10.5), electrostatic interactions of the PEST and ETS domains would greatly 
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reduce the charge-charge repulsion arising from the homodimer of the ETS domain. Reinforcing 
negative charges in the PEST domain facilitates the DNA-free dimerization of PU.1 ETS 
domain, and acidic crowders have the same effect on PU.1 ETS domain in the absence of the 
PEST domain. Therefore, the anionic charge of the PEST domain probably gives the driving 
force for DNA-free dimerization of the ETS domain. 
In the presence of DNA, the highly cationic ETS domain bound with the PEST domain 
probably releases it and bind with DNA because phosphate groups of DNA are much more 
acidic than the PEST domain. Consequently, upon DNA binding of the ETS domain, the released 
PEST domain becomes more dynamic than in the DNA-free homodimer. This is consistent with 
our observation by heteronuclear NOE (cf. Fig. 3.5 F and L). Our DNA-binding assays also 
revealed that the presence of the PEST domain increases affinity in the 1:1 PU.1/DNA complex. 
This is probably because the “free” PEST domain enhances the ETS:DNA interaction. 
3.6.4 Dynamic properties of the ETS domains – PU.1 vs. Ets-1 
It is important to understand whether or not autoinhibition changes backbone mobility of 
the ETS domain in the ETS family. In general, DNA-binding domains of transcription factors are 
dynamic (47,48). This feature enables DNA-binding domains to search for specific binding sites 
in a majority of nonspecific DNA until it is quenched upon specific DNA binding (47,48). This 
feature is probably common for all the ETS domains because DNA-binding interface in the ETS 
domains of Ets-1 and ETV6 are conformationally dynamic (33,37). Ets-1 shares the same 
binding interface for specific and nonspecific DNA binding (33), probably due to the flexibility 
in the DNA-binding interface. However, the flexibility in the ETS domain is likely to 
compromise due to the autoinhibitory module (IM) adjacent to the ETS domain. Thus, the ETS 
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domain of PU.1 (non-autoinhibited) is probably more flexible than that of Ets-1 (autoinhibited) 
in the absence of DNA. 
We studied the dynamic properties of PU.1 by amide hydrogen-deuterium exchange 
(HDX) experiments. An HDX experiment using the PU.1 ETS domain was done in the absence 
of DNA in physiological conditions. However, almost all the crosspeaks in HSQC disappeared 
immediately when we prepared the sample in 100% D2O (only in 15 minutes) (Fig. 3.6). In 
contrast, successful HDX experiments using unbound Ets-1 have been reported (35,36). 
Therefore, the unbound PU.1 protein is probably very flexible and not fixed unless it binds to 
DNA specifically. Thus, the backbone dynamics of PU.1 is quite different from that of Ets-1 in 
this respect, probably due to the absence of autoinhibition. 
3.6.5 Responsible sites of PU.1 ETS domain for PPIs 
To examine the structural perturbation in the ETS domain upon specific DNA binding, 
we carried out chemical shift perturbation (CSP) analysis of unbound and 1:1 DNA-bound ETS 
domain of hPU.1ΔN117. Quite large CSPs were observed for amides in H1, the turn between H2 
and H3, and the wing (S3/S4) (Fig. 3.7 A and B); this is consistent with the trend seen in the CSP 
analysis of unbound and 1:1 specific DNA-bound Ets-1ΔN301 reported previously (33). 
Considering the H2 and H3 also exhibit large CSPs for both PU.1 and Ets-1, we suggest that 
PU.1 and Ets-1 bind specific DNAs via the same interface of the ETS domain. 
Interestingly enough, H1 and the wing are also the most perturbed sites according to the 
CSP analyses of DNA-free dimer formation of PU.1 (138) and the SRR moiety of Ets-1 (a 
peptide) binding to PU.1 (150). Furthermore, Met185 alone or the loop between H1 and S1 is 
presumably responsible for conformational exchange in the absence of DNA as we discussed 
above. Therefore, H1, the loop between H1 and S1, and the wing are presumably responsible for 
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ligand binding and protein-protein interactions (PPIs) of PU.1 in the absence of DNA. The four 
consecutive charged residues (193DKDK196) of hPU.1 on the loop between S1 and S2 distal to the 
DNA-binding site are at the self-dimerization interface of PU.1 ETS domain in the presence of 
site-specific DNA as described in Chapter 2. Thus, the site responsible for DNA-free PU.1 
homodimerization (H1, the loop between H1 and S1, and the wing) is different from the DNA-
bound dimeric interface. 
3.7 Conclusion 
We successfully assigned at least ~90% of HSQC resonances of hPU.1sΔN165, ΔN165, 
and ΔN117 proteins both in the absence and presence (1:1 binding) of cognate DNA. This 
provided us with opportunities to further analyze the PU.1 protein using NMR such as fast (ps to 
ns) time scale spin relaxation experiments. The protein dynamics study using NMR spectroscopy 
yielded relaxation and internal dynamics parameters (T1, T2, and heteronuclear 1H{15N}c-NOE) 
for unbound and 1:1 DNA-bound PU.1 proteins. Mainly using the NOE values, we demonstrated 
that the presence of disordered PEST domain does not change the internal dynamics of the ETS 
domain upon 1:1 specific DNA binding. The acidic PEST domain has repulsion with DNA in the 
1:1 complex and becomes more dynamic than in the DNA-free PU.1, where the PEST domain 
stabilizes the homo-dimerization and transiently associates with the ETS domain. This study can 
mark a first step toward the characterization of self-regulatory mechanisms of some ETS family 
members that lack autoinhibition. 
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Figure 3.1 DOSY and 1H-15N HSQC NMR titrations of hPU.1117-270 by 23- and 16-bp site-
specific DNA. 
 
A, (a) A DOSY NMR titration of hPU.1ΔN117 with 23-bp specific DNA demonstrate two DNA-
bound states of PU.1 (dimer at DNA:protein = 0.5 and monomer at 1:1). PU.1 dimer is not a 2:2 
DNA complex like its homolog Ets-1 protein as indicated by the absence of a single minimum at 
DNA:protein = 1:1 when 23-bp DNA was used, as shown in red data points. The DOSY titration 
data using mPU.1ΔN167 and 16-bp specific DNA, as described in Chapter 2 (cf. Fig. 2.3), is 
shown in blue data points for comparison. (b) As shown in magenta data points, 16-bp DNA was 
not long enough for hPU.1ΔN117 protein to form the 1:1 and 2:1 PU.1/DNA complexes in direct 
response to the PU.1/DNA molar ratio. B, Uniformly 15N-labeled hPU.1ΔN117 was titrated with 
a 23-bp unlabeled specific DNA at the indicated molar ratios. C, (a) An overlay of the HSQC 
spectra of 1:1 hPU.1ΔN117 complex with 16-bp HA DNA (red) onto 23-bp HA DNA (green). 
Three consecutive residues K245-247 shifted a lot between these two states (circled in blue in 
the HSQC spectrum of the 23-bp DNA). (b) Mapping the K245-247 residues (highlighted in red) 
on the structure of 1:1 complex (PDB 1PUE). These residues reside at the center of the wing 
(S3/S4) (circled in blue), and therefore they are highly perturbed by the DNA length. 
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Figure 3.2 Primary sequence of hPU.1 and partial strips of 3D NMR spectra used in the 
sequential backbone assignment. 
 
A, Primary sequence of hPU.1117-270. The N- and C-terminal residues of sPU.1 (165-258 aa), 
hPU.1ΔN165 (165-270 aa), and hPU.1ΔN117 (117-270 aa) are shown in L-shaped lines. The 
five specific amino acids that have characteristic carbon chemical shifts (G, A, S, and T) or have 
no 1H attached to its 15N (P) are shown in color and bold (G: blue; A: green; S and T: red; P: 
gray). Consecutive residues among these were able to assign directly. Thus, they were used as 
starting points for sequential assignments. B, A representative set of strips of 3D NMR spectra 
(CACBCONH, HNCACB, and HNCA from left to right) of Q251, F252, S253, and G254 
residues of hPU.1ΔN165 in the absence of DNA. Connections of the alpha and beta carbon 
signals of each residue are shown in yellow lines. The red square indicates the beta carbon 
signals of S253. 
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(A) hPU.1 proteins in the absence of DNA 
  
93 
(B) hPU.1 proteins in 1:1 Complex with cognate DNA 
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Figure 3.3 1H-15N HSQC spectra of hPU.1 proteins (sΔN165, ΔN165, and ΔN117) in the 
absence of DNA and in the 1:1 complex with cognate DNA, with the resonances assigned. 
 
1H-15N HSQC resonances of hPU.1 proteins sΔN165 (top panel), ΔN165 (middle panel), and 
ΔN117 (bottom panel) in the absence of DNA (A), and sΔN165 (top panel), ΔN165 (middle 
panel), and ΔN117 (bottom panel) in 1:1 complex with cognate DNA (B) were sequentially 
assigned using 3D NMR experiments HNCO, HN(CA)CO, HNCA, HNCACB, and 
HN(CO)CACB. Note that the resonances of hPU.1sΔN165 in the 1:1 complex with 16-bp site-
specific DNA were assigned by our collaborator Dr. James Aramini. 
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Figure 3.4 The presence of the PEST domain does not perturb the PU.1 ETS domain 
structurally, and it remains disordered upon DNA binding. 
 
Overlaid HSQC spectra of hPU.1ΔN117 (red) and ΔN165 (blue) in the absence of DNA (A) and 
in the 1:1 complex with cognate DNA (B). 
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Figure 3.5 Fast (picosecond to nanosecond) time scale backbone dynamics of unbound 
and DNA-bound (1:1 complex) PU.1 obtained by 15N spin relaxation measurements. 
 
R1, R2, and heteronuclear 1H{15N}-NOE plots of unbound hPU.1ΔN165 (A-C) and 
ΔN117 (D-F) and 1:1 complex of ΔN165 (G-I) and ΔN117 (J-L) with 23-bp specific DNA (5’-
GCGAATAAGCGGAAGTGAAACCG-3’). The color scheme follows the HSQC in Fig. 3.4. 
Heteronuclear 1H{15N}-NOE error was derived by |𝑁𝑂𝐸|√{(
𝑛𝑜𝑖𝑠𝑒 𝑆𝑎𝑡
𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑆𝑎𝑡
)2 + (
𝑛𝑜𝑖𝑠𝑒 𝑈𝑛𝑠𝑎𝑡
𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑈𝑛𝑠𝑎𝑡
)2} 
using backgoround noise level of the spectra. Weak HSQC signals of M185 and K245 (M) 
resulted in high errors in the spin relaxation measurements. Subtracted heteronuclear NOE 
(ΔN165 - ΔN117) of DNA-free PU.1 (N) and 1:1 complex of PU.1 with the same DNA (O) are 
also shown.  
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Figure 3.6 Amide hydrogen-deuterium exchange (HDX) of the PU.1 ETS domain. 
 
A 1H-15N HSQC spectrum using mPU.1ΔN167 protein as a reference (A). The first 1H-15N 
HSQC spectrum of uniformly 15N-labeled mPU.1ΔN167 sample in 100% D2O. Because most of 
the PU.1 crosspeaks disappeared immediately after bringing up the PU.1 with 100% D2O and set 
up an HSQC experiment (only after ~15 min), slow amide-deuterium 1H exchange rates were not 
able to measure using this sample (B). The HSQC spectrum using the same PU.1 sample in 
100% D2O after ~1 h (C). 1D 1H NMR of the sample in (A) (top) and (C) (bottom), respectively. 
Note that the PU.1 protein in the bottom sample is folded judging from the methyl peaks. 
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Figure 3.7 1H-15N Chemical shift perturbations (CSPs) of unbound and DNA-bound (1:1 
complex) PU.1 ETS domain. 
 
A, an overlay of 1:1 specific DNA-bound (green) onto unbound (red) hPU.1ΔN117 HSQC 
spectra. B, weighed average of amide (15N and 1H) chemical shift perturbations (CSPs) from 
unbound and DNA-bound (1:1 complex with 23-bp specific DNA) PU.1 ETS domain (ΔN117), 
derived by Δδ = √{δ1H2 + 0.2 (δ15N)2}, are plotted as a function of residue number in hPU.1. 
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Supplemental Table 3.1 Relaxation rates of DNA-free hPU.1ΔN165. 
 
Res. R1 (1/s)   R2 (1/s)                NOE 
 
168 3.04 ± 0.18 4.67 ± 0.37 -0.514 ± 0.099 
169 3.09 ± 0.30 5.74 ± 0.33 0.272 ± 0.090 
170 2.86 ± 0.15 6.98 ± 0.15 0.465 ± 0.032 
171 2.70 ± 0.12 11.03 ± 0.34 0.670 ± 0.046 
173 2.24 ± 0.10 9.89 ± 0.26 0.970 ± 0.030 
174 1.88 ± 0.09 10.34 ± 0.13 0.892 ± 0.030 
175 2.07 ± 0.01 10.63 ± 0.16 0.921 ± 0.022 
176 1.70 ± 0.10 10.66 ± 0.39 0.921 ± 0.034 
177 1.61 ± 0.10 10.90 ± 0.26 0.802 ± 0.028 
178 1.64 ± 0.04 10.50 ± 0.29 0.909 ± 0.020 
179 1.47 ± 0.16 9.48 ± 0.16 0.878 ± 0.024 
180 1.46 ± 0.15 25.40 ± 1.39 0.970 ± 0.081 
181 1.79 ± 0.21 9.88 ± 0.36 1.004 ± 0.092 
182 1.95 ± 0.06 10.83 ± 0.47 0.841 ± 0.028 
183 2.13 ± 0.07 12.00 ± 0.34 0.870 ± 0.031 
184 2.12 ± 0.09 14.22 ± 0.43 0.832 ± 0.025 
185 1.65 ± 0.42 20.83 ± 0.48 0.856 ± 0.223 
186 1.77 ± 0.09 12.75 ± 0.52 0.959 ± 0.085 
187 2.11 ± 0.06 11.27 ± 0.33 0.830 ± 0.023 
188 1.83 ± 0.04 9.87 ± 0.30 0.876 ± 0.034 
189 1.96 ± 0.13 10.04 ± 0.23 0.917 ± 0.035 
190 2.07 ± 0.01 10.63 ± 0.16 0.921 ± 0.022 
191 1.63 ± 0.02 9.98 ± 0.24 0.892 ± 0.032 
192 1.74 ± 0.13 8.78 ± 0.23 0.861 ± 0.056 
193 2.00 ± 0.07 9.22 ± 0.24 0.842 ± 0.032 
194 2.98 ± 0.19 10.91 ± 0.29 0.848 ± 0.052 
195 2.52 ± 0.28 10.70 ± 0.25 0.839 ± 0.020 
196 1.55 ± 0.06 9.73 ± 0.21 0.820 ± 0.028 
197 1.61 ± 0.02 10.16 ± 0.61 0.836 ± 0.027 
198 1.87 ± 0.06 9.89 ± 0.39 0.875 ± 0.027 
199 1.89 ± 0.04 9.10 ± 0.42 0.922 ± 0.037 
200 1.83 ± 0.05 9.59 ± 0.28 0.862 ± 0.033 
201 1.97 ± 0.10 10.98 ± 0.34 0.877 ± 0.041 
202 2.14 ± 0.12 9.79 ± 0.18 0.824 ± 0.032 
205 2.71 ± 0.24 11.72 ± 0.47 0.869 ± 0.057 
206 2.81 ± 0.14 10.50 ± 0.42 0.781 ± 0.028 
207 2.17 ± 0.04 11.10 ± 0.30 0.861 ± 0.024 
208 2.10 ± 0.04 10.31 ± 0.26 0.895 ± 0.022 
209 1.58 ± 0.09 9.74 ± 0.40 0.820 ± 0.032 
210 1.28 ± 0.15 9.10 ± 0.57 0.917 ± 0.025 
211 2.15 ± 0.05 10.91 ± 0.30 0.867 ± 0.019 
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Res. R1 (1/s)   R2 (1/s)                NOE 
 
212 2.03 ± 0.16 10.89 ± 0.27 0.906 ± 0.024 
213 1.95 ± 0.07 9.35 ± 0.24 0.786 ± 0.024 
214 1.54 ± 0.10 10.91 ± 0.38 0.890 ± 0.037 
215 1.71 ± 0.11 11.17 ± 0.35 0.848 ± 0.013 
216 2.03 ± 0.14 9.63 ± 0.30 0.888 ± 0.026 
217 2.19 ± 0.14 12.45 ± 0.45 0.853 ± 0.026 
218 2.63 ± 0.10 12.52 ± 0.60 0.718 ± 0.044 
219 2.96 ± 0.24 11.40 ± 0.33 0.713 ± 0.043 
221 2.73 ± 0.14 9.90 ± 0.14 0.607 ± 0.053 
223 2.61 ± 0.09 11.22 ± 0.47 0.649 ± 0.035 
224 1.96 ± 0.03 11.55 ± 0.40 0.734 ± 0.033 
225 2.91 ± 0.13 11.23 ± 0.14 0.766 ± 0.056 
226 2.40 ± 0.10 12.15 ± 0.27 0.783 ± 0.024 
227 1.30 ± 0.12 10.45 ± 0.35 0.880 ± 0.032 
228 1.60 ± 0.06 9.84 ± 0.23 0.852 ± 0.025 
229 1.98 ± 0.18 10.39 ± 0.23 0.879 ± 0.025 
230 1.71 ± 0.11 11.17 ± 0.35 0.848 ± 0.013 
231 1.79 ± 0.18 9.59 ± 0.19 0.810 ± 0.020 
232 1.82 ± 0.13 10.54 ± 0.27 0.808 ± 0.024 
233 1.95 ± 0.13 9.86 ± 0.50 0.860 ± 0.022 
234 2.27 ± 0.15 10.39 ± 0.31 0.861 ± 0.021 
235 2.09 ± 0.14 10.40 ± 0.35 0.708 ± 0.022 
236 1.74 ± 0.06 10.04 ± 0.17 0.831 ± 0.025 
237 2.88 ± 0.17 10.95 ± 0.28 0.768 ± 0.039 
238 2.18 ± 0.05 11.76 ± 0.45 0.746 ± 0.032 
239 1.64 ± 0.06 9.18 ± 0.28 0.803 ± 0.029 
240 2.01 ± 0.05 9.55 ± 0.19 0.846 ± 0.023 
241 1.64 ± 0.09 10.13 ± 0.28 0.885 ± 0.027 
242 1.67 ± 0.06 8.57 ± 0.29 0.838 ± 0.038 
243 2.14 ± 0.03 8.30 ± 0.21 0.784 ± 0.027 
244 1.76 ± 0.12 9.37 ± 0.23 0.869 ± 0.041 
245 2.93 ± 0.39 11.01 ± 0.58 0.517 ± 0.151 
246 2.68 ± 0.11 7.01 ± 0.27 0.345 ± 0.029 
247 3.10 ± 0.39 11.27 ± 0.57 0.684 ± 0.155 
248 3.23 ± 0.37 10.02 ± 0.36 0.707 ± 0.097 
249 2.17 ± 0.09 9.50 ± 0.21 0.819 ± 0.032 
250 1.89 ± 0.05 10.45 ± 0.44 0.919 ± 0.040 
251 1.59 ± 0.09 9.85 ± 0.32 0.882 ± 0.039 
252 1.58 ± 0.12 10.61 ± 0.24 0.862 ± 0.036 
253 1.89 ± 0.12 11.04 ± 0.23 0.876 ± 0.026 
254 3.01 ± 0.20 10.16 ± 0.54 0.813 ± 0.043 
255 2.78 ± 0.26 10.30 ± 0.33 0.841 ± 0.025 
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Res. R1 (1/s)   R2 (1/s)                NOE 
 
256 1.76 ± 0.03 10.51 ± 0.28 0.853 ± 0.027 
257 1.78 ± 0.07 10.48 ± 0.24 0.900 ± 0.029 
258 2.39 ± 0.12 9.23 ± 0.36 0.788 ± 0.025 
259 2.64 ± 0.08 9.02 ± 0.21 0.701 ± 0.033 
260 2.78 ± 0.22 6.93 ± 0.28 0.483 ± 0.080 
261 2.95 ± 0.20 5.86 ± 0.18 0.237 ± 0.048 
262 3.21 ± 0.13 5.42 ± 0.13 0.261 ± 0.025 
263 2.86 ± 0.16 4.94 ± 0.17 -0.053 ± 0.026 
264 3.13 ± 0.12 4.85 ± 0.13 0.078 ± 0.022 
265 3.26 ± 0.23 5.01 ± 0.28 -0.166 ± 0.049 
266 2.06 ± 0.13 2.63 ± 0.16 -1.043 ± 0.160 
267 1.73 ± 0.12 2.47 ± 0.03 -1.172 ± 0.114 
270 1.68 ± 0.07 2.12 ± 0.06 -1.188 ± 0.032 
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Supplemental Table 3.2 Relaxation rates of DNA-free hPU.1ΔN117. 
 
Res. R1 (1/s)   R2 (1/s)                NOE 
 
118 4.50 ± 0.63 4.49 ± 1.01 -0.717 ± 0.205 
123 3.09 ± 0.28 4.82 ± 0.12 -0.410 ± 0.023 
125 3.99 ± 0.80 4.69 ± 0.27 -0.396 ± 0.044 
127 3.04 ± 0.18 6.57 ± 0.18 -0.318 ± 0.012 
128 2.70 ± 0.14 5.03 ± 0.12 -0.067 ± 0.007 
130 2.93 ± 0.21 5.65 ± 0.18 -0.110 ± 0.026 
131 3.58 ± 0.76 5.14 ± 0.20 0.017 ± 0.059 
132 3.03 ± 0.23 6.24 ± 0.40 0.104 ± 0.017 
133 2.70 ± 0.14 5.03 ± 0.12 -0.067 ± 0.007 
134 2.79 ± 0.10 5.42 ± 0.15 -0.239 ± 0.011 
135 2.79 ± 0.15 5.91 ± 0.18 0.146 ± 0.010 
136 3.12 ± 0.18 5.45 ± 0.19 0.141 ± 0.015 
137 3.01 ± 0.14 6.20 ± 0.21 0.240 ± 0.010 
138 2.21 ± 0.07 5.69 ± 0.14 0.168 ± 0.014 
139 2.57 ± 0.13 5.71 ± 0.12  
140 2.56 ± 0.37 7.94 ± 0.50 0.129 ± 0.030 
143 2.21 ± 0.07 5.69 ± 0.14 0.168 ± 0.014 
144 2.69 ± 0.09 6.21 ± 0.15 0.088 ± 0.013 
145 3.02 ± 0.21 6.07 ± 0.16 0.144 ± 0.015 
146 3.05 ± 0.23 6.58 ± 0.30 0.318 ± 0.026 
148 3.19 ± 0.26  0.123 ± 0.020 
150 4.11 ± 0.42 6.30 ± 0.55 0.409 ± 0.136 
151 3.00 ± 0.22 6.84 ± 0.16 0.194 ± 0.015 
152 2.68 ± 0.07 5.34 ± 0.16 0.205 ± 0.009 
153 2.58 ± 0.16 6.71 ± 0.37 0.202 ± 0.014 
154 2.49 ± 0.06 5.86 ± 0.15 0.144 ± 0.013 
156 3.00 ± 0.21 7.26 ± 0.47 0.233 ± 0.012 
158 3.13 ± 0.27 5.75 ± 0.08 0.129 ± 0.023 
159 2.65 ± 0.10 5.39 ± 0.15 0.163 ± 0.013 
160 2.10 ± 0.03 4.87 ± 0.27 0.113 ± 0.013 
162 3.16 ± 0.21 6.09 ± 0.54 0.180 ± 0.033 
163 3.39 ± 0.29 6.33 ± 0.26 0.332 ± 0.021 
164 3.10 ± 0.36 11.37 ± 1.05 0.228 ± 0.060 
165 3.60 ± 0.75 5.29 ± 0.67 0.200 ± 0.082 
166 0.00 ± 0.00 7.00 ± 0.90 0.247 ± 0.149 
167 3.01 ± 0.27 7.16 ± 0.66 0.350 ± 0.030 
170 2.65 ± 0.12 11.53 ± 0.47 0.564 ± 0.032 
171 2.94 ± 0.19 4.17 ± 0.15 0.451 ± 0.043 
173  14.56 ± 0.74 0.841 ± 0.068 
174 1.57 ± 0.20 15.14 ± 0.72 0.954 ± 0.064 
175 1.30 ± 0.16 15.33 ± 0.95 0.676 ± 0.032 
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Res. R1 (1/s)   R2 (1/s)                NOE 
 
176 0.86 ± 0.19 15.86 ± 0.63 0.820 ± 0.074 
177 1.28 ± 0.29 16.19 ± 0.60 0.829 ± 0.042 
178 1.39 ± 0.16 16.20 ± 0.48 0.816 ± 0.041 
179 1.48 ± 0.20 14.94 ± 0.68 0.870 ± 0.052 
181 1.11 ± 0.26 14.08 ± 0.54 0.937 ± 0.125 
182 1.49 ± 0.16 16.29 ± 0.57 0.895 ± 0.054 
183 1.92 ± 0.14 16.83 ± 0.82 0.731 ± 0.046 
184 1.59 ± 0.12 18.01 ± 0.78 0.644 ± 0.035 
185 0.00 ± 0.00 18.48 ± 2.13 0.542 ± 0.163 
186 1.65 ± 0.92 15.71 ± 2.03 0.782 ± 0.077 
187 0.87 ± 0.45 16.48 ± 0.91 0.770 ± 0.036 
188 1.47 ± 0.07 14.41 ± 0.38 0.761 ± 0.057 
189 1.25 ± 0.25 17.40 ± 2.22 0.808 ± 0.053 
190 1.44 ± 0.14 14.67 ± 0.64 0.845 ± 0.035 
191 1.21 ± 0.38 14.96 ± 0.56 0.777 ± 0.049 
192 1.78 ± 0.52 12.96 ± 0.37 0.725 ± 0.083 
193 1.97 ± 0.50 14.46 ± 0.69 0.703 ± 0.022 
194 3.40 ± 0.45 12.72 ± 0.58 0.805 ± 0.083 
195 1.98 ± 0.18 15.74 ± 0.18 0.727 ± 0.035 
196 1.15 ± 0.38 14.45 ± 0.59 0.752 ± 0.041 
197 1.43 ± 0.09 14.65 ± 0.75 0.733 ± 0.046 
198 1.38 ± 0.12 15.95 ± 0.39 0.955 ± 0.050 
199 1.30 ± 0.40 15.06 ± 0.87 0.811 ± 0.057 
200 1.21 ± 0.11 15.14 ± 0.94 0.751 ± 0.054 
201 1.35 ± 0.35 15.39 ± 0.66 0.830 ± 0.068 
202 1.98 ± 0.12 11.47 ± 0.45 0.376 ± 0.028 
205 2.00 ± 0.34 16.28 ± 0.87 0.708 ± 0.077 
206 2.25 ± 0.32 15.98 ± 0.64 0.814 ± 0.057 
207 1.89 ± 0.13 12.73 ± 1.12 0.617 ± 0.035 
208 1.87 ± 0.10 16.38 ± 0.42 0.884 ± 0.043 
209 1.41 ± 0.24 15.04 ± 0.36 0.748 ± 0.044 
210 1.17 ± 0.22 16.76 ± 0.45 0.750 ± 0.046 
211 1.43 ± 0.09 16.92 ± 0.71 0.779 ± 0.043 
212 2.13 ± 0.12 14.40 ± 0.54 0.703 ± 0.022 
213 2.21 ± 0.07   
214 1.99 ± 0.31 16.33 ± 0.97 0.753 ± 0.071 
215 1.49 ± 0.11 17.21 ± 1.00 0.801 ± 0.026 
216 1.81 ± 0.67 12.90 ± 0.90 0.834 ± 0.032 
217 1.52 ± 0.22 18.03 ± 0.59 0.822 ± 0.056 
218 2.21 ± 0.49 17.68 ± 2.39 0.779 ± 0.076 
219 2.44 ± 0.50 16.72 ± 1.92 0.615 ± 0.041 
223 2.68 ± 0.31 16.37 ± 2.14 0.626 ± 0.057 
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Res. R1 (1/s)   R2 (1/s)                NOE 
 
224 1.34 ± 0.18 17.97 ± 0.89 0.709 ± 0.061 
225 3.39 ± 0.30 12.90 ± 0.95 0.801 ± 0.109 
226 2.20 ± 0.09 15.86 ± 0.70 0.723 ± 0.043 
227 1.58 ± 0.17 15.23 ± 0.61 0.826 ± 0.042 
228 1.47 ± 0.10 15.67 ± 0.70 0.748 ± 0.053 
229 1.21 ± 0.18 16.48 ± 1.71 0.814 ± 0.048 
230 1.49 ± 0.11 16.92 ± 0.79 0.801 ± 0.026 
231 1.41 ± 0.12 14.56 ± 0.28 0.843 ± 0.045 
232 1.49 ± 0.14 16.02 ± 0.59 0.831 ± 0.053 
233 1.52 ± 0.15 15.16 ± 1.75 0.568 ± 0.025 
234 1.83 ± 0.09 14.61 ± 0.53 0.790 ± 0.038 
235 1.58 ± 0.31 15.33 ± 0.24 0.692 ± 0.026 
236 1.94 ± 0.34 13.72 ± 0.88 0.651 ± 0.028 
237 2.02 ± 0.21 15.63 ± 0.38 0.773 ± 0.032 
238 1.74 ± 0.22 15.10 ± 0.79 0.664 ± 0.043 
239 1.56 ± 0.10 13.52 ± 0.45 0.727 ± 0.043 
240 1.53 ± 0.12 15.09 ± 0.41 0.703 ± 0.043 
241  16.79 ± 0.72 0.778 ± 0.045 
242 1.50 ± 0.38 13.60 ± 0.39 0.817 ± 0.056 
243 1.48 ± 0.18 12.57 ± 0.28 0.756 ± 0.045 
244 1.67 ± 0.27 14.19 ± 0.76 0.794 ± 0.067 
245 2.60 ± 1.62 9.05 ± 1.54 0.792 ± 0.190 
246  9.69 ± 0.10  
248 2.53 ± 0.30 12.46 ± 0.73 0.674 ± 0.127 
249 3.59 ± 0.92 14.30 ± 0.37 0.722 ± 0.042 
250 1.26 ± 0.25 12.26 ± 0.43 0.818 ± 0.060 
251 1.31 ± 0.18 15.56 ± 0.89 0.732 ± 0.056 
252 1.31 ± 0.18 16.19 ± 0.82 0.777 ± 0.062 
253 1.72 ± 0.19 13.80 ± 1.87 0.735 ± 0.044 
254 2.63 ± 0.30 12.59 ± 0.60 0.859 ± 0.075 
255 2.47 ± 0.25 13.81 ± 0.58 0.680 ± 0.040 
256 1.65 ± 0.09 16.11 ± 0.76 0.836 ± 0.040 
257 1.31 ± 0.30 15.38 ± 0.28 0.692 ± 0.026 
258 1.76 ± 0.15 14.20 ± 0.55 0.775 ± 0.038 
259 2.53 ± 0.21 12.36 ± 0.31 0.587 ± 0.033 
260 3.29 ± 0.37 8.69 ± 0.73 0.363 ± 0.048 
261 2.68 ± 0.07 5.34 ± 0.16 0.205 ± 0.009 
262 3.07 ± 0.22 5.95 ± 0.20 0.080 ± 0.014 
263 3.09 ± 0.17 5.17 ± 0.20 -0.095 ± 0.011 
264 2.99 ± 0.16 5.26 ± 0.12 0.150 ± 0.013 
266 2.05 ± 0.16 3.08 ± 0.15 -0.492 ± 0.098 
267 1.68 ± 0.14 2.62 ± 0.07 -0.462 ± 0.060 
270 1.72 ± 0.06 2.30 ± 0.04 -0.669 ± 0.018 
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Supplemental Table 3.3 Relaxation rates of 1:1 DNA-bound hPU.1ΔN165. 
 
Res. R1 (1/s)   R2 (1/s)                NOE 
 
167 2.35 ± 0.36 16.70 ± 1.24 -0.136 ± 0.035 
168 2.94 ± 0.19 9.17 ± 0.85 0.163 ± 0.008 
169 2.87 ± 0.23 10.48 ± 1.38 0.114 ± 0.009 
170 2.95 ± 0.16 9.13 ± 0.97 0.195 ± 0.020 
171 1.63 ± 0.70 30.05 ± 2.55 0.885 ± 0.071 
172 1.25 ± 0.66 22.14 ± 3.54 0.818 ± 0.128 
173 1.59 ± 1.35 29.85 ± 1.57 0.894 ± 0.090 
174 0.80 ± 0.44 35.22 ± 3.89 0.894 ± 0.079 
175 1.92 ± 0.36 29.21 ± 4.22 0.732 ± 0.058 
177 1.29 ± 0.42 33.53 ± 1.81 0.859 ± 0.052 
178 3.31 ± 0.73 32.39 ± 2.72 0.789 ± 0.060 
179 0.74 ± 0.21 31.51 ± 1.91 0.889 ± 0.033 
180 1.29 ± 0.74 43.76 ± 4.01 1.023 ± 0.189 
181 1.10 ± 0.27 17.84 ± 1.30 0.770 ± 0.138 
182 0.73 ± 0.30 30.92 ± 1.80 0.838 ± 0.062 
183  29.91 ± 3.01 0.811 ± 0.066 
184 1.10 ± 0.35 33.45 ± 2.09 0.680 ± 0.048 
186 1.02 ± 0.30 31.17 ± 2.29 0.755 ± 0.072 
187 1.01 ± 0.26 34.93 ± 2.27 0.894 ± 0.052 
188 0.86 ± 0.13 34.77 ± 2.33 0.977 ± 0.103 
189 1.52 ± 0.47 29.90 ± 2.31 1.088 ± 0.078 
190 1.08 ± 0.21 31.51 ± 1.91 0.889 ± 0.033 
191 0.74 ± 0.17 29.55 ± 2.27 0.948 ± 0.077 
192 1.79 ± 0.30 26.59 ± 5.20 0.637 ± 0.137 
193 0.76 ± 0.61 30.05 ± 2.03 0.689 ± 0.050 
194 1.17 ± 0.56 29.97 ± 3.07 0.983 ± 0.147 
195 0.92 ± 0.37 36.29 ± 3.09 0.936 ± 0.062 
196 1.16 ± 0.35 30.43 ± 2.90 0.787 ± 0.065 
197 1.27 ± 0.43 30.25 ± 2.67 0.780 ± 0.045 
198 1.29 ± 0.41 32.76 ± 2.21 0.952 ± 0.059 
199 1.39 ± 0.61 28.50 ± 2.05 0.947 ± 0.081 
200 1.76 ± 0.40 28.59 ± 1.80 0.819 ± 0.038 
201  27.31 ± 1.82 0.880 ± 0.090 
202 1.97 ± 0.53 28.98 ± 4.69 0.874 ± 0.121 
204 1.03 ± 0.46 29.16 ± 2.37 0.688 ± 0.073 
205 3.05 ± 0.52 24.31 ± 2.57 0.787 ± 0.075 
206 1.08 ± 0.14 19.17 ± 2.59 0.688 ± 0.088 
208 1.46 ± 0.31 17.19 ± 4.28 0.833 ± 0.061 
209 1.21 ± 0.36 38.35 ± 2.67 0.655 ± 0.089 
210 1.13 ± 0.27 28.58 ± 2.00 0.727 ± 0.067 
211 1.56 ± 0.36 35.27 ± 3.41 0.733 ± 0.062 
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Res. R1 (1/s)   R2 (1/s)                NOE 
 
212 1.89 ± 0.46 36.99 ± 4.08 0.775 ± 0.067 
213 1.04 ± 0.56 36.93 ± 4.49 0.685 ± 0.050 
214 1.89 ± 1.05 33.81 ± 1.20 0.834 ± 0.155 
217 1.77 ± 0.11 33.50 ± 5.49 0.871 ± 0.080 
218 1.35 ± 0.20 31.39 ± 2.56 0.900 ± 0.072 
219 1.26 ± 0.30 35.78 ± 3.17 0.899 ± 0.064 
220 1.76 ± 0.40 28.59 ± 1.80 0.819 ± 0.038 
221 1.29 ± 0.23 31.24 ± 2.22 0.687 ± 0.062 
222 1.50 ± 0.37 27.25 ± 3.57 0.651 ± 0.079 
223 2.24 ± 0.69 30.29 ± 3.33 0.740 ± 0.101 
224  25.21 ± 2.51 0.863 ± 0.101 
225 0.93 ± 0.45 27.63 ± 2.18 0.888 ± 0.112 
226 1.59 ± 0.14 31.42 ± 2.49 0.860 ± 0.052 
227 2.13 ± 0.74 33.24 ± 2.24 0.830 ± 0.085 
228 1.25 ± 0.89 29.53 ± 2.09 0.822 ± 0.072 
229 1.75 ± 0.74 33.68 ± 4.06 0.943 ± 0.063 
230 1.30 ± 0.58 31.59 ± 2.22 0.879 ± 0.072 
231 1.63 ± 0.70 30.05 ± 2.55 0.885 ± 0.071 
232 1.64 ± 0.57 27.81 ± 3.04 0.713 ± 0.063 
233 1.21 ± 0.31 30.84 ± 3.20 0.885 ± 0.090 
234 1.87 ± 0.50 32.37 ± 1.67 0.785 ± 0.049 
235 1.54 ± 0.46 33.21 ± 2.25 0.817 ± 0.056 
236 0.54 ± 0.24 33.07 ± 2.69 0.760 ± 0.045 
237 1.13 ± 0.21 29.80 ± 1.35 0.502 ± 0.033 
238 1.28 ± 0.52 29.65 ± 2.39 0.801 ± 0.056 
239 0.95 ± 0.38 25.25 ± 1.76 0.684 ± 0.057 
240 1.74 ± 0.20 31.95 ± 1.82 0.889 ± 0.070 
241 2.12 ± 0.58 29.03 ± 2.76 0.845 ± 0.065 
242 2.21 ± 0.44 24.10 ± 1.98 0.681 ± 0.087 
243 1.53 ± 0.25 25.73 ± 1.98 0.827 ± 0.082 
244 2.27 ± 0.69 22.04 ± 2.61 1.189 ± 0.183 
245 0.96 ± 0.26 31.03 ± 2.89 0.836 ± 0.067 
246 1.16 ± 0.48 32.48 ± 1.85 0.601 ± 0.054 
247  33.81 ± 2.73 0.675 ± 0.089 
248 1.31 ± 0.34 29.68 ± 2.70 1.080 ± 0.183 
249 1.67 ± 0.28 16.34 ± 1.48 0.506 ± 0.032 
250 1.56 ± 0.43 25.60 ± 3.13 1.006 ± 0.109 
251 2.30 ± 0.21 28.14 ± 3.53 0.744 ± 0.069 
252 1.63 ± 0.80 25.69 ± 4.02 0.709 ± 0.084 
253 1.66 ± 0.21 33.45 ± 3.60 0.849 ± 0.083 
254 3.04 ± 0.74 29.33 ± 4.35 1.012 ± 0.096 
255 1.91 ± 0.54 33.68 ± 1.92 0.839 ± 0.056 
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Res. R1 (1/s)   R2 (1/s)                NOE 
 
256 1.22 ± 0.12 33.47 ± 2.85 0.763 ± 0.062 
257  30.84 ± 2.78 0.934 ± 0.084 
258 1.13 ± 0.39 29.65 ± 2.21 0.826 ± 0.049 
259 2.40 ± 0.27 25.95 ± 2.65 0.640 ± 0.028 
260 2.96 ± 0.45 14.33 ± 1.04 0.392 ± 0.024 
261 2.97 ± 0.31 13.00 ± 0.98 0.293 ± 0.012 
262 2.79 ± 0.21 10.62 ± 0.91 0.278 ± 0.008 
263 2.88 ± 0.16 9.09 ± 0.83 0.117 ± 0.007 
264 2.83 ± 0.15 8.67 ± 0.79 0.121 ± 0.006 
266 1.59 ± 0.32 4.75 ± 0.52 -0.717 ± 0.074 
267 1.51 ± 0.06 4.21 ± 0.50 -0.377 ± 0.036 
270 1.57 ± 0.08 3.53 ± 0.45 -0.868 ± 0.011 
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Supplemental Table 3.4 Relaxation rates of 1:1 DNA-bound hPU.1ΔN117. 
 
Res. R1 (1/s)   R2 (1/s)                NOE 
 
123 3.30 ± 0.21 5.66 ± 0.39 -0.560 ± 0.010 
125 3.40 ± 0.36 5.66 ± 0.39 -0.638 ± 0.015 
127 2.89 ± 0.15 3.61 ± 0.35 -0.576 ± 0.006 
128 2.48 ± 0.11 4.03 ± 0.27 -0.269 ± 0.002 
130 3.19 ± 0.22 5.38 ± 0.30 -0.364 ± 0.007 
131 3.38 ± 0.29 5.91 ± 0.36 -0.253 ± 0.010 
132 2.65 ± 0.12 4.46 ± 0.43 -0.241 ± 0.003 
134 2.23 ± 0.09 3.23 ± 0.38 -0.448 ± 0.005 
135 2.40 ± 0.09 3.71 ± 0.36 -0.228 ± 0.004 
136 2.68 ± 0.14 3.73 ± 0.37 -0.440 ± 0.004 
137 2.48 ± 0.11 4.03 ± 0.27 -0.269 ± 0.002 
138 1.78 ± 0.06 3.09 ± 0.25 -0.323 ± 0.004 
139 3.13 ± 0.19 4.71 ± 0.44 -0.201 ± 0.007 
140 3.08 ± 0.22 5.35 ± 0.30 -0.208 ± 0.008 
143 1.78 ± 0.06 3.09 ± 0.25 -0.323 ± 0.004 
144 2.59 ± 0.11 4.02 ± 0.31 -0.389 ± 0.006 
145 2.16 ± 0.09 2.76 ± 0.32 -0.216 ± 0.005 
146 3.13 ± 0.18 5.88 ± 0.72 -0.352 ± 0.007 
148 2.68 ± 0.14 3.49 ± 0.27 -0.440 ± 0.004 
150 3.17 ± 0.21 4.90 ± 0.31 -0.299 ± 0.042 
151 2.66 ± 0.14 5.34 ± 0.58 -0.388 ± 0.006 
152 2.30 ± 0.09 4.57 ± 0.29 -0.384 ± 0.003 
153 2.07 ± 0.08 3.27 ± 0.27 -0.296 ± 0.005 
154 2.01 ± 0.05 3.69 ± 0.29 -0.403 ± 0.006 
156 2.30 ± 0.09 4.57 ± 0.29 -0.384 ± 0.003 
158 2.77 ± 0.18 5.32 ± 0.41 -0.117 ± 0.006 
159 1.99 ± 0.07 4.20 ± 0.34 -0.120 ± 0.006 
160 1.70 ± 0.04 4.23 ± 0.34 -0.129 ± 0.006 
162 2.53 ± 0.31 5.87 ± 0.40 -0.008 ± 0.045 
163 2.70 ± 0.17 6.01 ± 0.39 0.101 ± 0.007 
164 3.21 ± 0.26 6.86 ± 0.47 -0.113 ± 0.010 
165 3.08 ± 0.27 6.46 ± 0.42 0.047 ± 0.010 
166 3.08 ± 0.21 8.54 ± 0.60 0.141 ± 0.010 
167 2.77 ± 0.18 6.99 ± 0.97 0.122 ± 0.010 
171 1.35 ± 0.78 25.78 ± 5.03 1.197 ± 0.175 
172   0.936 ± 0.251 
173 1.80 ± 0.83  1.087 ± 0.202 
174 1.19 ± 0.14 43.78 ± 5.86 0.935 ± 0.144 
176  20.22 ± 3.79 0.925 ± 0.155 
177 2.24 ± 1.02  1.004 ± 0.100 
178 1.63 ± 0.54 24.47 ± 4.46 0.781 ± 0.088 
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Res. R1 (1/s)   R2 (1/s)                NOE 
 
179 1.28 ± 0.51 32.24 ± 6.39 0.915 ± 0.057 
180   1.015 ± 0.228 
181 4.06 ± 1.20 25.21 ± 6.71 1.075 ± 0.216 
182 1.41 ± 0.82 32.44 ± 6.31 0.984 ± 0.094 
183 0.86 ± 0.87 25.42 ± 4.48 0.891 ± 0.117 
184 0.81 ± 0.22 22.89 ± 3.99 0.614 ± 0.057 
186 0.93 ± 0.79 27.11 ± 4.12 1.251 ± 0.185 
187 1.56 ± 0.46  0.878 ± 0.087 
188 1.14 ± 0.56 19.71 ± 2.96 0.761 ± 0.116 
190 1.28 ± 0.51 32.24 ± 6.39 0.915 ± 0.057 
191 0.98 ± 0.56 33.79 ± 5.29 0.764 ± 0.086 
192   0.653 ± 0.163 
193 1.48 ± 0.32 31.38 ± 3.07 0.843 ± 0.087 
194 2.62 ± 0.70  0.948 ± 0.168 
195 1.73 ± 0.40 29.23 ± 4.82 0.801 ± 0.074 
196 1.55 ± 0.99 38.90 ± 5.65 0.768 ± 0.095 
197 2.67 ± 0.35 30.78 ± 4.80 1.014 ± 0.105 
198 0.98 ± 0.23 29.77 ± 4.05 0.892 ± 0.079 
199 1.60 ± 0.77 28.49 ± 4.78 0.952 ± 0.127 
200 1.31 ± 0.49 31.17 ± 2.69 0.645 ± 0.056 
201 1.30 ± 0.47 30.83 ± 6.52 1.094 ± 0.205 
202 1.57 ± 0.14 18.35 ± 5.72 0.675 ± 0.021 
204 2.90 ± 0.30 24.93 ± 3.53 0.974 ± 0.139 
205 1.74 ± 0.30 25.50 ± 7.71 0.825 ± 0.108 
208 0.90 ± 0.43 40.53 ± 6.16 0.734 ± 0.084 
209 2.84 ± 0.62  0.827 ± 0.182 
210 2.61 ± 0.16  0.768 ± 0.150 
211 2.53 ± 0.67  0.849 ± 0.095 
212 3.90 ± 0.83 40.51 ± 6.02 1.000 ± 0.136 
214 1.12 ± 0.69  0.521 ± 0.155 
217 2.27 ± 0.92 29.88 ± 2.57 1.494 ± 0.218 
218 1.45 ± 0.78 33.38 ± 4.56 0.800 ± 0.102 
219 1.08 ± 0.50 31.53 ± 6.68 0.967 ± 0.096 
220 1.31 ± 0.49 31.17 ± 2.69 0.645 ± 0.056 
221 1.58 ± 0.56 32.20 ± 3.85 0.812 ± 0.106 
222 3.12 ± 0.45  0.466 ± 0.053 
223 1.81 ± 1.28 25.20 ± 4.93 0.961 ± 0.179 
224   0.758 ± 0.162 
225 4.98 ± 0.53  0.819 ± 0.160 
226 2.16 ± 0.67 37.63 ± 5.54 0.672 ± 0.070 
227 2.04 ± 0.80  0.642 ± 0.110 
228  21.65 ± 3.95 1.051 ± 0.159 
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Res. R1 (1/s)   R2 (1/s)                NOE 
 
229 2.99 ± 0.47 51.03 ± 10.17 0.706 ± 0.087 
230 2.87 ± 0.38 47.02 ± 3.32 0.877 ± 0.105 
231 1.35 ± 0.78 30.56 ± 3.67 1.197 ± 0.175 
232 2.86 ± 0.53 26.22 ± 8.18 0.573 ± 0.072 
233 2.80 ± 0.50  0.541 ± 0.074 
234 2.76 ± 0.44 41.05 ± 5.12 0.448 ± 0.069 
235 1.72 ± 0.60 31.87 ± 4.05 0.750 ± 0.081 
236 1.55 ± 0.84 36.55 ± 4.89 0.674 ± 0.067 
237 1.31 ± 0.27 27.89 ± 4.11 0.504 ± 0.048 
238 1.67 ± 0.65 26.74 ± 5.06 0.709 ± 0.076 
239 2.31 ± 0.81 27.35 ± 2.49 0.698 ± 0.086 
240 1.76 ± 0.46 39.32 ± 5.17 0.927 ± 0.114 
241 1.90 ± 0.13 32.00 ± 2.46 0.773 ± 0.092 
242 1.78 ± 0.93 26.25 ± 2.78 0.900 ± 0.154 
243 2.72 ± 0.30 31.61 ± 1.55 0.681 ± 0.085 
244 2.02 ± 1.38 22.85 ± 1.85 0.844 ± 0.199 
245 1.39 ± 0.74 42.52 ± 4.09 0.779 ± 0.093 
246 1.24 ± 0.80 39.22 ± 0.80 0.561 ± 0.085 
247 2.19 ± 0.53 31.74 ± 2.52 0.543 ± 0.139 
248  36.57 ± 2.36 0.988 ± 0.220 
249 3.01 ± 1.02 26.35 ± 3.62 0.795 ± 0.108 
250 1.30 ± 0.33 36.86 ± 3.69 0.967 ± 0.149 
251 1.99 ± 0.91 26.89 ± 4.87 0.875 ± 0.145 
252 2.10 ± 0.62 35.99 ± 3.06 1.280 ± 0.253 
254 3.55 ± 1.43 42.87 ± 4.19 0.738 ± 0.131 
255 1.89 ± 0.13  0.795 ± 0.041 
256 1.72 ± 0.54 38.22 ± 3.25 0.598 ± 0.070 
257 1.26 ± 0.33 33.51 ± 3.81 0.630 ± 0.083 
258 1.17 ± 0.46 37.31 ± 4.69 0.720 ± 0.063 
259 1.90 ± 0.22 24.19 ± 3.24 0.702 ± 0.040 
260 2.78 ± 0.32 10.52 ± 0.95 0.271 ± 0.019 
261 3.35 ± 0.43 12.73 ± 1.35 0.293 ± 0.013 
262 2.68 ± 0.11 7.88 ± 0.73 0.207 ± 0.008 
263 2.91 ± 0.17 5.53 ± 0.56 -0.157 ± 0.005 
264 2.55 ± 0.13 7.04 ± 0.42 0.178 ± 0.006 
266 1.35 ± 0.26 6.12 ± 0.26 -0.434 ± 0.062 
267 1.59 ± 0.08 3.19 ± 0.24 -0.318 ± 0.037 
270 1.61 ± 0.06 2.64 ± 0.16 -0.731 ± 0.010 
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4 CONCLUSIONS AND FUTURE DIRECTIONS 
The ETS family of transcription factors has a so-called ETS domain on which site-
specific DNA is bound. The ETS domains are structurally homologous but their primary 
sequences are divergent; for example, two ETS family members PU.1 and Ets-1 share only 30% 
sequence homology. PU.1 is an essential transcription factor and its main biological role is the 
development of hematopoietic stem cells (HSCs) in the immune system (15). PU.1 is a central 
transcriptional regulator of differentiation of HSCs into lymphocytes and myelocytes, B and T 
cell development, and maintenance of HSCs (16). This function spans from early to late stages of 
progression in a lineage- and cell type-specific manner; thus, it controls proliferation, terminal 
differentiation, and maintenance of HSCs (17). Therefore, PU.1 is a key transcriptional regulator 
within the hematopoietic system and plays critical roles in both the innate and adaptive immune 
systems by controlling cell differentiation. 
The biological activity of PU.1 is primarily controlled by up- and down-regulation of its 
expression. However, because the metabolic half-life of PU.1 spans the entire cell cycle (~50 h) 
(103), downregulation of its expression alone is probably not sufficient for PU.1 regulation. 
Therefore, PU.1 activity during its lifetime in the cell needs to be regulated as well. Only a few 
inhibitory mechanisms are known for PU.1 other than down-regulated expression. The most 
understood one involves the nature of PU.1 itself forming a heterodimer with other protein 
partners, such as GATA-1 (29). 
Autoinhibition is a regulatory mechanism of protein activity, whereby inhibitory module 
or domain of a protein interacts with another part of the protein so that it works for negative 
regulation (30). Protein expression is known to be regulated via autoinhibition. For example, 
autoinhibitory modules are removed by alternative splicing or proteolysis. Post-translational 
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modifications (PTM) or protein-protein interactions (PPI) in response to cellular signaling can 
relieve or reinforce autoinhibition and enable the protein to control downstream events (31). For 
ETS transcription factors, autoinhibition has been described as a key regulatory mechanism at 
the protein/DNA level (30). Autoinhibition in ETS family has a common mechanism in which 
autoinhibitory elements, typically helices (α- or 310-helix), adjacent to the ETS domain, make 
DNA binding unfavorable. Most of the 28 paralogs of ETS family in humans have been found to 
possess autoinhibition, while PU.1 is one of a few members that are not autoinhibited (31). 
In addition to transcriptionally active 1:1 protein/DNA complex, homodimerization of 
many ETS family members, including Ets-1, Elk-1, ETV1, ETV6, FEV, ERG, and PU.1, has 
been reported (66-70). Interestingly, all these ETS domain homodimers are 2:2 protein/DNA 
complex except for a 2:1 protein/DNA complex of Ets-1 in a non-reducing environment, where 
two Cys residues from each subunit are likely to form a disulfide bond (71). For example, 
positively co-operative binding of Ets-1 at 2:2 protein/DNA stoichiometry is observed at 
repeated (palindromic) specific DNA sites such as stromelysin-1 promoter (72). Such a 
positively cooperative DNA binding of Ets-1 is known to counteract to its autoinhibition (73). 
Three homodimeric structures of Ets-1 have been determined by crystallization (PDB: 2NNY, 
3MFK, and 3RI4) so far (72,74,75). In the case of Elk-1, homodimerization mediated by its ETS 
domain gives Elk-1 cytoplasmic stability to resist proteasomal degradation as well as localization 
to the nucleus (68). PU.1 in the nucleus forms DNA-free homodimer(s) but is monomeric upon 
specific DNA binding (68). Thus, PU.1 homodimerization mediated by the ETS domain is 
biologically relevant. This also raises a new question of whether PU.1 can dimerize in the 
presence of DNA. 
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Before the present study was undertaken, our group had observed the potential for the 
ETS domain of PU.1 to dimerize at a single specific site by ITC titration experiments (76). We 
observed two distinct DNA binding modes (1:1 and 2:1 protein:DNA ratio) for PU.1 protein. 
Also, the negative to positive transition in the reverse titration (namely, adding DNA to PU.1) of 
ITC implied that a 2:1 (PU.1:DNA) complex is formed in a negatively cooperative manner. The 
free energy of each of the four states of PU.1 (i.e. monomeric and dimeric PU.1 in the absence or 
presence of site-specific DNA) under standard state conditions revealed that the free energy (G°) 
gradient of the PU.1 ETS domain is described as unbound monomer > PU.1 dimer in the absence 
of DNA > 2:1 DNA-bound complex > 1:1 DNA-bound complex.  
In the present study (cf. Chapter 2 of this dissertation), we established a DNA-binding 
model of PU.1 using diffusion-ordered NMR spectroscopy (DOSY). Namely, the ETS domain of 
PU.1 dimerizes at a single cognate site in a negatively cooperative manner, unlike its auto-
inhibited family member Ets-1. We also detected a potential interface of DNA-bound PU.1 
dimer by using heteronuclear single quantum correlation (HSQC) NMR. We detected four 
consecutive charged residues (namely, 193DKDK196 in hPU.1) on the loop between β-sheets S1 
and S2 at the potential interface of DNA-bound dimer of PU.1, by overlaying the HSQC spectra. 
To assess the effect of electrostatic interactions on PU.1 dimerization in complex with DNA, we 
generated 193NINI196 mutant designed to remove the charges but maintain similar side-chain 
structures. This mutation abolished site-specific 2:1 PU.1/DNA binding. Furthermore, the DNA 
contact interface of the 2:1 PU.1/DNA complex made extended contacts with the DNA 
compared to the 1:1 complex. Taken together, the 2:1 PU.1/DNA complex is presumably a 
transcriptionally inactive form, and its formation is potentially a self-regulatory mechanism of 
PU.1 at the protein-DNA level, instead of auto-inhibition for other ETS proteins. 
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Expression levels of PU.1 in the cells are as high as those of housekeeping genes (133). 
Moreover, the estimated half-life of PU.1 in the cells is long enough as the lifespan (~50 hours) 
of the cells (cf. Chapter 2). Therefore, we proposed that excess PU.1 proteins are sequestered to 
form DNA-bound PU.1 dimers, as potentially a negative feedback mechanism for PU.1 activity 
(cf. Chapter 2). Our recent study demonstrated it using mammalian cells (138). We established a 
reporter gene system in HEK293 cells to measure PU.1 transactivation levels using tandem 
copies of specific ETS binding site (EBS) spaced by 20 bp. Since PU.1 is not expressed in 
HEK293 cells, the reporter is not activated unless we induce a plasmid encoding full-length PU.1 
that yields EGFP fluorescence. The fluorescence signals of PU.1 transactivation levels showed a 
bell-shaped response to the dose of the PU.1 plasmid. This suggests that excess PU.1 was used 
for negative feedback in the cells. Therefore, this study demonstrated that the formation of a 2:1 
PU.1/DNA complex using excess PU.1 is a self-regulatory mechanism. 
Our recent study also revealed the roles of IDRs on DNA-free PU.1 homodimerization, 
which was previously observed in vivo by Evans et al. (68,138). We found the PU.1 dimers in 
the absence and presence of DNA antagonize to each other, and the IDRs flanking the ETS 
domain (i.e., N-terminal PEST domain and C-terminal 12 residues) play key roles for this 
phenomenon (138). We also found that the presence of IDR modifies DNA recognition by the 
ETS domain of PU.1. The N-terminal PEST domain, which is intrinsically disordered, increases 
the affinity of 1:1 DNA complex but reduces that of 2:1 PU.1/DNA complex (138). On the other 
hand, the absence of C-terminal IDR does not affect DNA recognition of the ETS domain, but 
PU.1 is unable to form the DNA-free dimer without it (138). 
In the present study (cf. Chapter 3 of this dissertation), we tracked translational diffusion 
constants in a titration with 23- and 16-bp site-specific DNA by DOSY NMR in the same way as 
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described in Chapter 2. The result indicated that the PU.1 ETS domain retains its ability to form 
a DNA-bound homodimer in a negatively cooperative manner, even in the presence of the N-
terminal IDR (the PEST domain) flanking the ETS domain (namely, hPU.1ΔN117) (cf. Fig. 3.1 
A). This result is consistent with our observation for the PU.1 ETS domain in the absence of the 
PEST domain (namely, mPU.1ΔN167) with 16-bp specific DNA (cf. Fig. S 2.3). We also 
observed 23-bp specific DNA is long enough, but 16-bp is not, for ΔN117 to form the 1:1 and 
2:1 complexes in direct response to the PU.1/DNA molar ratios, presumably because the three 
positively charged residues (K245-247) in the “wing” are structurally perturbed due to charge-
charge repulsion with phosphate groups of DNA if the DNA is short (cf. Fig. 3.1 C). 
We also tested whether or not the PEST domain changes the internal dynamics of the 
ETS domain using NMR to study how the PEST domain modifies DNA recognition of PU.1. We 
successfully assigned ~90% or more HSQC resonances of hPU.1sΔN165, ΔN165, and ΔN117, 
both in the absence and presence (i.e., 1:1 binding) of cognate DNA. The backbone assignments 
provided us with opportunities to perform measurements of 15N relaxation parameters (namely, 
spin-lattice (R1) and spin-spin (R2) relaxation rate and the steady-state heteronuclear 1H{15N}-
NOE) for both DNA-free and 1:1 DNA-bound PU.1 proteins. The chemical shifts of the assigned 
HSQC resonances and the spin relaxation measurements suggest that the PEST domain remains 
disordered but becomes more dynamic upon 1:1 specific DNA binding of PU.1. The chemical 
shifts of the assigned HSQC resonances also suggest that the PEST domain does not structurally 
perturb the ETS domain upon specific DNA binding. Using the 15N relaxation parameters, we 
observed the presence of the PEST domain does not change the internal dynamics of the ETS 
domain upon 1:1 specific DNA binding. Taken together, we propose a role of the disordered 
PEST domain on 1:1 specific DNA binding of the PU.1 ETS domain. In the presence of DNA, 
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the highly cationic ETS domain bound with the basic PEST domain probably releases it and 
binds with DNA instead. The released PEST domain upon DNA binding of the ETS domain 
becomes more dynamic than in the DNA-free form. As a result, the presence of the PEST 
domain increases affinity in the 1:1 PU.1/DNA complex because the “free” PEST domain 
presumably enhances the ETS:DNA interaction. 
I propose future directions and studies as described below, on the basis of PU.1 studies 
done in this dissertation. It is reasonable to assume that the interfaces in PPIs have been evolved 
to optimize their functional requirement (44). In particular, weak and nonspecific interactions at 
the interfaces have been adjusted properly to survive against selective pressure. In the ETS 
family, autoinhibition has been lost through evolution: namely, PU.1 is evolutionary the newest 
and not autoinhibited. Therefore, it would be interesting to study the relationship between 
quaternary structures (or properties in dimeric interfaces) and the efficiency of self-regulation 
(i.e., inhibition) through dimerization in vivo in the ETS family. If the optimization of the 
physics of association at the dimeric interface has evolved by selective pressure (namely, in 
inverse proportion to autoinhibition), self-regulation of the protein through dimerization has 
probably been achieved most effectively in PU.1 among the ETS family members. 
We will be able to do NMR experiments further to characterize the DNA-free PU.1 
dimer. In particular, relaxation dispersion NMR to detect motions in the intermediate (i.e., 
microsecond to millisecond) time scale will be very useful. A conformational exchange rate 
constant Rex obtained by this experiment explains the chemical exchange processes that 
contribute to the decay in the transverse magnetization (R2). Large Rex values generally are 
derived from line broadening due to chemical (conformational) exchange processes between two 
states typically in the microsecond to millisecond time scale. Interpretation of the Rex constant is 
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somewhat complicated because this parameter includes exchange rate, chemical shift difference, 
and fractional populations at the exchange sites. Nevertheless, large Rex values suggest that 
dynamic exchange occurs at the corresponding residues in the microsecond to millisecond time 
scale. As discussed above, we have detected the PU.1 residues that reflect structural perturbation 
between two states (DNA-free monomer and dimer) using chemical shift perturbations (CSPs) 
(138). Also, as discussed in Chapter 3, we have detected the PU.1 residues that are dynamic in 
the fast (i.e., picosecond to nanosecond) time scale, using heteronuclear NOE in the absence of 
DNA: These PU.1 residues are presumably responsible for DNA-free dimer formation. 
Therefore, once Rex values are obtained for a DNA-free PU.1 dimer sample, it helps us further 
characterize the dynamic properties of PU.1 and detect the residues that are responsible for the 
dimerization. 
To further characterize the interface of the DNA-bound dimer of PU.1, we will be able to 
test 193AAAA196 and 193NANA196 mutant to study the effects of hydrophobicity in the 
corresponding region on the PPI in the 2:1 DNA-bound dimer. Even though the 193NINI196 
mutant was designed to abrogate charges but maintain similar side-chain structures and 
secondary structure propensities to WT protein, the 193NINI196 surface is much more 
hydrophobic than that of WT since Ile is one of the most hydrophobic amino acids. Therefore, by 
using the above mutants, we can estimate the contribution from the hydrophobicity of the side 
chain (or hydrophobic interactions introduced by the Ile side chain) to affect the 2:1 binding. If 
the 193NANA196 mutant does not abolish the 2:1 binding but the 193AAAA196 mutant does, then 
we could estimate the effect of hydrophilicity of the Asp residues in this region for the 2:1 
complex formation. We could subsequently test if hydrophilicity is more important than 
electrostatic interactions for this protein-protein interaction. 
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If we can detect other component(s) of the dimeric interface in the 2:1 PU.1/DNA 
complex besides the 193DKDK196 site, then such a component would be very useful to 
characterize the DNA-bound PU.1 dimer. One of the ideas to test this is to generate “193NINI196 + 
R230A/R233A” mutant and to conduct the same DNA binding experiment like the one using the 
R230A/R233A mutant (138), as described above. Thus, we are probably able to designate the 
binding order: WT PU.1 always binds to DNA and the mutant binds to the 1:1 PU.1/DNA 
complex. If the mutant forms a 2:1 complex without forming a 1:1 complex, then it provides us 
with proof that the presence of the other dimeric interface. Furthermore, capturing the 2:1 
complex in an HSQC spectrum would also be very useful to characterize the DNA-bound PU.1 
dimer. We will be able to reach this goal by making the 1:1 PU.1/DNA complex first using 
unlabeled PU.1 and subsequently by adding the equivalent amount of 15N-labeled R230A/R233A 
mutant. Under the conditions, each monomeric components of the DNA-bound PU.1 dimer are 
not probably interchangeable because the mutant PU.1 cannot bind DNA. Therefore, the 
crosspeaks of the 2:1 complex will be visible, and therefore we should be able to see the 
crosspeaks of the 2:1 complex. If this experiment works, then we could plan to label WT PU.1 
by 15N and do the same experiment. Then, we will be able to do spin relaxation measurements. If 
we successfully obtain Rex rates for PU.1 residues, we can detect the residues responsible for 
dimerization. 
Moreover, we could try to determine the crystal structure of the 2:1 PU.1/DNA complex. 
We will need to use the PU.1 protein without IDRs (s∆N165) for the study because the presence 
of intrinsically disordered regions makes protein crystallization difficult and also does not 
facilitate the DNA-bound dimer formation. Our data show that the two monomers of PU.1 in this 
complex are interconvertible (cf. Fig. 2.3 B). Namely, PU.1 in the 2:1 complex is highly 
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dynamic, and crystallization may be difficult. If the 2:1 complex using WT PU.1 is not 
crystallized by any means, then the R230A/R233A mutant can be analyzed by NMR. If we mix 
WT PU.1, R230A/R233A mutant, and specific DNA at 1:1:1 molar ratio, then we will obtain a 
2:1 PU.1/DNA complex. It is reasonable to assume that well-dispersed HSQC crosspeaks of 
PU.1 in the 2:1 complex will be obtained because the interconversion of the two PU.1 monomers 
is disturbed in this experiment, as discussed above. 
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APPENDICES  
Appendix A: Introduction 
PU.1 expression levels in the cells are as high as those of housekeeping genes (133), and 
the estimated PU.1 half-life in the cells is as long as the lifespan of the cells (~50 hours) (cf. 
Chapter 2). Thus, excess DNA-free PU.1 should be sequestered by forming a presumably 
inactive 2:1 PU.1/DNA complex, as a negative feedback mechanism for PU.1. Our mammalian 
cell study recently provided us with proof that excess PU.1 was used for negative feedback in the 
cells (138). Therefore, our recent study demonstrated that the formation of 2:1 PU.1/DNA 
complex with excess PU.1 is by a negative feedback mechanism for PU.1. 
As we directly demonstrated using the diffusion coefficients of PU.1 by titration with 
site-specific DNA (> 10-bp), the DNA-bound PU.1 dimer is not a 2:2 complex (Fig. S 2.3). The 
2:2 ETS/DNA complex is often seen in the ETS family (66-70). This finding also suggests that 
the DNA-bound dimer of PU.1 ETS domain is not formed by simple electrostatic interactions 
between two PU.1 molecules using the charges of 193DKDK196 side-chains. If the 193DKDK196 
sites of two PU.1 molecules interact to form a DNA-bound dimer, a 2:2 complex should 
eventually be formed because the DNA-binding surface (namely, the surface opposite to the 
193DKDK196 site) is available for both monomers of PU.1. Thus, the DNA-bound dimer of PU.1 
ETS domain is asymmetric (i.e., not a “head-to-head” binding), and the dimeric interface 
consists of the 193DKDK196 site and another site of the ETS domain. A mutant study in our recent 
report confirmed the asymmetric configuration of the DNA-bound PU.1 dimer (138). We 
mutated two Arg residues to Ala (R230A/R233A) in the DNA-recognition helix H3 and 
confirmed this mutant alone does not bind to site-specific DNA. In the presence of a negligible 
concentration of WT PU.1, this mutant PU.1 only formed a 2:1 PU.1/DNA complex upon 
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specific DNA binding, at similar binding affinity to WT protein. In this assay, the sub-saturating 
concentration of WT PU.1 was used to form a 1:1 WT PU.1/DNA complex, where the mutant 
PU.1 protein was added to form a heterodimeric PU.1 dimer in complex with DNA. 
Moreover, nonspecific DNA binding by PU.1 ETS domain is quite different from specific 
binding (cf. supplemental Fig. S2.3 C). In a DOSY titration of PU.1 with 16-bp nonspecific 
DNA, only an inflection point was observed at a DNA/PU.1 ratio of ~0.5, and it had a stable 
diffusion coefficient at a higher molar ratio. Thus, nonspecific DNA binding of PU.1 yields only 
a DNA-bound dimer, which is distinct from the DNA-bound dimer with specific DNA, judging 
from the diffusion coefficients. In the present study, we further characterized the nonspecific 
DNA binding of PU.1. The results provide us with a comparison of PU.1 with Ets-1. 
Appendix B: Materials and methods 
Proteins. DNA fragments of mutant PU.1 ETS domain (i.e., mPU.1∆N167) were 
obtained by PCR amplification and subcloned directly into the NcoI/HindIII sites of pET28b 
vector. All the constructs were verified by Sanger sequencing (Macrogen). The protein samples 
(namely, wildtype hPU.1∆N165, mutant mPU.1∆N167, and Ets-1∆N280) were expressed and 
purified in the same way as described in Chapters 2 and 3. 
Nucleic acids. 16-bp nonspecific DNA (5’-GCAAGCGAGAGTGAGC- 3’) was 
purchased from Integrated DNA Technologies as synthetic DNA oligos and annealed as 
described in Chapter 2. Fluorescent DNA probes were constructed by annealing a Cy3-labeled 
oligo with excess unlabeled complementary strand, as described in Chapter 2. 
NMR spectroscopy. Uniformly 15N-labeled mPU.1∆N167 (0.75 mM) or Ets-1∆N280 
(~0.3 mM) was dialyzed with 16-bp nonspecific DNA (~2 mM) in separate dialysis tubings 
against 22 mM MES, pH 6.5, 55 mM NaCl, 0.5 mM EDTA, 0.02% NaN3, and 5 mM DTT, and 
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D2O was added at a final concentration of 10%. Note that the DNA was titrated into protein to 
achieve the desired DNA/protein ratios. 1H-15N correlated measurements were made using a 
phase-sensitive, double inept transfer with a GARP decoupling sequence, and solvent 
suppression (hsqcf3gpph19). Spectra were acquired with 1024 × 144 data points and zero-filled 
to 4096 × 4096. 
Fluorescence polarization titrations. DNA binding experiments by fluorescence 
anisotropy measurements of a Cy3-labeled DNA probe were performed as described 
(111,113,151). Briefly, graded concentrations of WT hPU.1ΔN165 or mutants were incubated to 
equilibrium with a Cy3-labeled 23-bp DNA duplex oligo harboring the high-affinity PU.1 target 
site 5’-AGCGGAAGTG-3’. The binding assay samples were made in 10 mM Tris-HCl (pH 7.4) 
buffer with 0.15 M total [Na+], and 0.1 mg/mL BSA. 
Circular dichroism spectroscopy. Purified PU.1 proteins at graded concentrations were 
scanned for far-UV (200 to 250 nm) spectra in 10 mM NaH2PO4/Na2HPO4 (pH 7.4), 50 mM 
total [Na+] at 25°C using a Jasco J-810 instrument. 
Appendix C: Results and discussion 
Appendix C.1: Asymmetric configuration of the PU.1 dimer in the presence of DNA 
In Chapter 2, we observed ~80% of the HSQC crosspeaks of the DNA-bound PU.1 dimer 
disappeared (cf. Fig. 2.3 B). We presumed that it was due to the conformational exchange of 
PU.1, but not due to disorder. To confirm it, we assigned the 1H-15N resonances of PU.1 ETS 
domain in complex with nonspecific DNA because most (>90%) of the crosspeaks also 
disappeared in a titration of mPU.1∆N167 protein with 16-bp nonspecific DNA at protein:DNA 
molar ratio of 1:0.5 and more (Appendix Fig. 1 A). By overlaying the HSQC spectrum at 1:0.5 
molar ratio with that of fully-assigned unbound PU.1 resonances shown in Chapter 3 (cf. Fig. 
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3.3), we were able to assign the remaining resonances. The assigned peaks were only in the N- 
(before K171) and C-terminal (after G262) loops (Appendix Fig. 1 B-C). Thus, all the PU.1 ETS 
domain residues in the structured region disappeared upon nonspecific DNA binding, while the 
residues in the intrinsically disordered regions did not. This indicates that the HSQC peak 
disappearance of PU.1 upon DNA binding is due to conformational exchange, but not disorder of 
the protein. This confirmed our idea that chemical exchange is the reason for the HSQC 
crosspeak disappearance in the 2:1 complex of PU.1 with site-specific DNA (cf. Fig. 2.3 B). 
To further characterize the DNA-bound dimer that was studied in Chapter2, secondary 
structures of PU.1 in the DNA-bound dimer were examined using CD spectroscopy. Negligible 
changes in the secondary structure content were observed in the titration of PU.1 ETS domain 
with cognate DNA (Appendix Fig. 2). DNA-free (PDB: 5W3G) and 1:1 DNA-bound (PDB: 
1PUE) PU.1 structures are similar, as seen by solved structures (cf. Fig. 1.5). Thus, the CD data 
above indicate that the DNA-bound PU.1 dimer consists of a DNA-free and a 1:1 DNA-bound 
monomer. Namely, the structures of the PU.1 subunits (i.e., PU.1 monomers) in the DNA-bound 
dimer are probably similar to each of the solved structures (i.e., PDB: 5W3G and 1PUE). 
Furthermore, each subunit of the DNA-bound PU.1 dimer presumably interconverts with each 
other. Therefore, this data provided us with proof that the disappeared HSQC crosspeaks of the 
DNA-bound dimer (cf. Fig. 2.3 B) are due to conformational exchange between the two states of 
PU.1. 
In sharp contrast, the CD spectra of the DNA-free PU.1 dimer exhibits completely 
different secondary structures content due to a great contribution by random coils, compared to 
the DNA-bound dimer (138). The DNA-bound PU.1 dimer is therefore conformationally distinct 
from the DNA-free dimer. Our group also found that the DNA-bound dimer is asymmetric, as 
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described above (138). Thus, we tested whether the DNA-free dimer is symmetric or not. We 
generated a mutant that is suitable to discuss this, namely the 193DKCDK197’ mutant. This mutant 
is obligated to form a dimer of head-to-head ETS domains using the crosslink between the 
inserted Cys residues in non-reducing conditions. The CD spectrum of the 193DKCDK197’ dimer 
(Appendix Fig. 3 A) is utterly different from that of WT PU.1 monomer, whereas it is similar to 
that of DNA-free PU.1 dimer (WT ΔN165 at ~800 μM at 50 mM salt concentration) which we 
reported recently (138). Therefore, the DNA-free dimer of PU.1 is suggested to be symmetric, in 
contrast with the DNA-bound dimer. The 193DKCDK197’ PU.1 dimer binds to cognate DNA 
>100-fold weakly than WT (Appendix Fig. 3 B), which further suggests that the DNA-free and -
bound PU.1 dimers are conformationally distinct. 
Appendix C.2: Electrostatic components responsible for DNA-bound PU.1 
dimerization 
The 193NINI196 (in hPU.1) mutant study indicated that electrostatic interactions via the 
side-chain charges of 193DKDK196 are important for PU.1 to form the 2:1 complex, as described 
in Chapter 2 (cf. Fig. 2.5 H). Therefore, we introduced more mutations at this site to further study 
which electrostatic components are responsible for DNA-bound PU.1 dimer formation. We used 
three mutants 193AKAK196, 193DADA196, and 193TGDG196. The first two mutants were designed 
to remove either all the positive or negative charges. The third mutant was designed from the 
same site (357TGDG360) of Ets-1, which is a close structural homolog of PU.1 but does not form a 
2:1 complex with DNA in non-reducing conditions. DNA binding assays of fluorescence 
anisotropy using these mutants showed none of these mutants abolished the 2:1 DNA binding 
(Appendix Fig. 4 A (a)-(d) and Appendix Table 1). 193DADA196 mutation did not change in 
binding affinity of the 1:1 and 2:1 complex. In sharp contrast, 193AKAK196 and 193TGDG196 
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mutations made the binding affinities of both 1:1 and 2:1 complex lower than that of WT. 
Namely, for 193AKAK196 mutation, KD1 was ~3-fold and KD2 was ~8-fold lower. For 193TGDG196 
mutation, KD1 was ~4-fold and KD2 was ~12-fold lower. Furthermore, 193NINI196 mutation (i.e., 
abrogating all the charges from the 193DKDK196 site) abolished the 2:1 binding (cf. Fig. 2.5 H). 
Taken together, PU.1 forms the 2:1 complex with a similar dissociation constant to WT even if 
the cationic charge is completely lost from the 193DKDK196 site. In contrast, losing at least one 
Asp residue from the 193DKDK196 site compromises the 2:1 binding. Thus, anionic charge in the 
193DKDK196 site is important for the 2:1 complex formation. The CD signals of the mutants 
suggest that 193DADA196 and 193AKAK196 mutation do not change the structure of PU.1, but 
193TGDG196 mutation causes a significant change in the structure (Appendix Fig. 4 B). Thus, 
193TGDG196 mutation not only abrogates three of four charged residues but also it changes PU.1 
structure significantly. This may be the reason why removing one Asp residue by the 
193TGDG196 mutation compromises the 2:1 binding more than removing two Asp residues by the 
193AKAK196 mutation. 
As a potential major driving force for the PU.1 self-association other than electrostatic 
interactions, the hydrophilicity of the 193DKDK196 surface may be important for the association 
of two PU.1 molecules if water-mediated contact drives the association at the interface of PPI. In 
general, hydration greatly contributes to protein packing and association in general, thus water 
molecules play important roles in PPIs (152). The reliability of information about solvent 
molecules depends on the resolution in crystallographic structures. There are on average 1.0 
interfacial water molecules per 100 Å2, discovered from an analysis of a dataset of homo- protein 
complexes (<2.6 Å resolution) (153). The majority of these water molecules make hydrogen 
bonds with both partners of the association (154). It has been proposed that PPIs involve similar 
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levels of water-mediated contacts to direct contacts (154). Some interfacial water molecules are 
conserved among structurally homologous protein complexes, according to high-resolution 
crystal structures (152). Some amino acids of one protein at a PPI interface make both direct and 
water-mediated contacts with the other protein partner. Water-mediated contacts have been 
demonstrated to contribute to the energy of interaction (155). Thus, interfacial water molecules 
could facilitate interactions and recognition between protein partners in PPIs. 
Appendix C.3: Nonspecific DNA binding of Ets-1 primarily perturbs the autoinhibitory 
module and H3 
In striking contrast to the titration of PU.1 with nonspecific DNA as described above (cf. 
Appendix fig. 1 A), the 1H-15N HSQC crosspeaks of Ets-1∆N280 do not disappear upon 
nonspecific DNA binding (Appendix Fig. 5 A(a)). Using the DNA-free and -bound Ets-1 
backbone assignments reported previously (33,36), we were able to assign the HSQC resonances 
of both unbound Ets-1∆N280 and its complex with 16-bp nonspecific DNA (at 1:1 Ets-1/DNA 
molar ratio) (Appendix Fig. 5 A(b)). Then, 1H-15N CSPs were calculated from the assigned 
HSQC resonances (Appendix Fig. 5 B). The CSPs as a whole are small, suggesting that 
nonspecific DNA binding marginally changes the structure of Ets-1, consistent with the literature 
(33). The residues that have large CSPs were mainly in HI-2, H3, H4, and H5. This indicates that 
nonspecific DNA binding of Ets-1 primarily perturbs the autoinhibitory module and H3, which is 
also consistent with the literature (33). 
Our study of Ets-1 binding with nonspecific DNA confirmed the trend seen in the Ets-1 
complex with nonspecific DNA, reported by Desjardins et al. (33). They previously reported that 
HI-1 and HI-2 of Ets-1 become predominantly unfolded, yet the protein is still ordered upon 
DNA binding, regardless of specific or nonspecific binding (33). Their NMR studies 
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demonstrated that nonspecific DNA binding of Ets-1 also contrasts with specific DNA binding, 
in that the structural and dynamic changes for Ets-1 are much larger with specific DNA than with 
nonspecific DNA (33). Their amide chemical shift perturbation mapping showed that dynamic 
electrostatic interactions drive association of Ets-1 with both specific and nonspecific DNA, 
through the same canonical interface of the ETS domain, whereas the formation of well-ordered 
complexes is driven by hydrogen bonding, with specific DNA (33). 
For transcription factors in general, DNA-binding domains are dynamic to search for 
specific binding sites in a majority of nonspecific DNA until the DNA-scanning is quenched 
upon specific DNA binding (47,48). DNA-binding interface in the ETS domains of Ets-1 and 
ETV6 has also been demonstrated to be conformationally dynamic (33,37), and this feature is 
probably common for all the ETS domains. Such flexibility in the DNA-binding interface also 
explains why Ets-1 protein shares the same binding interface for specific and nonspecific DNA 
binding (33). However, the autoinhibitory module adjacent to the ETS domain is likely to 
compromise the flexibility in the ETS domain (or the DNA-binding interface), suggesting that 
the ETS domain of PU.1 (non-autoinhibited) is more flexible than that of Ets-1 (autoinhibited). 
Because of the flexibility of the ETS domain of PU.1, HSQC resonances of the ETS domain in 
complex with nonspecific DNA disappeared, in contrast to nonspecific DNA binding of Ets-1 
(cf. Both Ets-1 (33) and PU.1 form a dimer with nonspecific DNA.) (cf. Fig. S2.3 C, Appendix 
Fig. 1 A, and Appendix Fig. 5 A(b)). 
Appendix D: Conclusion 
We observed the HSQC resonances of all the PU.1 ETS domain residues in the structured 
region (i.e., ETS domain) disappeared upon nonspecific DNA binding in a titration of PU.1 with 
nonspecific DNA, while the residues in the disordered regions did not. Thus, the HSQC peak 
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disappearance of PU.1 upon DNA binding was confirmed to be due to conformational exchange, 
but not disorder of the protein. We also studied which electrostatic components at the dimeric 
interface (193DKDK196) are responsible for DNA-bound PU.1 dimer formation. Anionic charge, 
but not cationic, in the 193DKDK196 site is important for the 2:1 complex formation. The DNA-
free PU.1 dimer (symmetric) and DNA-bound one (asymmetric) are conformationally distinct. 
Furthermore, we observed HSQC resonances of the PU.1 ETS domain in complex with 
nonspecific DNA disappeared, in contrast to nonspecific DNA binding of Ets-1, because of the 
flexibility of the ETS domain of PU.1. Even though nonspecific DNA binding of Ets-1 
marginally changes the structure of Ets-1, it primarily perturbs the autoinhibitory module and 
H3, through the same binding interface as for specific DNA binding. 
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Appendix Table 1 Dissociation constants of WT and mutants of PU.1 ETS domain from 
fluorescent anisotropy at 150 mM total [Na+]. 
 
Dissociation constants of WT and mutants of PU.1 ETS domain at 150 mM total [Na+] were 
obtained using fluorescent anisotropy. Note that the dissociation constant for the 193DKCDK197’ 
dimer was obtained by Ms. Suela Xhani. 
 
 KD1, M KD2, M 
WT (1.1 ± 0.5) × 10-8 (1.6 ± 1.0) × 10-6 
193AKAK196 mutant (3.2 ± 1.4) × 10-8 (1.2 ± 1.3) × 10-5 
193DADA196 mutant (7.9 ± 1.7) × 10-9 (1.1 ± 0.7) × 10-6 
193TGDG196 mutant (4.5 ± 1.3) × 10-8 (2.0 ± 2.5) × 10-5 
193DKCDK197’ mutant (dimer) (3.1 ± 0.9) × 10-6  
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Appendix Figure 1 Assigned HSQC resonances revealed that the ETS domain of PU.1 in 
complex with nonspecific DNA is exchange-broadened, but not disordered. 
 
A, 1H-15N HSQC titration of mPU.1ΔN167 with 16-bp nonspecific DNA. B, assigned HSQC 
resonances of PU.1 in complex with 16-bp nonspecific DNA at 1:1 PU.1/DNA molar ratio. C, 
assigned HSQC resonances were mapped on the PU.1 structure (PDB: 5W3G). The assigned 
PU.1 residues are only in the N- and C-terminal disordered regions. 
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Appendix Figure 2 Far-UV CD spectra of the DNA-bound mPU.1ΔN167 upon 
subtracting the spectrum of the DNA acquired under identical conditions. 
 
Far-UV CD spectra of the DNA-bound mPU.1ΔN167 in the unbound (black), 2:1 DNA-bound 
(blue), and 1:1 DNA-bound (red) form, upon subtracting the spectrum of the DNA acquired 
under identical conditions (75 μM, 0.15 M [Na+]). The CD-detected structure of PU.1 showed 
negligible changes upon titration by DNA. 
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Appendix Figure 3 The 193DKCDK197’ dimer of hPU.1ΔN165, mimicking the symmetric 
DNA-free dimer of PU.1 ETS domain, is conformationally distinct from the asymmetric DNA-
bound PU.1 dimer. 
 
CD spectrum of WT ΔN165 (blue) and the 193DKCDK197’ dimer (green) (~400 μM proteins at 
0.05 M [Na+]) (A). The 193DKCDK197’ dimer is not conformationally similar to DNA-bound 
PU.1 dimer but resembles the DNA-free dimer (138). Fluorescence anisotropy of cognate DNA 
binding by WT hPU.1ΔN165 (blue) and the 193DKCDK197’ mutant (green) (B). Note that the CD 
measurements and the DNA binding assay using 193DKCDK197’ were conducted by Ms. Suela 
Xhani. 
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Appendix Figure 4 Fluorescence anisotropy of cognate DNA binding by WT 
hPU.1ΔN165, 193AKAK196, 193DADA196, and 193TGDG196 mutants, and CD spectra of these PU.1 
proteins. 
 
A, DNA binding assays of fluorescence anisotropy using (a) wild-type hPU.1ΔN165 and three 
PU.1 ETS domain mutants (b) 193AKAK196, (c) 193DADA196, and (d) 193TGDG196 with a 23-bp 
cognate DNA. The 193AKAK196 and 193DADA196 mutants were designed to remove either all the 
positive or negative charges from the wild-type sequence (193DKDK196). The 193TGDG196 mutant 
was designed from the same site (357TGDG360) of Ets-1. B, Far-UV CD spectra of DNA-free 
PU.1 WT (black), 193AKAK196 (blue), 193DADA196 (red), and 193TGDG196 (magenta) at 150 μM 
and 0.15 M [Na+]. The CD-detected structures of 193AKAK196 and 193DADA196 showed 
negligible changes, but 193TGDG196 showed significant changes, in comparison with WT. 
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Appendix Figure 5 Nonspecific DNA binding of Ets-1 primarily perturbs H3 and the 
autoinhibitory module. 
 
A, 1H-15N HSQC resonances of (a) unbound and (b) 1:1 nonspecific DNA-bound Ets-1ΔN280. 
Resonances were assigned based on previous reports on Ets-1 (33,36). B, weighed average of 
amide (15N and 1H) chemical shift perturbations (CSPs) from unbound and 1:1 nonspecific 
DNA-bound Ets-1ΔN280, derived by Δδ = √{δ1H2 + 0.2 (δ15N)2}, are plotted as a function of 
residue number. 
 
